UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-K

(Mark One)

x                              ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED
JANUARY 1, 2005

or

o                                 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM                   TO                  

Commission file number: 000-18032


LATTICE SEMICONDUCTOR CORPORATION

(Exact name of Registrant as specified in its Charter)

Delaware

 

93-0835214

(State of Incorporation)

 

(I.R.S. Employer Identification Number)

5555 NE Moore Court Hillsboro, Oregon

 

97124-6421

(Address of principal executive offices)

 

(Zip Code))

 

Registrant’s telephone number, including area code: (503) 268-8000

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:

 

Title of Class

 

 

Common Stock, $.01 par value

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes x No o

As of July 3, 2004 (the last business day of the Registrant’s second quarter of fiscal 2004), the aggregate market value of the shares of voting stock (Common Stock) of the Registrant held by non-affiliates was approximately $452.5 million based on the last sales price of the Registrant’s Common Stock on the Nasdaq National Market on such date. Shares of Common Stock held by each officer and director and by each person who owns 5% or more of the outstanding Common Stock have been excluded in that such persons may be deemed affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

As of March 11, 2005, 113,611,860 shares of the Registrant’s common stock were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the definitive proxy statement of the Registrant to be filed pursuant to Regulation 14A for the 2005 Annual Meeting of Stockholders to be held on May 3, 2005 are incorporated by reference in Part III hereof.

 




 

LATTICE SEMICONDUCTOR CORPORATION
FORM 10-K
ANNUAL REPORT

TABLE OF CONTENTS

ITEM OF FORM 10-K

 

 

 

Page

PART I

 

 

 

 

Item 1.

 

- Business

 

2

Item 2.

 

- Properties

 

12

Item 3.

 

- Legal Proceedings

 

12

Item 4.

 

- Submission of Matters to a Vote of Security Holders

 

13

PART II

 

 

 

 

Item 5.

 

- Market for the Registrant’s Common Stock, Related Stockholder Matters, and Issuer Purchases of Equity Securities

 

14

Item 6.

 

- Selected Financial Data

 

15

Item 7.

 

- Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

16

Item 7(a)

 

- Quantitative and Qualitative Disclosures About Market Risk

 

35

Item 8.

 

- Financial Statements and Supplementary Data

 

36

Item 9.

 

- Changes in and Disagreements with Accountants On Accounting and Financial Disclosure

 

64

Item 9A.

 

- Controls and Procedures

 

64

Item 9B.

 

- Other Information

 

65

PART III

 

 

 

 

Item 10.

 

- Directors and Executive Officers of the Registrant

 

66

Item 11.

 

- Executive Compensation

 

66

Item 12.

 

- Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

66

Item 13.

 

- Certain Relationships and Related Transactions

 

67

Item 14.

 

- Principal Accountant Fees and Services

 

67

PART IV

 

 

 

 

Item 15.

 

- Exhibits and Financial Statement Schedules

 

68

Signatures

 

71

Financial Statement Schedule

 

S-1

 

 

1




Forward-Looking Statements

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. We use words or phrases such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “projects,” “may,” “will,” “should,” “continue,” “ongoing,” “future,” “potential” and similar words or phrases to identify forward-looking statements.

Forward-looking statements involve estimates, assumptions, risks and uncertainties that could cause actual results to differ materially from those expressed in them. Among the key factors that could cause our actual results to differ materially from the forward-looking statements are delay in product or technology development, change in economic conditions of the various markets we serve, lack of market acceptance or demand for our new products, dependencies on silicon wafer suppliers and semiconductor assemblers, the impact of competitive products and pricing, opportunities or acquisitions that we pursue, the availability and terms of financing, and the other risks that are described herein and that are otherwise described from time to time in our filings with the Securities and Exchange Commission, including but not limited to the items discussed in “Factors Affecting Future Results” set forth in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of this report. You should not unduly rely on forward-looking statements because our actual results could differ materially from those expressed in any forward-looking statement made by us. Further, any forward-looking statement applies only as of the date on which it is made. We are not required to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

Item 1. Business.

Lattice Semiconductor Corporation designs, develops and markets high performance programmable logic products and related software. Programmable logic products are widely-used semiconductor components that can be configured by end customers as specific logic circuits, and thus enable shorter design cycle times and reduced development costs. Our end customers are primarily original equipment manufacturers in the communications, computing, consumer, industrial, automotive, medical and military end markets.

Lattice was incorporated in Oregon in 1983 and reincorporated in Delaware in 1985. Our principal offices are located at 5555 N.E. Moore Court, Hillsboro, Oregon 97124, our telephone number is (503) 268-8000 and our website can be accessed at www.latticesemi.com. Information contained or referenced on our website is not incorporated by reference in and does not form a part of this Annual Report on Form 10-K.

We report based on a 52 or 53 week year ending on the Saturday closest to December 31. For ease of presentation, we have adopted the convention of using March 31, June 30, September 30 and December 31 as period end dates for all financial statement information. Our fiscal 2004 and 2002 were 52-week years. Our 2003 fiscal year was a 53-week year.

Programmable Logic Market Background

Three principal types of digital integrated circuits are used in most electronic systems: microprocessors, memory and logic. Microprocessors are used for control and computing tasks, memory is used to store programming instructions and data, and logic is employed to manage the interchange and manipulation of digital signals within a system. Logic contains interconnected groupings of simple logical “and” and logical “or” functions, commonly described as “gates.” Typically, complex combinations of individual gates are required to implement the specialized logic functions required for systems

2




applications. While system designers use a relatively small variety of standard products to meet their microprocessor and memory needs, they require a wide variety of logic products in order to achieve end product functionality and differentiation.

Logic circuits are found in a wide range of today’s digital electronic equipment including communications, computing, consumer, industrial, automotive, medical, and military systems. According to Gartner1, logic accounted for approximately 37% of the estimated $220 billion worldwide semiconductor market in 2004. The logic market encompasses general purpose logic semiconductor products, which include programmable logic devices, and application-specific semiconductor devices, which includes ASICs (devices marketed to a single user) and ASSPs (devices marketed to multiple users).

Manufacturers of electronic equipment are challenged to bring differentiated products to market quickly. These competitive pressures often preclude the use of custom-designed ASICs, which generally entail significant design risks, non-recurring costs and time delays. Standard logic products, an alternative to custom-designed ASICs, limit a manufacturer’s flexibility to adequately customize an end system. Programmable logic addresses this inherent dilemma. Programmable logic is a standard semiconductor product, purchased by systems manufacturers in a “blank” state, that can be custom configured into virtually unlimited combinations of specific logic functions by programming the device with electrical signals. Programmable logic gives system designers the ability to quickly create custom logic functions to provide product differentiation without sacrificing rapid time to market.

According to Gartner1, the programmable logic market was approximately $3.1 billion in 2004. Within this market, there are two main segments, programmable logic devices (“PLDs”) and field programmable gate arrays (“FPGAs”), each representing a distinct silicon architectural approach. Our company believes that, in 2004, PLD was a $0.6 billion market while FPGA was a $2.5 billion market. Products based on the two alternative programmable logic architectures are generally optimal for different types of logic functions, although many logic functions can be implemented using either architecture. PLDs are characterized by a regular building block structure of wide-input logic cells, called macrocells, and use a centralized logic interconnect scheme. FPGAs are characterized by a narrow-input logic cell and use a distributed interconnect scheme. FPGAs may also contain dedicated blocks of fixed circuits such as memory, high-speed input/output interfaces or processors. Although PLDs and FPGAs are typically suited for use in distinct types of logic applications, we believe that a substantial portion of programmable logic customers utilize both PLD and FPGA products.

Lattice Products

We strive to offer innovative and differentiated programmable solutions based on our proprietary technology and intellectual property.


(1)          Semiconductor Forecast Worldwide—Forecast Database,” Richard Gordon, Gartner, Feb 15, 2005

3




FPGA Products

In 2002, we entered the FPGA market as a result of our acquisition of the FPGA business of Agere and the introduction of our internally developed ispXP™ product families. During 2004, approximately 19% of our revenue was derived from FPGA products, as compared to 18% in 2003 and 12% in 2002. In the future, we plan to introduce new families of innovative, high performance and higher density FPGAs. The key features of our newest FPGA families currently in production are described in the table below:

FPGA Family

 

 

 

Process
Technology (nm)

 

Operating
Voltage

 

Logic
(K LUTs)

 

Logic
(K Gates)

 

Max
RAM (kB)

 

I/O Pins

 

LatticeEC™/ECP™

 

 

130

 

 

1.2

 

1.5-32.8

 

50-1,800

 

 

666

 

 

67-496

 

ORCA® 4 FPSC

 

 

160

 

 

1.5

 

5.0-16.2

 

200-3,400

 

 

148

 

 

204-498

 

IspXP

 

 

180

 

 

3.3/2.5/1.8

 

0.5-15.4

 

25-1,250

 

 

512

 

 

141-496

 

 

The Lattice EC/ECP families, introduced in 2004, are our newest FPGA products available in volume production. These families were designed to provide customers the lowest total solution cost and support emerging requirements in high volume applications. Additionally, these families provide several unique, performance enhancing features not currently available in competitive low-cost FPGA families. These features include built-in double data rate (“DDR”) memory support, a flexible high-performance DSP block and support for industry standard, low cost, SPI-flash boot memories.

Our ORCA 4 family of field programmable system chips (“FPSCs”) combines generic FPGAs with embedded intellectual property cores on a single programmable chip, offering customers the ability to quickly implement complex system-level designs in a flexible manner. Currently, we offer eight FPSC devices, the ORT82G5, ORT42G5, ORT8850L, ORT8850H, ORLI10G, ORSO82G5, ORSO42G5 and ORSPI4, based on the ORCA 4 FPGA platform. These devices incorporate high-speed interface protocols, offering up to 3.7 Gbs SERDES, and other application-specific circuit blocks that allow customers to develop high performance designs to implement 10 Gigabit Ethernet and SONET applications within advanced communications systems.

Our ispXP families feature extended programmability (“XP™”) technology and represent our first generation of non-volatile FPGA products. XP technology provides customers with several benefits compared to traditional volatile FPGAs, based on SRAM technology, which currently make up the majority of the FPGA market. These benefits include enhanced security, instant-on logic functionality and elimination of external programming devices.

We also offer an additional product family, the ispGDX®, that targets a unique aspect of the programmable logic market. This family extends in-system programmability to the circuit board level using an innovative digital cross-point switch architecture. Offered with propagation delays as low as 3.0 nanoseconds, ispGDX products are targeted toward digital signal interconnect and interface applications.

4




PLD Products

During 2004, approximately 81% of our revenue was derived from PLD products, as compared to 82% in 2003 and 88% in 2002. At present, we offer the industry’s broadest line of PLDs based on our numerous families of ispLSI®, ispMACH™ and GAL® products. In the future, we plan to continue to introduce new families of innovative PLD products, as well as improve the performance and reduce the manufacturing cost of our existing product families based on market needs. We believe that our multiple families of leadership PLD products provide us with a competitive advantage in this market. The key features of our newest PLD families are described in the table below:

PLD Family

 

 

 

Process
Technology (nm)

 

Operating
Voltage

 

Maximum
Speed
(MHz)

 

Minimum
Prop Delay
(Nanoseconds)

 

Logic
(Macrocells)

 

I/O Pins

 

ispMACH 4000V/B/C

 

 

180

 

 

3.3/2.5/1.8

 

 

400

 

 

 

2.5

 

 

 

32-512

 

 

30-208

 

ispMACH 4000Z

 

 

180

 

 

1.8

 

 

267

 

 

 

3.5

 

 

 

32-256

 

 

32-128

 

 

In addition to high performance, the ispMACH 4000Z family features an architecture optimized to ensure ultra-low power consumption. Devices within this new family, targeted toward handheld and portable equipment, typically operate using 10-15 microamps of current while in standby mode.

We also offer the industry’s broadest line of low-density simple PLDs (“SPLD”), based on our 18 families of GAL products offered in over 200 speed, power, package and temperature range combinations. These devices range in complexity from approximately 200 to 1,000 logic gates and are typically assembled in 20-, 24-and 28-pin standard dual in-line packages and in 20-and 28-pin standard plastic leaded chip carrier packages. We offer the standard 16V8, 20V8 and 22V10 architectures in a variety of speed grades, with propagation delays as low as 3.5 nanoseconds, the highest performance in the industry.

In addition, we have recently introduced the ispPAC®-CLK and ispPAC-PWR families of programmable mixed signal devices. These devices, featuring a combination of programmable logic and programmable analog, allow system designers to quickly and easily implement a wide variety of power and clock management functions within a single integrated circuit. ispPAC products can replace numerous discrete components while providing customers with additional design flexibility and time to market benefits. We believe these devices provide an opportunity to extend our proprietary technology to an untapped potential market.

Software Development Tools

Our products are supported by the ispLEVER® 4.2 software development tool suite and PAC-Designer™ software. Supporting the PC, UNIX and LINUX platforms, ispLEVER software allows our customers to enter, verify and synthesize a design, perform logic simulation and timing analysis, assign input/output pins, designate critical paths, debug, execute automatic timing-driven place and route tasks, and download logic and input/output configurations to one of our devices. Seamlessly integrated with third-party electronic design automation environments, ispLEVER software provides a front-to-back design flow that leverages a customer’s prior investment in tools offered by Cadence, Mentor Graphics, Synopsys and Synplicity. In the future, we plan to continue to enhance and expand the capability of our software development tool suite.

Product Development

We place substantial emphasis on new product development and believe that continued investment in this area is required to maintain and improve our competitive position. Our product development activities emphasize new proprietary products, enhancement of existing products and process technologies and

5




improvement of software development tools. Product development activities occur in Hillsboro, Oregon; San Jose, California; Broomfield, Colorado; Naperville, Illinois; Bethlehem, Pennsylvania; Austin, Texas; Salt Lake City, Utah; Shanghai, China; and Chippenham, England.

Research and development expenses were $91.0 million in 2004, $87.1 million in 2003 and $85.8 million in 2002. We expect to continue to make significant future investments in research and development.

Operations

We do not manufacture our own silicon wafers. We maintain strategic relationships with large semiconductor foundries to source our finished silicon wafers. This strategy allows us to focus our internal resources on product, process and market development, and eliminates the fixed cost of owning and operating manufacturing facilities. We are also able to take advantage of the ongoing advanced process technology development efforts of semiconductor foundries. In addition, all of our assembly operations and most of our test operations are performed by outside suppliers. We perform certain test operations and reliability and quality assurance processes internally. We have achieved and maintained ISO 9001 quality certification since 1993, which is an indication of our high internal operational standards.

Wafer Fabrication

We source silicon wafers from our foundry partners, Fujitsu Limited (“Fujitsu”) in Japan, Seiko Epson in Japan, United Microelectronics Corporation (“UMC”) in Taiwan and Chartered Semiconductor Manufacturing, Ltd. (“Chartered Semiconductor”) in Singapore, pursuant to agreements with each company and their respective affiliates. We negotiate wafer volumes, prices and other terms with our foundry partners and their respective affiliates on a periodic basis.

Assembly

After wafer fabrication and initial testing, we ship wafers to independent subcontractors for assembly. During assembly, wafers are separated into individual die and encapsulated in plastic or ceramic packages. Presently, we have qualified long-term assembly partners in China, Japan, Malaysia, the Philippines, South Korea, and Taiwan. We negotiate assembly prices, volumes, and other terms with our assembly partners and their respective affiliates on a periodic basis.

Testing

We electrically test the die on each wafer prior to shipment for assembly. Following assembly, prior to customer shipment, each product undergoes final testing and quality assurance procedures. Final testing on certain products is performed by independent contractors in China, Malaysia, the Philippines, South Korea and Taiwan, and at our Oregon facility.

Marketing, Sales and Customers

We sell our products directly to end customers through a network of independent manufacturers’ representatives and indirectly through a network of independent distributors. We also employ a direct sales management and field applications engineering organization to support our end customers and indirect sales resources. Our end customers are primarily original equipment manufacturers in the communications, computing, consumer, industrial, automotive, medical and military end markets.

As of December 2004, we used 20 manufacturers’ representatives and two distributors, Arrow Electronics, Inc. and Avnet Inc., in North America. We have also established export sales channels in over 25 foreign countries through a network of over 25 sales representatives and distributors. The majority of our sales are made through distributors.

6




We protect each of our North American distributors and some of our foreign distributors against reductions in published prices, and expect to continue this policy in the foreseeable future. We also allow returns from these distributors of unsold products under certain conditions. For these reasons, we do not recognize revenue until products are resold by these distributors to an end customer.

We provide technical and marketing support to our end customers with engineering staff based at our headquarters, product development centers and selected field sales offices. We maintain numerous domestic and international field sales offices in major metropolitan areas.

Export sales as a percentage of our total revenue were 71% in 2004, 68% in 2003 and 60% in 2002. Export sales to Japan were approximately 14% of revenue in 2004, 11% of revenue in 2003 and 8% of revenue in 2002, while export sales to China were 13% of revenue in 2004, slightly less than 10% in 2003, and approximately 6% in 2002. Both export and domestic sales are denominated in U.S. dollars, with the exception of sales to Japan, which are denominated in yen. If our export sales decline significantly there would be a material adverse impact on our business and results of operations.

Our products are sold to a large and diverse group of customers. No individual end customer accounted for more than 10% of total revenue in 2004, 2003 or 2002.

Backlog

Our backlog of scheduled and released orders as of December 31, 2004 was approximately $25.5 million as compared to approximately $45.1 million as of December 31, 2003. This backlog consists of direct customer and distributor orders scheduled for delivery within the next 90 days. Distributor orders accounted for the majority of the backlog in both periods. Direct customer orders may be changed, rescheduled or cancelled under certain circumstances without penalty prior to shipment. Additionally, distributor orders generally may be changed, rescheduled or cancelled without penalty prior to shipment. Furthermore, certain of our distributor shipments are subject to rights of return and price adjustment. Revenue associated with these distributor shipments are not recognized until the product is resold to an end customer. Typically, the majority of our revenue results from orders placed and filled within the same period. Such orders are referred to as “turns orders.” By definition, turns orders are not captured in a backlog measurement made at the beginning of a period. We do not anticipate a significant change in this business pattern. For all these reasons, backlog as of any particular date should not be used as a predictor of revenue for any future period.

Competition

The semiconductor industry is intensely competitive and characterized by rapid rates of technological change, product obsolescence and price erosion. Our current and potential competitors include a broad range of semiconductor companies from emerging companies to large, established companies, many of which have greater financial, technical, manufacturing, marketing and sales resources than we do.

The principal competitive factors in the programmable logic market include product features, price, customer support, and sales, marketing and distribution strength. The availability of competitive software development tools is also critical. In addition to product features such as density, speed, power consumption, reprogrammability, design flexibility and reliability, competition occurs on the basis of price and market acceptance of specific products and technology. We intend to continue to address these competitive factors by working to continually introduce product enhancements and new products, by seeking to establish our products as industry standards in their respective markets, and by working to reduce the manufacturing cost of our products.

We compete directly with Actel Corporation, Altera Corporation and Xilinx Inc., all of whom offer competing products. We also indirectly compete with other semiconductor companies who provide logic

7




solutions that are not user programmable. Although to date we have not experienced direct competition from companies located outside the United States, such companies may become a more significant competitive factor in the future. Competition may also increase if other semiconductor companies seek to expand into our market. Any such increases in competition could have a material adverse effect on our operating results.

Patents

We seek to protect our products and technologies primarily through patents, trade secrecy measures, copyrights, mask work protection, trademark registrations, licensing restrictions, confidentiality agreements and other approaches designed to protect proprietary information. There can be no assurance that others may not independently develop competitive technology not covered by our intellectual property rights or that measures we take to protect our technology will be effective.

We hold numerous domestic, European and Asian patents and have patent applications pending in the United States, Asia and Europe. Our current patents will expire at various times between 2005 and 2023. There can be no assurance that pending patent applications or other applications that may be filed will result in issued patents, or that any issued patents will survive challenges to their validity. Although we believe that our patents have value, there can be no assurance that our patents, or any additional patents that may be issued in the future, will provide meaningful protection from competition. We believe that our success will depend primarily upon the technical expertise, experience, creativity and the sales and marketing abilities of our personnel.

Patent and other proprietary rights infringement claims are common in our industry. There can be no assurance that, with respect to any claim made against us, we could obtain a license on terms or under conditions that would not harm our business.

Licenses and Agreements

Advanced Micro Devices

In 1999, as part of our acquisition of Vantis Corporation, a wholly-owned subsidiary of Advanced Micro Devices, Inc. (“AMD”), we entered into an agreement with AMD pursuant to which we have cross-licensed Vantis patents with AMD patents, having an effective filing date on or before June 15, 1999, related to programmable logic products. This cross-license was made on a worldwide, non-exclusive and royalty-free basis. Additionally, as part of our acquisition of Vantis, we acquired certain third-party license rights held by Vantis prior to the acquisition. Included are rights to use certain Xilinx patents to manufacture, market and sell products.

Agere Systems

In 2002, as part of our acquisition of the FPGA business of Agere, we entered into an intellectual property agreement with Agere and Agere Systems Guardian Corporation. Pursuant to this agreement, these Agere companies assigned or licensed to us certain FPGA and FPSC patents, trademarks, software and other intellectual property rights and technology, and we licensed back rights in these same assets. These cross-licenses were made on a worldwide and royalty-free basis.

Altera

In 2001, we entered into a comprehensive, royalty-free patent cross-license agreement and a multi-year patent peace agreement with Altera.

8




Fujitsu

On September 10, 2004, we entered into an Advance Payment and Purchase Agreement (the “Fujitsu Agreement”) with Fujitsu Limited (“Fujitsu”), pursuant to which we will advance $125.0 million to Fujitsu in support of the development and construction of a new 300mm wafer fabrication facility in Mie, Japan. The initial two payments of $25.0 million each were made in October 2004 and January 2005, with the remaining payments to be made in two stages upon the achievement of certain milestones. We currently anticipate that the advance payment will be paid in full by the second quarter of 2006.

Our $125.0 million advance will be credited against the purchase price of 300 mm wafers from the new wafer fabrication facility. The Fujitsu Agreement will continue until the full amount of the advance payment has been returned to us in the form of wafers or other repayment, subject to the right of either party to terminate the agreement upon the occurrence of certain events. We may request a refund of the unused amount of the advance payment if we have not used all of our wafer credits by December 31, 2007. The repayment obligation of Fujitsu is unsecured.

Seiko Epson/Epson Electronics America

Epson Electronics America (“EEA”), an affiliated U.S. distributor of Seiko Epson, has agreed to provide us with manufactured wafers in quantities based on six-month rolling forecasts. Prices for the wafers obtained from EEA are reviewed and adjusted periodically. Wafers for our products are manufactured in Japan at Seiko Epson’s wafer fabrication facilities and are delivered to us by EEA.

In 1997 we entered into an advance payment production agreement with Seiko Epson and Epson Electronics America, Inc. (“EEA”) which was subsequently amended in 2002 and March 2004. Under this agreement we advanced $51.3 million to Seiko Epson to finance construction of an eight-inch sub-micron semiconductor wafer manufacturing facility. The advance is to be repaid with semiconductor wafers over a multi-year period. No interest income is recorded. The agreement calls for wafers to be supplied by Seiko Epson through EEA pursuant to purchase agreements with EEA. Cumulatively, $26.2 million of these payments have been repaid to us in the form of semiconductor wafers. We currently estimate that approximately $12.9 million of the outstanding advances are expected to be repaid with semiconductor wafers during the next twelve months and are thus reflected as part of Other current assets in our Consolidated Balance Sheet. We are not obligated to make additional payments under this agreement.

UMC Group

In 1995, we entered into a series of agreements with United Microelectronics Corporation (“UMC”), a public Taiwanese company, pursuant to which we agreed to join UMC and several other companies to form a separate Taiwanese corporation, (“UICC”), for the purpose of building and operating an advanced semiconductor manufacturing facility in Taiwan, Republic of China. Under the terms of the agreements, we invested approximately $49.7 million for an approximate 10% equity interest in the corporation and the right to receive a percentage of the facility’s wafer production at market prices.

In 1996, we entered into an agreement with Utek Corporation (“Utek”), a public Taiwanese company in the wafer foundry business that became affiliated with the UMC group in 1998, pursuant to which we agreed to make a series of equity investments in Utek under specific terms. In exchange for these investments, we received the right to purchase a percentage of Utek’s wafer production. Under this agreement, we invested approximately $17.5 million. In 2000, UICC and Utek merged into UMC.

We owned approximately 60.8 million shares of UMC common stock at December 31, 2004, of which approximately 23.3 million shares are restricted from sale for more than one year by the terms of our agreement with UMC. Under the terms of the UMC agreement, if we sell any of these restricted shares, our rights to guaranteed wafer capacity at UMC may be reduced on a pro-rata basis based on the number

9




of shares that we sell. If we sell over 10.1 million of these restricted shares, we may lose all of our rights to guaranteed wafer capacity at UMC.

For financial reporting purposes, all of our UMC shares are accounted for as available-for-sale and marked to market in our Consolidated Balance Sheet until they are sold, at which time a gain or loss is recognized in our Consolidated Statement of Operations. Unrealized gains and losses are included in Accumulated other comprehensive income within Stockholders’ equity. An other than temporary impairment of UMC share value could result in a reduction of the Consolidated Balance Sheet carrying value and would result in a charge to our Consolidated Statement of Operations.

Employees

As of December 31, 2004 we had 1,008 full-time employees. We believe that our future success will depend, in part, on our ability to continue to attract and retain highly skilled technical and management personnel. None of our employees is subject to a collective bargaining agreement. We have never experienced a work stoppage and consider our employee relations to be good.

10




EXECUTIVE OFFICERS AND DIRECTORS OF THE REGISTRANT

The following individuals currently serve as our executive officers and directors:

Name

 

 

 

Age

 

Position

Cyrus Y. Tsui

 

59

 

Chief Executive Officer and Chairman of the Board

Stephen A. Skaggs

 

42

 

President and Secretary

Jan Johannessen

 

49

 

Corporate Vice President and Chief Financial Officer

Frank J. Barone

 

65

 

Corporate Vice President, Product Operations

Stephen M. Donovan

 

53

 

Corporate Vice President, Sales

Martin R. Baker

 

49

 

Vice President and General Counsel

Rodney F. Sloss

 

61

 

Vice President, Finance

David E. Coreson

 

58

 

Director

Mark O. Hatfield

 

82

 

Director

Daniel S. Hauer

 

68

 

Director

Patrick S. Jones

 

60

 

Director

Soo Boon Koh

 

54

 

Director

Harry A. Merlo

 

79

 

Director

 

Cyrus Y. Tsui joined Lattice in September 1988 as President and Chief Executive Officer and in March 1991 was named Chairman of the Board. From 1987 until he joined Lattice, Mr. Tsui was Corporate Vice President and General Manager of the Programmable Logic Division of AMD. He was Vice President and General Manager of the Commercial Products Divisions of Monolithic Memories Incorporated (MMI) from 1983 until its merger with AMD in 1987. Mr. Tsui has held technical and managerial positions in the semiconductor industry for over 30 years and has worked in the programmable logic industry since its inception.

Stephen A. Skaggs joined Lattice in December 1992 as Director, Corporate Development. He was elected Senior Vice President, Chief Financial Officer and Secretary in August 1996. In October 2003 he was elected President.

Jan Johannessen rejoined Lattice in October 2001 as Vice President, Investments. In October 2003, he was elected Corporate Vice President and Chief Financial Officer. He originally joined Lattice in 1983 and served as Vice President and Chief Financial Officer between 1987 and 1993. From 1993 to 2001 he worked as an independent venture capitalist.

Frank J. Barone joined Lattice in June 1999 as a Corporate Vice President as a result of our Vantis acquisition. From September 1997 until he joined our company, Mr. Barone was Chief Operating Officer of Vantis. Prior thereto, Mr. Barone held various technical and managerial positions at AMD. He has worked in the programmable logic industry since 1978.

Stephen M. Donovan joined Lattice in October 1989 and served as Director of Marketing and Director of International Sales. He was elected Vice President, International Sales in August 1993. He was promoted to Corporate Vice President, Sales, in May 1998. Mr. Donovan has worked in the programmable logic industry since 1982.

Martin R. Baker joined Lattice in January 1997 as Vice President and General Counsel. From 1991 until he joined Lattice, Mr. Baker held legal positions with Altera Corporation.

Rodney F. Sloss joined Lattice in May 1994 as Vice President, Finance.

David E. Coreson joined our board of directors in February 2005. Mr. Coreson is the former Senior Vice President of Tektronix where his responsibilities included worldwide manufacturing, worldwide

11




customer service, central engineering, Tek-Japan, Tek-China and MaxTek, a wholly owned subsidiary of Tektronix which manufactures custom hybrids.

Mark O. Hatfield has been a member of our board of directors since 1997. Mr. Hatfield is a former U.S. Senator from Oregon, a position he held until January 1997. He has served as a Distinguished Professor at Portland State University since 1997, a Distinguished Professor at George Fox University since 1997 and an Adjunct Professor at Lewis & Clark College since 2000.

Daniel S. Hauer has been a member of our board of directors since 1987. Mr. Hauer served as the Chairman of the Board and Chief Executive Officer of Epson Electronics America until November 1998. Since that time, Mr. Hauer has worked as a business consultant.

Patrick S. Jones joined our board of directors in February 2005. Mr. Jones is the former Chief Financial Officer of Gemplus SA and former Vice President, Finance and Corporate Controller of Intel Corporation. He was also previously Chief Financial Officer of LSI Logic Corporation.

Soo Boon Koh joined our board of directors in August 2000. Ms. Koh has served as Managing Partner of iGlobe Partners Fund, L.P., a venture capital firm located in Singapore and the United States, since October 1999. She previously served as Sr. Vice President and Deputy General Manager of Vertex Management Pte., Ltd. until June 1999.

Harry A. Merlo was a founding member of our board of directors in 1983. Mr. Merlo has been the President of Merlo Corporation since July 1995. He was the founding President and previously served as the President and Chairman of the Board of Louisiana-Pacific Corporation until June 1995.

Available Information

We make available free of charge through our website at www.latticesemi.com, via a link to the SEC’s website at www.sec.gov, our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K and amendments to those reports as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the SEC. You may also obtain free copies of these materials by contacting our Investor Relations Department at 5555 N.E. Moore Court, Hillsboro, Oregon 97124-6421, telephone (503) 268-8000.

Item 2. Properties.

Our corporate headquarters consists of land and 200,000 square feet of buildings we own in Hillsboro, Oregon. We also own two research and development facilities totaling 29,000 square feet and approximately 6,000 square feet of dormitory facilities in Shanghai, China. We lease a 133,000 square foot research and development facility in San Jose, California through 2008; a 25,000 square foot research and development facility in Austin, Texas through 2011; and a 7,500 square foot research and development facility in the United Kingdom through 2013. We also lease, on a short-term basis, research and development facilities in Colorado, Illinois, Pennsylvania and Utah, and office facilities in multiple metropolitan locations for our domestic and international sales staff. Additionally, we lease (through 2006) an 84,000 square foot facility in Sunnyvale, California that has been subleased to a third party through the end of the lease term. We believe that our existing facilities are adequate for our current and foreseeable future needs.

Item 3. Legal Proceedings.

In September and October 2004, three putative class action complaints were filed in the United States District Court for the District of Oregon against Lattice Semiconductor Corporation, our Chief Executive Officer Cyrus Y. Tsui, and our President Stephen A. Skaggs. These complaints were filed on behalf of a putative class of investors who purchased our stock between April 22, 2003 and April 19, 2004. They

12




generally allege violations of federal securities laws arising out of our previously announced restatement of financial results for the first, second, and third quarters of 2003. Consistent with the usual procedures for cases of this kind, these cases were amended and consolidated into a single action. In such amended and consolidated complaint filed January 27, 2005 our former President and our former Controller were added as defendants. We believe that the complaints are without merit, and we intend to vigorously defend against the lawsuits.

In September and October 2004, two shareholder derivative complaints were filed, purportedly on behalf of Lattice Semiconductor Corporation, in the Circuit Court of the State of Oregon for the County of Washington, against all of our current directors, certain former directors, and certain executive officers. The derivative plaintiffs make allegations substantially similar to those in the putative class action complaints, as well as allegations of breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets, and unjust enrichment. Consistent with the usual procedures for cases of this kind, these cases were consolidated into a single putative shareholder derivative action. An amended and consolidated complaint is expected to be filed by April 1, 2005.

All of the complaints generally seek an unspecified amount of damages, as well as attorney fees and costs. The cases are still in the preliminary stages, and it is not possible for us to quantify the extent of our potential liability, if any. An unfavorable outcome in any of these matters could have a material adverse effect on our business and financial results. In addition, defending any litigation may be costly and divert management’s attention from the day-to-day operations of our business.

We are exposed to certain asserted and unasserted potential claims. There can be no assurance that, with respect to potential claims made against us, we could resolve such claims under terms and conditions that would not have a material adverse effect on our business and financial results.

Item 4. Submission of Matters to a Vote of Security Holders.

Not applicable.

13




PART II

Item 5. Market for the Registrant’s Common Stock, Related Stockholder Matters, and Issuer Purchases of Equity Securities.

Our common stock is traded on the over-the-counter market and prices are quoted on the Nasdaq National Market under the symbol “LSCC.” The following table sets forth the low and high sale prices for our common stock for the last two fiscal years, as reported by the Nasdaq National Market. As of March 11, 2005, we had approximately 490 stockholders of record.

 

 

Low

 

High

 

2003:

 

 

 

 

 

First Quarter

 

$

6.47

 

$

10.30

 

Second Quarter

 

7.13

 

9.56

 

Third Quarter

 

6.99

 

9.74

 

Fourth Quarter

 

7.00

 

10.05

 

2004:

 

 

 

 

 

First Quarter

 

$

7.95

 

$

13.40

 

Second Quarter

 

6.47

 

10.16

 

Third Quarter

 

3.96

 

6.35

 

Fourth Quarter

 

4.91

 

6.00

 

 

The payment of dividends on our common stock is within the discretion of our Board of Directors. We intend to retain earnings to finance the growth of our business. We have never paid cash dividends.

14




Item 6. Selected Financial Data.

 

 

Year Ended

 

 

 

December 31,
2004

 

December 31,
2003

 

December 31,
2002

 

December 31,
2001

 

December 31,
2000

 

 

 

(in thousands, except per share data)

 

STATEMENT OF OPERATIONS DATA:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

$

225,832

 

 

 

$

209,662

 

 

 

$

229,126

 

 

 

$

295,326

 

 

 

$

567,759

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of products sold

 

 

96,857

 

 

 

89,266

 

 

 

91,546

 

 

 

111,498

 

 

 

217,830

 

 

Research and development

 

 

90,957

 

 

 

87,092

 

 

 

85,776

 

 

 

71,679

 

 

 

77,057

 

 

Selling, general and administrative

 

 

53,803

 

 

 

50,773

 

 

 

48,099

 

 

 

53,027

 

 

 

81,082

 

 

In-process research and development

 

 

 

 

 

 

 

 

29,853

 

 

 

 

 

 

 

 

Amortization of intangible assets(1)

 

 

47,249

 

 

 

77,127

 

 

 

73,415

 

 

 

84,349

 

 

 

81,873

 

 

 

 

 

288,866

 

 

 

304,258

 

 

 

328,689

 

 

 

320,553

 

 

 

457,842

 

 

(Loss) income from operations

 

 

(63,034

)

 

 

(94,596

)

 

 

(99,563

)

 

 

(25,227

)

 

 

109,917

 

 

(Loss) gain on foundry investments 

 

 

 

 

 

 

 

 

 

 

 

(152,795

)

 

 

149,960

 

 

Interest and other income (expense), net

 

 

11,373

 

 

 

(3,064

)

 

 

6,194

 

 

 

4,056

 

 

 

2,194

 

 

(Loss) income before (benefit) provision for income taxes

 

 

(51,661

)

 

 

(97,660

)

 

 

(93,369

)

 

 

(173,966

)

 

 

262,071

 

 

(Benefit) provision for income taxes

 

 

318

 

 

 

(5,854

)

 

 

81,866

 

 

 

(64,447

)

 

 

94,184

 

 

Net (loss) income

 

 

$

(51,979

)

 

 

$

(91,806

)

 

 

$

(175,235

)

 

 

$

(109,519

)

 

 

$

167,887

 

 

Basic net (loss) income per share

 

 

$

(0.46

)

 

 

$

(0.82

)

 

 

$

(1.59

)

 

 

$

(1.01

)

 

 

$

1.65

 

 

Diluted net (loss) income per share

 

 

$

(0.46

)

 

 

$

(0.82

)

 

 

$

(1.59

)

 

 

$

(1.01

)

 

 

$

1.47

 

 

Shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

112,976

 

 

 

111,794

 

 

 

110,193

 

 

 

108,814

 

 

 

101,716

 

 

Diluted

 

 

112,976

 

 

 

111,794

 

 

 

110,193

 

 

 

108,814

 

 

 

120,321

 

 

 

 

 

At

 

 

 

December 31,
2004

 

December 31,
2003

 

December 31,
2002

 

December 31,
2001

 

December 31,
2000

 

 

 

(in thousands)

 

BALANCE SHEET DATA:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and marketable securities

 

 

$

296,295

 

 

 

$

277,750

 

 

 

$

276,880

 

 

$

531,566

 

$

535,408

 

Total assets

 

 

$

810,906

 

 

 

$

851,628

 

 

 

$

941,263

 

 

$

1,185,982

 

$

1,295,884

 

Convertible notes

 

 

$

169,000

 

 

 

$

184,000

 

 

 

$

208,061

 

 

$

260,000

 

$

260,000

 

Stockholders’ equity

 

 

$

542,591

 

 

 

$

606,112

 

 

 

$

661,135

 

 

$

839,770

 

$

855,655

 


(1)          Includes $3,418, $5,745, $2,962, and $397 of amortization of deferred stock compensation expense for the years ended December 31, 2004, December 31, 2003, December 31, 2002, and December 31, 2001, respectively, attributable to research and development activities.

All share and per share amounts have been adjusted retroactively to reflect a two-for-one stock split effected in the form of a stock dividend paid on October 11, 2000.

15




Unaudited Quarterly Data

 

 

2004

 

2003

 

 

 

Dec.

 

Sept.

 

June

 

Mar.

 

Dec.

 

Sept.

 

June

 

Mar.

 

 

 

(in thousands, except per share data)

 

Revenue

 

$

48,541

 

$

57,281

 

$

60,939

 

$

59,071

 

$

52,757

 

$

43,033

 

$

56,575

 

$

57,297

 

Gross profit

 

$

27,483

 

$

32,433

 

$

34,707

 

$

34,352

 

$

28,943

 

$

23,602

 

$

33,582

 

$

34,269

 

Net loss

 

$

(13,138

)

$

(6,324

)

$

(15,976

)

$

(16,541

)

$

(25,244

)

$

(28,661

)

$

(18,232

)

$

(19,669

)

Basic net loss per share

 

$

(0.12

)

$

(0.06

)

$

(0.14

)

$

(0.15

)

$

(0.22

)

$

(0.26

)

$

(0.16

)

$

(0.18

)

Diluted net loss per share

 

$

(0.12

)

$

(0.06

)

$

(0.14

)

$

(0.15

)

$

(0.22

)

$

(0.26

)

$

(0.16

)

$

(0.18

)

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Lattice Semiconductor Corporation designs, develops and markets high performance programmable logic products and related software. Programmable logic products are widely-used semiconductor components that can be configured by the end customer as specific logic circuits, and thus enable shorter design cycle times and reduced development costs. Within this market there are two groups of products—programmable logic devices (“PLDs”) and field programmable gate arrays (“FPGAs”)—each representing a distinct silicon architectural approach. Products based on the two alternative programmable logic architectures are generally optimal for different types of logic functions, although many logic functions can be implemented using either architecture. We believe that a substantial portion of programmable logic customers utilize both PLD and FPGA architectures. Our end customers are primarily original equipment manufacturers in the communications, computing, industrial, consumer, automotive, medical and military markets.

Overview of 2004

Revenue for our business in 2004 increased to approximately $225.8 million as compared to approximately $209.7 million in 2003 due to growth of our New* products partially offset by a decline in revenues from Mature* products. There was a decline in business conditions beginning in the third quarter of 2004 which has continued into the first quarter of 2005 attributable to general weakening in the communications end market. Among other things, future revenue growth is dependent on overall economic conditions for our industry and market acceptance of our new FPGA products.

Our gross margin in 2004 and 2003 was 57% for the year. Lower production yields and average selling prices on our new products held margins down below the 60% level achieved in 2002.

Research and development expenses increased to approximately $91.0 million (40% of revenue) in 2004 compared to approximately $87.1 million (41% of revenue) in 2003. Research and development spending is predominantly related to the continued development of next generation FPGA products. We expect to continue to make significant future investments in research and development.

Selling, general and administrative expenses were approximately $53.8 million (24% of revenue) in 2004 as compared to approximately $50.8 million (24% of revenue) in 2003 and increased primarily due to sales commissions and marketing expenses related to new products and increased professional fees primarily related to compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002. To the extent our revenues continue to grow, we expect that there will be a less than proportionate increase in our selling, general and administrative expenses.

Amortization of intangible assets of approximately $47.2 million in 2004 will decline to approximately $16.2 million in 2005 as amortization of intangible assets acquired in the Vantis acquisition was completed in the June 2004 quarter.

16




Interest and other income (expense) of approximately $11.4 million in 2004 includes approximately $4.4 million of interest income from marketable securities and cash equivalents, and approximately $8.8 million of gains from the sale of UMC common stock and extinguishment of Zero Coupon Convertible Subordinated Notes due July 1, 2010 partially offset by amortization of issuance costs of Zero Coupon Convertible Subordinated Notes due July 1, 2010. To the extent market conditions allow, we may make similar extinguishments of our Zero Coupon Convertible Subordinated Notes due July 1, 2010 and sales of UMC shares in future quarters.

We are not currently paying federal or state income taxes and do not expect to pay or accrue such taxes in 2005. We expect to continue to pay foreign income taxes at current levels.

* Product classification

New:

Lattice EC/P, FPSC, XPLD, XPGA, GDX2, ORCA 4, ispMACH 4000/Z, ispPAC-PWR, ispCLK

Mainstream:

ORCA 3, GDX/V, ispMACH L/V, ispLSI 2000V, ispLSI 5000V, ispLSI 8000V, ispMACH 5000 V/G, and Other

Mature:

ORCA 2, all 5-volt CPLDs, all SPLDs

 

Results of Operations

The following table sets forth, for the periods indicated, the percentage of revenue represented by selected items reflected in our Consolidated Statement of Operations:

 

 

Years Ended December 31,

 

 

 

 2004 

 

 2003 

 

 2002 

 

Revenue

 

 

100

%

 

 

100

%

 

 

100

%

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of products sold

 

 

43

 

 

 

43

 

 

 

40

 

 

Research and development

 

 

40

 

 

 

41

 

 

 

38

 

 

Selling, general and administrative

 

 

24

 

 

 

24

 

 

 

21

 

 

In-process research and development

 

 

 

 

 

 

 

 

13

 

 

Amortization of intangible assets

 

 

21

 

 

 

37

 

 

 

32

 

 

Total costs and expenses

 

 

128

 

 

 

145

 

 

 

144

 

 

Loss from operations

 

 

(28

)

 

 

(45

)

 

 

(44

)

 

Interest and other income (expense), net

 

 

5

 

 

 

(2

)

 

 

3

 

 

Loss before (benefit) provision for income taxes

 

 

(23

)

 

 

(47

)

 

 

(41

)

 

(Benefit) provision for income taxes

 

 

0

 

 

 

(3

)

 

 

36

 

 

Net loss

 

 

(23

)%

 

 

(44

)%

 

 

(76

)%

 

 

Acquisitions.   On August 26, 2002, we completed the stock for stock acquisition of Cerdelinx Technologies, Inc. (“Cerdelinx”) for 2.6 million shares of our common stock valued at $8.30 per share. This transaction was accounted for as an asset purchase, and accordingly, the results of operations for Cerdelinx and estimated fair value of assets acquired and liabilities assumed are included in our Consolidated Financial Statements beginning August 26, 2002. In estimating the fair value of the assets acquired, management considered various factors, including an appraisal. In-process research and development (“IPR&D”) costs were appraised at $5.7 million and charged to operations on the acquisition date. Remaining intangible asset costs are being amortized to operations over a period averaging five years. See Note 4 to our Consolidated Financial Statements.

On January 18, 2002, we completed the acquisition of the field-programmable gate array (“FPGA”) business (“Agere FPGA”) of Agere Systems Inc. (“Agere”) for $250 million in cash. This transaction was accounted for as a purchase, and accordingly, the results of operations for Agere FPGA and estimated fair

17




value of assets acquired and liabilities assumed are included in our Consolidated Financial Statements beginning January 18, 2002. In estimating the fair value of the assets acquired, management considered various factors, including an appraisal. IPR&D costs were appraised at $24.2 million and charged to operations on the acquisition date. Remaining intangible asset costs are being amortized to operations over 6.3 years. See Note 5 to our Consolidated Financial Statements.

Revenue.   Revenue was $225.8 million in 2004, an increase of 7.7% from 2003. Revenue was $209.7 million in 2003, a decrease of 8.5% from 2002 revenue of $ 229.1 million. The composition of our revenue by product family for the years presented was as follows:

 

 

Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

FPGA

 

 

19

%

 

 

18

%

 

 

12

%

 

PLD

 

 

81

%

 

 

82

%

 

 

88

%

 

 

Prior to the acquisition of Agere FPGA, we had no revenue from FPGA products.

The increase in revenue in 2004 as compared to 2003 was primarily due to growth of our product sales in Asia attributable to stronger business conditions offset in part by a decline in business conditions beginning in the third quarter of 2004 attributable to general weakening in the communications end market. During 2003, our revenue was adversely affected by the business downturn experienced by the semiconductor and programmable logic markets that began in 2001, offset in part by a general business recovery experienced late in 2003.

Revenue from export sales as a percentage of total revenue was approximately 71% for 2004, 68% for 2003, and 60% for 2002. We expect export sales to continue to represent a significant portion of revenue.

Our sales by geographic region were as follows (in thousands):

 

 

Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

United States

 

$

65,044

 

$

66,740

 

$

92,086

 

Export sales:

 

 

 

 

 

 

 

Europe

 

50,867

 

52,142

 

58,871

 

Asia Pacific (other than Japan and China)

 

42,584

 

37,062

 

36,775

 

Japan

 

31,134

 

23,000

 

17,635

 

China

 

29,802

 

20,298

 

12,914

 

Other

 

6,401

 

10,420

 

10,845

 

Total revenue from export sales

 

160,788

 

142,922

 

137,040

 

Total revenue

 

$

225,832

 

$

209,662

 

$

229,126

 

 

During 2004, total units sold increased by 10% while overall average selling prices declined by 3% when compared to 2003. The 2004 increase in units sold is attributable to sales of New* products while the decrease in average selling prices is attributable to lower selling prices of Mature* products. Average selling prices of Mainstream* products increased by 4% in 2004 compared to 2003 while units sold were flat. From a product line viewpoint, in 2004 there was a 36% increase in FPGA units sold, partially offset by a 15% decrease in average selling prices when compared to 2003. For PLD products in 2004, units sold increased 10% while average selling prices decreased by 3% when compared to 2003. During 2003, total units sold and our overall average selling prices both decreased by approximately nine percent when compared to 2002. In 2003, both units sold and average selling price were adversely impacted by the business downturn in the semiconductor and programmable logic markets that began in 2001. Our ability to maintain or increase the level of our average selling price is dependent on the continued development, introduction and market acceptance of new products. See “Factors Affecting Future Results.”

18




Gross Margin.   Our gross margin percentage was 57% for 2004 and 2003, and 60% for 2002. Similar margins in 2004 compared to 2003 reflect the growth of sales of New* products, that currently carry lower margins, offset by higher margins in Mature* products that declined in revenue in 2004. The decrease in gross margin percentage in 2003 compared to 2002 was primarily attributable to a provision for an allowance for price protection and sales returns for distributors in the September 2003 quarter. To a lesser extent, this decrease in gross margin also reflects the increased proportion of fixed manufacturing costs as a result of lower revenue levels in 2003.

Research and Development.   Research and development expense was $91.0 million for 2004 compared to $87.1 million for 2003 and $85.8 million in 2002. Research and development expenses consist primarily of personnel, masks, prototype wafers, third-party design automation software, assembly tooling and qualification expenses. The increases in 2004 and 2003 when compared to the prior year were primarily due to the continued development of new products, including especially engineering mask costs. We believe that a continued commitment to research and development is essential in order to maintain product leadership and provide innovative new product offerings, and therefore we expect to continue to make significant future investments in research and development. As we continue to move to more advanced process technologies such as 130nm, 90nm and beyond, mask costs are becoming increasingly more expensive and will therefore increasingly represent a greater proportion of total research and development expenses.

Selling, General and Administrative.   Selling, general and administrative expense was $53.8 million in 2004, $50.8 million in 2003, and $48.1 million in 2002. The 2004 increase compared to 2003 was primarily due to the increase in sales commissions and marketing expenses related to new products and increased professional and legal fees related to initial compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002. The increase in 2003 when compared to 2002 was primarily due to increased marketing expense related to new products and increased professional fees including those related to the restatement of the first, second and third quarter 2003 financial statements.

In-Process Research and Development.   IPR&D consisted of those products obtained through acquisition that were not yet proven to be technologically feasible but had been developed to a point where there was value associated with them in relation to potential future revenue. Because technological feasibility was not yet proven and no alternative future uses were believed to exist for the in-process technologies, the assigned value was expensed immediately upon the closing date of the acquisitions. IPR&D recorded in 2002 resulted from the completion of the Agere FPGA and Cerdelinx acquisitions described below:

Cerdelinx

The fair value underlying the $5.7 million assigned to acquired IPR&D from the Cerdelinx acquisition (recognized in the third quarter of 2002) was determined by identifying research projects in areas for which technological feasibility had not been established and there were no alternative future uses. The acquired IPR&D consisted of low-power CMOS transceivers and backplane interfaces with embedded high-speed SERDES I/O. These projects were approximately 60% complete and were estimated to be completed in 2003 at an estimated cost of approximately $2.0 million. During 2004, new products based on this technology were completed. In addition, this technology along with subsequently developed technology is being integrated into other new products expected to be completed in 2005. There has been no material change in the estimated cost of these projects.

The fair value was determined by an income approach where fair value is the present value of projected free cash flows that will be generated by the products incorporating the acquired technologies under development, assuming they are successfully completed. The estimated net free cash flows generated by the products over six year periods were discounted at rates ranging from 15% to 17% in

19




relation to the stage of completion and the technical risks associated with achieving technological feasibility. The net cash flows for such projects were based on management’s estimates of revenue, expenses and asset requirements.

The remaining portion of these projects has completion risk related to silicon functionality, architecture performance, packaging technology, continued availability of key technical personnel and product reliability. To the extent that estimated completion dates are not met, the risk of competitive product introduction is greater and revenue opportunity may be permanently lost.

Agere FPGA

The fair value underlying the $24.2 million assigned to acquired IPR&D in the Agere FPGA acquisition was determined by identifying research projects in areas for which technological feasibility had not been established and there was no alternative future use. Projects in the IPR&D category were the ORCA 4 FPGA family, the next generation FPGA family and the FPSC field-programmable system chips. The following is a brief description of these projects. The ORCA 4 FPGA family project, increasing speed and density and enhancing yields, was approximately 85% complete and estimated to be completed by 2003 at an estimated cost of $1.5 million. This project was completed during 2002 with no material change in cost. The next generation FPGA family project, increasing speed and density while reducing die size, was approximately 50% complete and estimated to be completed by 2004 at an estimated cost of $2.0 million. This project was significantly redefined and is now expected to be completed during 2005. The future development of FPSC field-programmable system chips was approximately 25% to 90% complete, and estimated to be completed by 2004 at an estimated cost of $2.0 million. This project was completed during 2004 with no material change in cost.

The IPR&D value of $24.2 million was determined by an income approach where fair value is the present value of projected free cash flows that will be generated by the products incorporating the acquired technologies under development, assuming they are successfully completed. The estimated net free cash flows generated by the products over 5-7 year periods were discounted at rates ranging from 23% to 25% in relation to the stage of completion and the technical risks associated with achieving technological feasibility. The net cash flows for such projects were based on management’s estimates of revenue, expenses and asset requirements. Any delays or failures in the completion of these projects could impact our expected return on investment and future results. In addition, our financial condition would be adversely affected if the value of other intangible assets acquired became impaired.

The remaining project has completion risks related to silicon functionality, architecture performance, packaging technology, continued availability of key technical personnel and product reliability. To the extent that estimated completion dates are not met, the risk of competitors’ product introductions is greater and revenue opportunity may be permanently lost.

Amortization of Intangible Assets.   Amortization of intangible assets is related to our 2002 acquisitions, discussed above, our 1999 Vantis acquisition and our 2001 acquisition of Integrated Intellectual Property, Inc. (“I2P”). Amortization expense was $47.2 million in 2004, $77.1 million in 2003, and $73.4 million in 2002. The decrease in amortization expense in 2004 was attributable to intangible assets from the Vantis acquisition which were fully amortized during 2004. The increase in amortization for 2003 when compared with 2002 was due to a full year of amortization of intangible assets related to our 2002 acquisitions, and approximately $2.2 million incremental amortization of deferred stock compensation in association with the accelerated write-off of accrued deferred compensation recorded in conjunction with certain assumed in-the-money stock options as part of a stock option exchange program completed during the first quarter of 2003 (see Note 13 to our Consolidated Financial Statements).

20




Interest Income.   Interest income was $4.4 million in 2004, $3.6 million in 2003 and $5.4 million in 2002. The increase in 2004 when compared to 2003 is attributable to higher balances and interest rates. The decrease in 2003 when compared to 2002 was due to lower interest rates on invested balances.

Interest Expense.   Interest expense was insignificant in 2004, $7.1 million in 2003, and $12.6 million in 2002. Substantially all interest expense resulted from the debt issued to partially fund our Vantis acquisition. The decrease in 2004 when compared to 2003 and in 2003 when compared to 2002 was due to the extinguishment of our remaining 43¤4% Convertible Subordinated Notes in July 2003. (See Note 12 to our Consolidated Financial Statements).

Other Income, net.   Other income, net, was $7.0 million in 2004, $0.4 million in 2003, and $13.4 million in 2002. For 2004, Other income, net, consists of a $6.1 million gain on sale of UMC shares and a $2.8 million gain on extinguishment of Zero Coupon Convertible Subordinated Notes due 2010 net of $1.9 million amortization of convertible note issuance costs and other costs. For 2003, Other income, net, consists of $1.4 million of gain recorded on the partial extinguishment of our Zero Coupon Convertible Subordinated Notes due 2010, substantially offset by the $4.7 million call premium associated with the extinguishment of our 43¤4% Convertible Subordinated Notes (see Note 12 to our Consolidated Financial Statements). For 2002, the amount recorded consists primarily of a $9.3 million gain in conjunction with the extinguishment of a portion of our 43¤4% Convertible Subordinated Notes (see Note 12 to our Consolidated Financial Statements), and a $4.0 million gain in conjunction with the sale of a portion of our UMC shares (see Note 7 to our Consolidated Financial Statements).

Provision (Benefit) for Income Taxes.   The 2004 tax provision is related to income taxes on our foreign subsidiaries primarily engaged in selling and research and development activities. The tax benefit in 2003 is primarily a result of releasing $3.4 million of tax reserves as the related statute of limitations expired and a $2.5 million refund of Federal income taxes. The provision for income taxes for 2002 of $81.9 million is primarily the result of a $118.6 million charge to income tax expense recorded in the fourth quarter of 2002, representing a full valuation allowance for our recorded deferred tax assets (see Note 11 to our Consolidated Financial Statements).

Critical Accounting Policies and Estimates

Critical Accounting Policies are those that are both most important to the portrayal of a company’s financial condition and results, and require management’s most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. A description of our critical accounting policies follows.

Use of Estimates.   The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, such as accounts receivable, inventory and deferred income taxes and liabilities, such as accrued liabilities, income taxes and deferred income, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the fiscal periods presented. Actual results could differ from those estimates.

Revenue recognition.   Revenue from direct customers is recognized upon shipment provided that persuasive evidence of a sales arrangement exists, the price is fixed and determinable, title has transferred, collection of resulting receivables is probable, there are no customer acceptance requirements and no remaining significant obligations. Certain of our sales are made to distributors under agreements providing price protection and right of return on unsold merchandise. Revenue and costs relating to such distributor sales are deferred until the product is sold by the distributor and related revenue and costs are then reflected in income.

21




Our method of revenue recognition for deferred distributor sales is based on certain assumptions including our average collection experience compared to resale reported by the distributors. To the extent actual results differ from these assumptions, revenue will change accordingly.

Deferred income.   In determining the balance in the deferred income account, we make estimates of salable and returnable inventory at certain distributors and we make estimates similar to those used to value inventory on hand to value inventory at these distributors. To the extent actual results differ from these estimates, the balances of reported deferred income, revenue and cost of products sold will change accordingly.

Inventory.   We value inventory at the lower of cost or market on a quarterly basis. In addition, we write down unproven, excess and obsolete inventories to net realizable value. To value our inventory, we make a number of estimates and assumptions including future price declines and forecasted demand for our products. To the extent actual results differ from these estimates and assumptions, the balances of reported inventory and cost of products sold will change accordingly.

Long-Lived Assets.   We account for our long-lived assets, primarily property and equipment and amortizable intangible assets, in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 144, “Accounting for the Disposal of Long-Lived Assets,” which requires us to review the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment is determined by comparing the estimated undiscounted cash flows to the carrying amount. A loss is recorded if the carrying amount of the asset exceeds the estimated undiscounted cash flows. Intangible assets are generally being amortized over five years, and fifteen years for income tax purposes, on a straight-line basis.

Accounting for income taxes.   To report income tax expense related to operating results, we record current and deferred income tax assets and liabilities in our balance sheet. In determining the value of our deferred tax assets, we make estimates of future taxable income. As of December 31, 2004, 2003 and 2002, we have recorded full valuation allowances for all of our deferred tax assets due to uncertainties regarding their realization. In determining the value of income tax liabilities, we make estimates of the results of future examinations of our income tax returns by taxing authorities. To the extent actual results differ from these estimates, our income tax provision will be affected accordingly.

Liquidity and Capital Resources

As of December 31, 2004, our principal source of liquidity was $296.3 million of cash and marketable securities, which was approximately $18.5 million greater than the balance of $277.8 million at December 31, 2003. Working capital decreased to $328.5 million at December 31, 2004 from $363.6 million at December 31, 2003. This decrease was primarily due to payments to Fujitsu pursuant to the Advance Payment Agreement entered into in September 2004. During 2004 we generated approximately $6.0 million of cash and cash equivalents from our operations, net of a $25.0 million payment to Fujitsu Limited (discussed below), compared with $34.8 million during 2003, of which approximately $26.0 million was attributable to income tax refunds.

Accounts Receivable declined $7.2 million at December 31, 2004 compared to December 31, 2003 due to lower billings in the later portion of the fourth quarter of 2004 as compared to the similar period in 2003 combined with lower revenues in the December 2004 quarter compared to the December 2003 quarter.

Inventories decreased approximately $8.0 million, or 17%, at December 31, 2004 compared to December 31, 2003 and decreased by $9.6 million, or 17%, at December 31, 2003 as compared to the balance at the end of the prior year primarily due to reduced starts and receipts of wafers in response to changing revenue levels.

22




Prepaid expenses and other current assets increased by approximately $6.2 million in December 31, 2004 as compared to December 31, 2003 primarily due to: increased amounts of prepaid wafers expected to be used in the next twelve months (see Note 7 to our Consolidated Financial Statements); increases in prepaid software licenses, maintenance contracts and insurance; and additional income tax refunds receivable. Prepaid expenses and other current assets decreased by approximately $18.9 million, or 54%, at December 31, 2003 as compared to December 31, 2002 primarily due to a decrease in refundable income taxes, offsetting an approximate $6.2 million increase in the amount of prepaid wafers expected to be used in the next twelve months (see Note 7 to our Consolidated Financial Statements).

The current portion of equity securities available for sale decreased from $35.4 million to $24.2 million at December 31, 2004 as compared to December 31, 2003. These securities represent the portion of our investment in UMC that are available for sale during 2005 (see Note 7 to our Consolidated Financial Statements). The current portion of equity securities available for sale increased by $35.4 million, or 100%, at December 31, 2003 as compared to December 31, 2002.

Property and equipment, less accumulated depreciation, decreased by $6.2 million at December 31, 2004 as compared to December 31, 2003 and decreased by $9.0 million in 2003 as compared to the balance in the prior year due to lower expenditures for capital equipment. Net intangible assets decreased by $43.8 million and $71.3 million in 2004 and 2003 as compared to the balance of the prior year, respectively, which is attributable to amortization of these assets.

Capital expenditures were approximately $10.7 million, $9.7 million, and $17.5 million in 2004, 2003 and 2002, respectively. We expect to spend approximately $15 million to $20 million on capital expenditures for the fiscal year ended December 31, 2005.

Foundry investments, advances and other assets increased by approximately $11.0 million at December 31, 2004 compared to December 31, 2003 due to a $50.0 million recorded advance for wafer supply to Fujitsu (see Note 7 to our Consolidated Financial Statements) partially offset by a decline in our UMC investment due to $36.6 million of shares sold and a $13.2 million market price decline. Foundry investments, advances and other assets decreased by approximately $17.6 million, or 17%, at December 31, 2003 as compared to the balance of the prior year. This was primarily due to the $35.4 million of our UMC investment reclassified to equity securities available for sale and the $6.2 million reclassified to prepaid expenses and other current assets related to prepaid wafers, partially offset by a $24.6 million gain recorded in accumulated other comprehensive income related to changes in the market value of our UMC shares.

As of December 31, 2004, we owned 60.8 million shares of UMC common stock of which 23.3 million shares were restricted from sale for more than one year by the terms of our agreement with UMC. During 2002, we sold approximately 7.6 million shares of UMC common stock for approximately $9.9 million in cash, resulting in a gain of $4.0 million. During 2004, we sold 36.6 million of our UMC shares for approximately $29.6 million in cash, resulting in a gain of approximately $6.1 million. In the future, we may choose to liquidate additional UMC shares.

In 1997 we entered into an advance payment production agreement with Seiko Epson and Epson Electronics America, Inc. (“EEA”), which was subsequently amended in 2002 and March 2004. Under this agreement we advanced $51.3 million to Seiko Epson to finance construction of an eight-inch sub-micron semiconductor wafer manufacturing facility. The advance is to be repaid with semiconductor wafers over a multi-year period. No interest income is recorded. The agreement calls for wafers to be supplied by Seiko Epson through EEA pursuant to purchase agreements with EEA. Cumulatively, $26.2 million of these payments have been repaid to us in the form of semiconductor wafers. We currently estimate that approximately $12.9 million of the outstanding advances are expected to be repaid with semiconductor wafers during the next twelve months and are thus reflected as part of Other current assets in our Consolidated Balance Sheet. We are not obligated to make additional payments under this agreement.

23




On June 20, 2003, we issued $200.0 million in Zero Coupon Convertible Subordinated Notes due July 1, 2010. No interest will accrue or be payable related to these notes. Holders of these notes may convert the notes into shares of our common stock at any time before the close of business on the date of their maturity, unless the notes have been previously redeemed or repurchased, if (1) the price of our common stock issuable upon conversion of a note reaches a specified threshold, (2) the notes are called for redemption, (3) if we request a redemption, or make a distribution to common stockholders that is dilutive to note holders or if we become a party to a merger or consolidation or sale of substantially all of our assets or (4) the trading price of the notes falls below certain thresholds. The conversion price is approximately $12.06 per share, subject to adjustment in certain circumstances. On or after July 1, 2008, we have the option to redeem all or a portion of the notes that have not been previously repurchased or converted at 100% of the principal amount of the notes. On July 1, 2008, holders have the option to require us to purchase all or a portion of their notes in cash at 100% of the principal amount of the notes. Holders also have the right, subject to certain conditions, to require us to repurchase the notes in the event of a “fundamental change” (as defined in the indenture governing the notes) at 100% of the principal amount of the notes. Generally, a fundamental change is an occurrence resulting in substantially all of our common stock being converted into common stock which is not listed on a United States stock exchange or Nasdaq.

The notes are subordinated in right of payment to all of our senior indebtedness, and are structurally subordinated as to the revenues and assets of our subsidiaries to all debt and other liabilities of our subsidiaries. At December 31, 2004, we had no senior indebtedness and our subsidiaries had approximately $2.2 million of debt and other liabilities outstanding. Issuance costs relative to these convertible notes are included in “Foundry investments, advances and other assets” and aggregated approximately $5.4 million and are being amortized to expense over the lives of the notes. Accumulated amortization of these issuance costs was approximately $3.2 million and $1.4 million as of December 31, 2004 and December 31, 2003, respectively.

In October 2003, our board of directors authorized management to repurchase up to $100.0 million of our Zero Coupon Convertible Subordinated Notes due July 1, 2010. During 2004, we extinguished approximately $15.0 million of these notes for approximately $12.0 million in cash and recognized a net gain of approximately $2.8 million after writing off approximately $0.2 million of unamortized issuance costs. During 2003, we extinguished approximately $16.0 million of these notes for approximately $14.2 million in cash and recognized a net gain of approximately $1.4 million. In connection with this transaction, we also wrote off approximately $0.4 million of unamortized issuance costs. In the first quarter through March 11, 2005 we extinguished $5.3 million of our Zero Coupon Convertible Subordinated Notes due July 1, 2010 for $4.5 million resulting in a gain of $0.7 million which will be included in Interest and other income (expense) for the March 31, 2005 quarter. In the future we may choose to extinguish additional Zero Coupon Convertible Subordinated Notes due July 1, 2010.

The estimated fair value of the Zero Coupon Convertible Subordinated Notes due July 1, 2010, based on quoted market prices, was approximately $145.1 million at December 31, 2004.

On July 21, 2003, we extinguished for cash all of our outstanding 43¤4% Convertible Subordinated Notes due in 2006, originally issued in October 1999, plus accrued interest. Total cash paid at extinguishment approximated $178.8 million, including par value of $172.3 million, accrued interest of approximately $1.8 million and a call premium of 2.71% of the outstanding notes, or approximately $4.7 million. This call premium, plus unamortized issuance costs of approximately $1.0 million as of the extinguishment date, was recorded as “Other expense” in the quarter ended September 30, 2003.

During 2002, we extinguished approximately $51.9 million face value of our 43¤4% Convertible Subordinated Notes due in 2006 for approximately $42.8 million in cash, including accrued interest. We recognized a net gain of approximately $9.3 million in connection with these transactions.

24




On September 10, 2004, we entered into an Advance Payment and Purchase Agreement (the “Fujitsu Agreement”) with Fujitsu Limited (“Fujitsu”), pursuant to which we will advance $125.0 million to Fujitsu in support of the development and construction of a new 300mm wafer fabrication facility in Mie, Japan. The initial two payments of $25.0 million each were made in October 2004 and January 2005, with the remaining payments to be made in two stages upon the achievement of certain milestones. We currently anticipate that the advance payment will be paid in full by the second quarter of 2006.

Our $125.0 million advance will be credited against the purchase price of 300 mm wafers from the new wafer fabrication facility. The Fujitsu Agreement will continue until the full amount of the advance payment has been returned to us in the form of wafers or other repayment, subject to the right of either party to terminate the agreement upon the occurrence of certain events. We may request a refund of the unused amount of the advance payment if we have not used all of our wafer credits by December 31, 2007. The repayment obligation of Fujitsu is unsecured.

The foregoing summary description of the Fujitsu Agreement is qualified in its entirety by reference to the Fujitsu Agreement, which is filed as an exhibit to our Form 10Q for the quarter ended September 30, 2004.

The following table summarizes our significant contractual cash obligations at December 31, 2004 (in thousands):

Fiscal Year

 

 

 

 Operating 
leases(1)

 

Inventory and
Related Purchase
Obligations(2)

 

Advance
Payment and
Purchase
Agreement(3)

 

Zero Coupon
Convertible
Subordinated
Notes due
July 1, 2010

 

2005

 

 

$

9,049

 

 

 

$

5,954

 

 

 

$

 

 

 

$

 

 

2006

 

 

7,327

 

 

 

 

 

 

75,000

 

 

 

 

 

2007

 

 

6,075

 

 

 

 

 

 

 

 

 

 

 

2008

 

 

5,615

 

 

 

 

 

 

 

 

 

 

 

2009

 

 

1,108

 

 

 

 

 

 

 

 

 

 

 

Later years

 

 

1,404

 

 

 

 

 

 

 

 

 

169,000

 

 

 

 

 

$

30,578

 

 

 

$

5,954

 

 

 

$

75,000

 

 

 

$

169,000

 

 


(1)          Certain of our facilities and equipment are leased under operating leases, which expire at various times through 2013. Rental expense under the operating leases was approximately $5.9 million, $5.8 million, and $6.0 million for 2004, 2003 and 2002, respectively.

(2)          We depend entirely upon subcontractors to manufacture our silicon wafers. Other subcontractors provide substantially all of our assembly and test services. Due to lengthy subcontractor lead times, we must order these materials and services well in advance, and we are obligated to pay for these materials and services once they are completed. We expect to receive the material and pay the purchase obligation within four to six months subsequent to December 31, 2004.

(3)          Represents obligations to make payments upon completion of milestones presently estimated to occur by the second quarter of 2006.

25




Included in the above operating lease amounts are certain properties which are currently subleased. A portion of this sublease income is payable to the property owner. Future minimum sublease receipts, based on agreements in place at December 31, 2004, net of such payments are as follows (in thousands):

Fiscal Year

 

 

 

Amount

 

2005

 

$

3,026

 

2006

 

997

 

 

 

$

4,023

 

 

In December 2000, our Board of Directors authorized management to repurchase up to five million shares of our common stock. As of December 31, 2004, we had repurchased 1,136,000 shares at an aggregate cost of approximately $20.0 million. There were no repurchases of common stock in 2002, 2003 or 2004.

Congress adopted the American Jobs Creation Act of 2004 which among other things provides companies with foreign subsidiaries the opportunity to repatriate earnings of such subsidiaries at a reduced tax rate. Presently we have substantial tax loss carryforwards which could be used to offset tax liabilities arising from repatriation of foreign subsidiary earnings. We are not planning to repatriate earnings of our foreign subsidiaries.

We believe that our existing liquid resources and expected cash generated from operations combined with our ability to borrow additional funds will be adequate to meet our operating and capital requirements and obligations for the next 12 months. We may in the future seek new or additional sources of funding. In addition, in order to secure additional wafer supply, we may from time to time consider various financial arrangements including joint ventures, equity investments, advance purchase payments, loans, or similar arrangements with independent wafer manufacturers in exchange for committed wafer capacity. To the extent that we pursue any such additional financing arrangements, additional debt or equity financing may be required. There can be no assurance that such additional financing will be available when needed or, if available, will be on favorable terms. Any future equity financing will decrease existing stockholders’ equity percentage ownership and may, depending on the price at which the equity is sold, result in dilution.

New Accounting Pronouncements

In March 2004, the Emerging Issues Task Force reached a consensus on recognition and measurement guidance previously discussed under EITF 03-01. The consensus clarifies the meaning of other-than-temporary impairment and its application to investments classified as either available-for-sale or held-to-maturity under SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities.” The recognition and measurement guidance for which the consensus was reached in the March 2004 meeting is to be applied to other-than-temporary impairment evaluations in reporting periods beginning after June 15, 2004. In November 2004, the FASB staff indicated that the FASB will delay until 2005 the FASB Staff Position on EITF Issue No. 03-01, “The Meaning of Other-Than-Temporary Impairment and its Application to Certain Investments.” Management will evaluate the affect of adopting the recognition and measurement guidance when the matter is finalized.

In December 2004, the FASB issued a Statement “Share Based Payment—a revision of SFAS No. 123 ‘Accounting for Stock Based Compensation’,” that addresses the accounting for share-based payment transactions in which a company receives employee services in exchange for either equity instruments of the company or liabilities that are based on the fair value of the company’s equity instruments or that may be settled by the issuance of such equity instruments. The statement eliminates the ability to account for share-based compensation transactions using the intrinsic method currently used by the company and generally would require that such transactions be accounted for using a fair-value-based method and

26




recognized as expense in the company’s Consolidated Statement of Operations. The effective date of the standard is for interim or fiscal periods beginning after June 15, 2005. This statement will have a significant impact on our Consolidated Statement of Operations, as we will be required to expense the fair value of our stock option grants and stock purchases under our employee stock purchase plan. At this time we have not made an estimate of the impact of this statement on our future financial results. Please refer to Note 13 to our Consolidated Financial Statements which provides historical information that may be useful in assessing the impact of this standard on our Consolidated Financial Statements.

Off-Balance Sheet Arrangements

We do not have any financial partnerships with unconsolidated entities, such as entities often referred to as structured finance or special purpose entities, which are often established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purpose. Accordingly, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had such relationships.

Factors Affecting Future Results

We may be unsuccessful in defining, developing or selling new products required to maintain or expand our business.

As a semiconductor company, we operate in a dynamic environment marked by rapid product obsolescence. Our future success depends on our ability to introduce new or improved silicon and software products that meet customer needs while achieving acceptable margins. We are presently in the process of releasing next generation FPGA product families that are critical to our ability to address the FPGA segment of the programmable logic market. If we fail to introduce these, or other, new products in a timely manner or such products fail to achieve market acceptance, our operating results would be harmed.

Fujitsu Limited has agreed to manufacture our next generation FPGA products on its 130 nanometer and 90 nanometer CMOS process technologies, as well as on a 130 nanometer technology with embedded Flash memory that we have jointly developed with Fujitsu. The success of our next generation FPGA products is dependent on our ability to successfully partner with Fujitsu, which has not previously manufactured any of our products. If for any reason we are unsuccessful in our efforts to partner with Fujitsu in connection with these next generation FPGA products, our future revenue growth would be materially adversely affected.

The introduction of new silicon and software products in a dynamic market environment presents significant business challenges. Product development commitments and expenditures must be made well in advance of product sales. The market reception of new products depends on accurate projections of long-term customer demand, which by their nature are uncertain.

Our future revenue growth is dependent on market acceptance of our new silicon and software product families and the continued market acceptance of our current products. The success of these products is dependent on a variety of specific technical factors including:

·       successful product definition;

·       timely and efficient completion of product design;

·       timely and efficient implementation of wafer manufacturing and assembly processes;

·       product performance;

·       product cost; and

·       the quality and reliability of the product.

27




If, due to these or other factors, our new silicon and software products do not achieve market acceptance, our operating results would be harmed.

Our products may not be competitive if we are unsuccessful in migrating our manufacturing processes to more advanced technologies or alternative fabrication facilities.

To develop new products and maintain the competitiveness of existing products, we need to migrate to more advanced wafer manufacturing processes that use larger wafer sizes and smaller device geometries. We also may need to use additional foundries. Because we depend upon foundries to provide their facilities and support for our process technology development, we may experience delays in the availability of advanced wafer manufacturing process technologies at existing or new wafer fabrication facilities. As a result, volume production of our advanced process technologies at the fabs of Seiko Epson, UMC, Chartered Semiconductor, Fujitsu or future foundries may not be achieved. This could harm our operating results.

The cyclical nature of the semiconductor industry may limit our ability to maintain or increase revenue levels and operating results during industry downturns.

The semiconductor industry is highly cyclical, to a greater extent than other less technology-driven industries. Our financial performance has periodically been negatively affected by downturns in the semiconductor industry. Factors that contribute to these industry downturns include:

·       the cyclical nature of the demand for the products of semiconductor customers;

·       general reductions in inventory levels by customers;

·       excess production capacity;

·       general decline in end-user demand; and

·       accelerated declines in average selling prices.

Historically, the semiconductor industry has experienced periodic downturns of varying degrees of severity and duration. Typically, after such downturns, semiconductor industry conditions improve, although such improvement may not be significant or sustainable. Increased demand for semiconductor industry products may not proportionately increase demand for programmable logic products in general, or our products in particular. Even if demand for our products increases, average sales prices for our products may not increase, and could decline. Whenever adverse semiconductor industry conditions or other similar conditions exist, there is likely to be an adverse effect on our operating results.

A downturn in the communications equipment and computing end markets could cause a reduction in demand for our products and limit our ability to maintain or increase revenue levels and operating results.

The majority of our revenue is derived from customers in the communications equipment and computing end markets. Any deterioration in these end markets or any reduction in technology capital spending could lead to a reduction in demand for our products. Whenever adverse economic or end market conditions exist, there is likely to be an adverse effect on our operating results.

28




We face risks related to implementation of new Sarbanes-Oxley Section 404 Controls Audit requirements.

Section 404 of the Sarbanes-Oxley Act of 2002 requires that our management assess our internal control over financial reporting annually and include a report on its assessment in our annual report. Our independent registered public accounting firm is required to audit both the design and operating effectiveness of our internal controls and management’s assessment of the design and the operating effectiveness of its internal controls. Through its assessment process, management believes there are no known material weaknesses at this time. This is the first year we have undergone an audit of our internal controls and procedures. We will continue to perform similar assessments and it is possible that material weaknesses will be found and reported to our shareholders in the future. Further, if we are unable to remediate any such weaknesses our independent registered public accounting firm may issue an adverse opinion on our internal controls. If this were to occur, particularly in light of our restatement of 2003 quarterly financial statements, investor confidence regarding our internal controls could be harmed and our stock price could decline.

We face risks related to our recent accounting restatement.

On January 22, 2004, we announced that we had discovered possible accounting inaccuracies in previously reported quarterly financial statements. An internal investigation was conducted by the Audit Committee of our Board of Directors to determine the scope and magnitude of these inaccuracies. On March 24, 2004, we announced that the Audit Committee had completed its internal accounting investigation and, as a result, we restated our financial statements for the first, second and third quarters of 2003 to correct inappropriate accounting entries and a failure to record a change in accounting estimate related to deferred income. On April 19, 2004, we filed such restated financial statements with Form 10Q/A for the affected quarters.

The restatement of these financial statements has led to litigation claims and may lead to further litigation claims and/or regulatory proceedings against us. The defense of any such claims or proceedings may cause the diversion of management’s attention and resources, and we may be required to pay damages if any such claims or proceedings are not resolved in our favor. Any litigation or regulatory proceeding, even if resolved in our favor, could cause us to incur significant legal and other expenses. Moreover, we may be the subject of negative publicity focusing on the financial statement inaccuracies and resulting restatement. The occurrence of any of the foregoing could harm our business and reputation and cause the price of our common stock to decline.

If we are unable to effectively and efficiently implement our plan to improve our internal controls there could be a material adverse effect on our operations or financial results.

We received notice from our independent registered public accounting firm that, in connection with the 2003 year-end audit, the independent registered public accounting firm identified a material weakness in our internal controls and procedures relating to separation of duties and establishment of standards for review of journal entries and related file documentation. Although we have implemented various initiatives that have remedied this material weakness, we intend to make additional changes to our internal controls to address the issues that gave rise to the material weakness.

During our 2004 fiscal year end financial statement closing we identified a significant deficiency in our internal controls relating to a mechanical error in calculating a unique inventory allowance, which resulted from manual calculations performed by newly assigned employees who did not recognize that the required allowance had been calculated and recorded by existing procedures. The error was not present in previously issued financial statements and was corrected before the current fiscal year end financial statements were issued. Additional training and review procedures have been instituted to remedy this situation. During 2005 we intend to perform more staff training and staff cross training as well as identify

29




ways to modify and automate our inventory compilation processes to make them less vulnerable to manual errors and implement related procedures.

No assurance can be given that we will be able to successfully implement our revised internal controls and procedures or that our revised controls and procedures will have the desired effect. In addition, we may be required to hire additional employees, and may experience higher than anticipated capital expenditures and operating expenses, during the implementation of these changes and thereafter. Furthermore, future assessments of our internal controls and procedures may reveal new material weaknesses or significant deficiencies. If we are unable to implement the changes to our internal controls and procedures effectively or efficiently, or if we discover additional material weaknesses or significant deficiencies, there could be a material adverse effect on our operations or financial results. Moreover, we could be subject to additional regulatory oversight and our business and reputation could be harmed.

We face risks related to pending litigation.

In September and October 2004, three putative class action complaints were filed in the United States District Court for the District of Oregon against Lattice Semiconductor Corporation, our Chief Executive Officer Cyrus Y. Tsui, and our President Stephen A. Skaggs. These complaints were filed on behalf of a putative class of investors who purchased our stock between April 22, 2003 and April 19, 2004. They generally allege violations of federal securities laws arising out of our previously announced restatement of financial results for the first, second, and third quarters of 2003. Consistent with the usual procedures for cases of this kind, these cases were amended and consolidated into a single action. In such amended and consolidated complaint filed January 27, 2005 our former President and our former Controller were added as defendants. We believe that the complaints are without merit, and we intend to vigorously defend against the lawsuits.

In September and October 2004, two shareholder derivative complaints were filed, purportedly on behalf of Lattice Semiconductor Corporation, in the Circuit Court of the State of Oregon for the County of Washington, against all of our current directors, certain former directors, and certain executive officers. The derivative plaintiffs make allegations substantially similar to those in the putative class action complaints, as well as allegations of breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets, and unjust enrichment. Consistent with the usual procedures for cases of this kind, these cases were consolidated into a single putative shareholder derivative action. An amended and consolidated complaint is expected to be filed by April 1, 2005.

All of the complaints generally seek an unspecified amount of damages, as well as attorney fees and costs. The cases are still in the preliminary stages, and it is not possible for us to quantify the extent of our potential liability, if any. An unfavorable outcome in any of these matters could have a material adverse effect on our business and financial results. In addition, defending any litigation may be costly and divert management’s attention from the day-to-day operations of our business.

We are exposed to certain asserted and unasserted potential claims. There can be no assurance that, with respect to potential claims made against us, we could resolve such claims under terms and conditions that would not have a material adverse effect on our business and financial results.

Our future quarterly operating results may fluctuate and therefore may fail to meet expectations.

Our quarterly operating results have fluctuated and may continue to fluctuate. Consequently, our operating results may fail to meet the expectations of analysts and investors. As a result of industry conditions and the following specific factors, our quarterly operating results are more likely to fluctuate and are more difficult to predict than a typical non-technology company of our size and maturity:

·       general economic conditions in the countries where we sell our products;

30




·       conditions within the end markets into which we sell our products;

·       the cyclical nature of demand for our customers’ products;

·       excessive inventory accumulation by our end customers;

·       the timing of our and our competitors’ new product introductions;

·       product obsolescence;

·       the scheduling, rescheduling and cancellation of large orders by our customers;

·       our ability to develop new process technologies and achieve volume production at the fabs of Seiko Epson, UMC, Chartered Semiconductor, Fujitsu or at other foundries;

·       changes in manufacturing yields including delays in achieving target yields on New products;

·       adverse movements in exchange rates, interest rates or tax rates; and

·       the availability of adequate supply commitments from our wafer foundries and assembly and test subcontractors.

As a result of these factors, our past financial results are not necessarily a good predictor of our future results.

Our stock price may continue to experience large fluctuations.

In recent years, the price of our common stock has fluctuated greatly. These price fluctuations have been rapid and severe and have left investors little time to react. The price of our common stock may continue to fluctuate greatly in the future due to a variety of company specific factors, including:

·       quarter-to-quarter variations in our operating results;

·       shortfalls in revenue or earnings from levels expected by securities analysts; and

·       announcements of technological innovations or new products by other companies.

At December 31, 2004, our book value per share was $4.78, compared to our stock price which has ranged from a low of $3.96 per share to a high of $6.35 per share in the six months ended December 31, 2004. Presently, our stock price is trading near our consolidated book value. Should our stock price drop below book value for a sustained period, it may become necessary to record an impairment charge to goodwill which would reduce our results of operations (see Note 8 of our Consolidated Financial Statements).

Our wafer supply may be interrupted or reduced, which may result in a shortage of products available for sale.

We do not manufacture finished silicon wafers. Currently, our silicon wafers are manufactured by Seiko Epson in Japan, UMC in Taiwan, and Chartered Semiconductor in Singapore. If any of our current or future foundry partners significantly interrupts or reduces our wafer supply, our operating results could be harmed.

In the past, we have experienced delays in obtaining wafers and in securing supply commitments from our foundries. At present, we anticipate that our supply commitments are adequate. However, these existing supply commitments may not be sufficient for us to satisfy customer demand in future periods. Additionally, notwithstanding our supply commitments we may still have difficulty in obtaining wafer deliveries consistent with the supply commitments. We negotiate wafer prices and supply commitments from our suppliers on at least an annual basis. If any of our foundry partners were to reduce its supply

31




commitment or increase its wafer prices, and we cannot find alternative sources of wafer supply, our operating results could be harmed.

Many other factors that could disrupt our wafer supply are beyond our control. Since worldwide manufacturing capacity for silicon wafers is limited and inelastic, we could be harmed by significant industry-wide increases in overall wafer demand or interruptions in wafer supply. Additionally, a future disruption of any of our foundry partners’ foundry operations as a result of a fire, earthquake, act of terrorism, political unrest, governmental uncertainty, war, or other natural disaster or catastrophic event could disrupt our wafer supply and could harm our operating results.

If our foundry partners experience quality or yield problems, we may face a shortage of products available for sale.

We depend on our foundries to deliver reliable silicon wafers with acceptable yields in a timely manner. As is common in our industry, we have experienced wafer yield problems and delivery delays. If our foundries are unable for a prolonged period to produce silicon wafers that meet our specifications, with acceptable yields, our operating results could be harmed.

The majority of our revenue is derived from products based on a specialized silicon wafer manufacturing process technology called E²CMOS®. The reliable manufacture of high performance E²CMOS semiconductor wafers is a complicated and technically demanding process requiring:

·       a high degree of technical skill;

·       state-of-the-art equipment;

·       the absence of defects in production wafers;

·       the elimination of minute impurities and errors in each step of the fabrication process; and

·       effective cooperation between the wafer supplier and us.

As a result, our foundries may experience difficulties in achieving acceptable quality and yield levels when manufacturing our silicon wafers.

If our assembly and test contractors experience quality or yield problems, we may face a shortage of products available for sale.

We rely on contractors to assemble and test our devices with acceptable quality and yield levels. As is common in our industry, we have experienced quality and yield problems in the past. If we experience prolonged quality or yield problems in the future, our operating results could be harmed.

The majority of our revenue is derived from semiconductor devices assembled in advanced packages. The assembly of advanced packages is a complex process requiring:

·       a high degree of technical skill;

·       state-of-the-art equipment;

·       the absence of defects in assembly and packaging manufacturing;

·       the elimination of raw material impurities and errors in each step of the process; and

·       effective cooperation between the assembly contractor and us.

As a result, our contractors may experience difficulties in achieving acceptable quality and yield levels when assembling and testing our semiconductor devices.

32




Deterioration of conditions in Asia may disrupt our existing supply arrangements and result in a shortage of finished products available for sale.

All of our major silicon wafer suppliers operate fabs located in Asia. Our finished silicon wafers are assembled and tested by independent contractors located in China, Japan, Malaysia, the Philippines, South Korea and Taiwan. Economic, financial, social and political conditions in Asia have historically been volatile. Financial difficulties, governmental actions or restrictions, prolonged work stoppages, political unrest, war or any other difficulties experienced by our suppliers may disrupt our supply and could harm our operating results.

Export sales account for a substantial portion of our revenues and may decline in the future due to economic and governmental uncertainties.

Our export sales are affected by unique risks frequently associated with foreign economies including:

·       changes in local economic conditions;

·       exchange rate volatility;

·       governmental controls and trade restrictions;

·       export license requirements and restrictions on the export of technology;

·       political instability, war or terrorism;

·       changes in tax rates, tariffs or freight rates;

·       interruptions in air transportation; and

·       difficulties in staffing and managing foreign sales offices.

We may not be able to successfully compete in the highly competitive semiconductor industry.

The semiconductor industry is intensely competitive and many of our direct and indirect competitors have substantially greater financial, technological, manufacturing, marketing and sales resources. If we are unable to compete successfully in this environment, our future results will be adversely affected.

The current level of competition in the programmable logic market is high and may increase in the future. We currently compete directly with companies that have licensed our technology or have developed similar products. We also compete indirectly with numerous semiconductor companies that offer products based on alternative technical solutions. These direct and indirect competitors are established multinational semiconductor companies as well as emerging companies.

We may fail to retain or attract the specialized technical and management personnel required to successfully operate our business.

To a greater degree than most non-technology companies or larger technology companies, our future success depends on our ability to attract and retain highly qualified technical and management personnel. As a mid-sized company, we are particularly dependent on a relatively small group of key employees. Competition for skilled technical and management employees is intense within our industry. As a result, we may not be able to retain our existing key technical and management personnel. In addition, we may not be able to attract additional qualified employees in the future. If we are unable to retain existing key employees or are unable to hire new qualified employees, our operating results could be adversely affected.

33




If we are unable to adequately protect our intellectual property rights, our financial results and competitive position may suffer.

Our success depends in part on our proprietary technology. However, we may fail to adequately protect this technology. As a result, we may lose our competitive position or face significant expense to protect or enforce our intellectual property rights.

We intend to continue to protect our proprietary technology through patents, copyrights and trade secrets. Despite this intention, we may not be successful in achieving adequate protection. Claims allowed on any of our patents may not be sufficiently broad to protect our technology. Patents issued to us also may be challenged, invalidated or circumvented. Finally, our competitors may develop similar technology independently.

Companies in the semiconductor industry vigorously pursue their intellectual property rights. If we become involved in protracted intellectual property disputes or litigation we may be forced to use substantial financial and management resources, which could have an adverse effect on our operating results.

Our industry is characterized by frequent claims regarding patents and other intellectual property rights of others. We have been, and from time-to-time expect to be, notified of claims that we are infringing the intellectual property rights of others. If any third party makes a valid claim against us, we could face significant liability and could be required to make material changes to our products and processes. In response to any claims of infringement, we may seek licenses under patents that we are alleged to be infringing. However, we may not be able to obtain a license on favorable terms, or at all, without our operating results being adversely affected.

Our marketable securities, which we hold for strategic reasons, are subject to equity price risk and their value may fluctuate.

Currently we hold substantial equity in UMC, which we acquired as part of a strategic investment to obtain certain manufacturing rights. The market price and valuation of these equity shares has fluctuated widely due to business, stock market or other conditions over which we have little control. During the year ended December 31, 2001, we recorded a pre-tax impairment loss related to this investment. In the future, UMC shares may continue to experience significant price volatility. In 2002 and in 2004, we sold a portion of our UMC shares, but have otherwise not attempted to reduce or eliminate this equity price risk through hedging or similar techniques and hence substantial, sustained changes in the market price of UMC shares could impact our financial results. To the extent that the market value of our UMC shares experiences a significant decline for an extended period of time, our operating results could be adversely affected.

Changes in accounting for equity compensation will adversely affect operating results and could adversely affect our ability to attract and retain employees.

We have historically used stock options as a key component of employee compensation in order to align employees’ interests with the interests of our stockholders, encourage employee retention, and provide competitive compensation packages. The Financial Accounting Standards Board has adopted changes to generally accepted accounting principles that require us and other companies to record a charge to earnings for employee stock option grants and other equity incentives beginning in the quarter ended September 30, 2005. To the extent that these or other new regulations make it more difficult or expensive to grant options to employees, we will incur increased compensation costs. We may also change our equity compensation strategy or find it difficult to attract, retain and motivate employees. Any of these results could materially and adversely affect our business.

34




Item 7(a). Quantitative and Qualitative Disclosures About Market Risk.

As of December 31, 2004 and December 31, 2003 our investment portfolio consisted of fixed income securities of $287.0 million and $275.0 million, respectively. As with all fixed income instruments, these securities are subject to interest rate risk and will decline in value if market interest rates increase. If market rates were to increase immediately and uniformly by 10% from levels as of December 31, 2004 and December 31, 2003, the decline in the fair value of our portfolio would not be material. Furthermore, we have the ability to hold our fixed income investments until maturity and, therefore, we would not expect to recognize such an adverse impact in our results from operations or statement of cash flows.

We have international subsidiary and branch operations. Additionally, we sell products to Japanese customers denominated in Yen. We therefore are subject to foreign currency rate exposure. To minimize foreign exchange risk related to Yen-based net assets on our Consolidated Balance Sheet, on August 11, 2004, we entered into an agreement with a bank under the terms of which we can borrow up to $6.0 million in Japanese Yen in a revolving line of credit arrangement. Outstanding borrowing is collateralized by marketable securities. Interest on outstanding borrowing is based on the Japanese LIBOR Fixed Rate, and averaged 1.04% for the year ended December 31, 2004. Outstanding borrowing at December 31, 2004 was $2.9 million. This arrangement can be terminated at anytime by either party.

We are exposed to equity price risk due to our equity investment in UMC (see note 7 to our Consolidated Financial Statements). Neither a 10% increase nor a further 10% decrease in equity price related to this investment would have a material effect on our Consolidated Financial Statements as of December 31, 2004 or December 31, 2003. We have not attempted to reduce or eliminate this equity price risk through hedging or similar techniques. As a result, sustained changes in the market price of UMC shares could impact our financial results. To the extent that the market value of our UMC shares experiences further deterioration for an extended period of time, our operating results could be adversely affected.

35




 

Item 8. Financial Statements and Supplementary Data.

Index to Consolidated Financial Statements and Consolidated Financial Statement Schedules

 

Page

 

Consolidated Financial Statements:

 

 

 

 

Consolidated Balance Sheet, December 31, 2004 and December 31, 2003

 

37

 

 

Consolidated Statement of Operations, Years ended December 31, 2004, 2003 and 2002

 

38

 

 

Consolidated Statement of Changes in Stockholders’ Equity, Years ended December 31, 2004, 2003 and 2002

 

39

 

 

Consolidated Statement of Cash Flows, Years ended December 31, 2004, 2003 and 2002

 

40

 

 

Notes to Consolidated Financial Statements

 

41

 

 

Report of Independent Registered Public Accounting Firm

 

62

 

 

Consolidated Financial Statement Schedule:

 

 

 

 

Schedule II-Valuation and Qualifying Accounts

 

S-1

 

 

 

36




LATTICE SEMICONDUCTOR CORPORATION
CONSOLIDATED BALANCE SHEET
(in thousands, except share and par value amounts)

 

 

December 31,
2004

 

December 31,
2003

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

$

44,816

 

 

 

$

35,276

 

 

Marketable securities

 

 

251,479

 

 

 

242,474

 

 

Accounts receivable, net

 

 

19,587

 

 

 

26,796

 

 

Inventories (note 2)

 

 

38,634

 

 

 

46,630

 

 

Prepaid expenses and other current assets (notes 7 and 11)

 

 

22,325

 

 

 

16,173

 

 

Equity securities available for sale (note 7)

 

 

24,202

 

 

 

35,364

 

 

Total current assets

 

 

401,043

 

 

 

402,713

 

 

Foundry investments, advances and other assets (note 7)

 

 

97,877

 

 

 

86,883

 

 

Property and equipment, less accumulated depreciation (note 3)

 

 

47,586

 

 

 

53,800

 

 

Intangible assets, less accumulated amortization (notes 4, 5, 6 and 8)

 

 

40,795

 

 

 

84,627

 

 

Goodwill (notes 5 and 6)

 

 

223,605

 

 

 

223,605

 

 

 

 

 

$

810,906

 

 

 

$

851,628

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

$

46,364

 

 

 

$

15,376

 

 

Accrued payroll obligations

 

 

14,774

 

 

 

13,124

 

 

Income taxes payable (note 11)

 

 

23

 

 

 

37

 

 

Deferred income

 

 

11,399

 

 

 

10,564

 

 

Total current liabilities

 

 

72,560

 

 

 

39,101

 

 

Zero Coupon Convertible Subordinated Notes due in 2010
(notes 12 and 18)

 

 

169,000

 

 

 

184,000

 

 

Other long-term liabilities (note 14)

 

 

26,755

 

 

 

22,415

 

 

Commitments and contingencies (notes 7, 10, 14, and 15)

 

 

 

 

 

 

 

Stockholders’ equity (note 13):

 

 

 

 

 

 

 

 

 

Preferred stock, $.01 par value, 10,000,000 shares authorized; none issued and outstanding

 

 

 

 

 

 

 

Common stock, $.01 par value, 300,000,000 shares authorized; 113,610,000 and 113,040,000 shares issued and outstanding

 

 

1,136

 

 

 

1,130

 

 

Paid-in capital

 

 

590,270

 

 

 

586,834

 

 

Deferred stock compensation

 

 

(1,867

)

 

 

(5,444

)

 

Accumulated other comprehensive income

 

 

1,642

 

 

 

20,203

 

 

(Deficit) retained earnings

 

 

(48,590

)

 

 

3,389

 

 

 

 

 

542,591

 

 

 

606,112

 

 

 

 

 

$

810,906

 

 

 

$

851,628

 

 

 

The accompanying notes are an integral part of this statement.

37




LATTICE SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except per share amounts)

 

 

Year Ended December 31,

 

 

 

2004

 

2003

 

2002

 

Revenue (note 17)

 

$

225,832

 

$

209,662

 

$

229,126

 

Costs and expenses:

 

 

 

 

 

 

 

Cost of products sold

 

96,857

 

89,266

 

91,546

 

Research and development

 

90,957

 

87,092

 

85,776

 

Selling, general and administrative (note 16)

 

53,803

 

50,773

 

48,099

 

In-process research and development (notes 4 and 5)

 

 

 

29,853

 

Amortization of intangible assets (1) (notes 4, 5, 6 and 8)

 

47,249

 

77,127

 

73,415

 

 

 

288,866

 

304,258

 

328,689

 

Loss from operations

 

(63,034

)

(94,596

)

(99,563

)

Interest and other income (expense), net:

 

 

 

 

 

 

 

Interest income

 

4,409

 

3,635

 

5,362

 

Interest expense (note 12)

 

(16

)

(7,140

)

(12,611

)

Other income, net (notes 7 and 12)

 

6,980

 

441

 

13,443

 

 

 

11,373

 

(3,064

)

6,194

 

Loss before (benefit) provision for income taxes

 

(51,661

)

(97,660

)

(93,369

)

Provision (Benefit) for income taxes (note 11)

 

318

 

(5,854

)

81,866

 

Net loss

 

$

(51,979

)

$

(91,806

)

$

(175,235

)

Basic net loss per share

 

$

(0.46

)

$

(0.82

)

$

(1.59

)

Diluted net loss per share

 

$

(0.46

)

$

(0.82

)

$

(1.59

)

Shares used in per share calculations:

 

 

 

 

 

 

 

Basic

 

112,976

 

111,794

 

110,193

 

Diluted

 

112,976

 

111,794

 

110,193

 

 


(1)          Includes $3,418, $5,745, and $2,962 of amortization of deferred stock compensation expense for the years ended December 31, 2004, December 31, 2003 and December 31, 2002, respectively attributable to research and development activities.

The accompanying notes are an integral part of this statement.

38




LATTICE SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands, except par value)

 

 

Common stock
($.01 par value)

 

Paid-in

 

Deferred
Stock

 

Accumulated
other
comprehensive

 

Retained
earnings

 

 

 

 

 

Shares

 

 Amount 

 

capital

 

comp.

 

(loss) income

 

(Deficit)

 

Total

 

Balances, Dec. 31, 2001

 

109,428

 

 

$

1,094

 

 

$

548,053

 

$

(2,739

)

 

$

22,932

 

 

$

270,430

 

$

839,770

 

Common stock issued

 

2,930

 

 

30

 

 

20,287

 

 

 

 

 

 

20,317

 

Tax benefit of option exercises

 

 

 

 

 

884

 

 

 

 

 

 

884

 

Recognized gain on sale of foundry investment, previously unrealized

 

 

 

 

 

 

 

 

(3,398

)

 

 

 

Unrealized loss on foundry
investments

 

 

 

 

 

 

 

 

(24,878

)

 

 

 

Deferred stock compensation

 

 

 

 

 

11,763

 

(11,763

)

 

 

 

 

 

Amortization of deferred stock compensation

 

 

 

 

 

 

2,962

 

 

 

 

 

2,962

 

Translation adjustments

 

 

 

 

 

 

 

 

713

 

 

 

 

Net loss for 2002

 

 

 

 

 

 

 

 

 

 

(175,235

)

 

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(202,798

)

Balances, Dec. 31, 2002

 

112,358

 

 

1,124

 

 

580,987

 

(11,540

)

 

(4,631

)

 

95,195

 

661,135

 

Common stock issued

 

682

 

 

6

 

 

6,198

 

 

 

 

 

 

6,204

 

Unrealized gain on other investments

 

 

 

 

 

 

 

 

49

 

 

 

 

Unrealized gain on foundry
investments

 

 

 

 

 

 

 

 

24,583

 

 

 

 

Deferred stock compensation

 

 

 

 

 

(351

)

351

 

 

 

 

 

 

Amortization of deferred stock compensation

 

 

 

 

 

 

5,745

 

 

 

 

 

5,745

 

Translation adjustments

 

 

 

 

 

 

 

 

202

 

 

 

 

Net loss for 2003

 

 

 

 

 

 

 

 

 

 

(91,806

)

 

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(66,972

)

Balances, Dec. 31, 2003

 

113,040

 

 

1,130

 

 

586,834

 

(5,444

)

 

20,203

 

 

3,389

 

606,112

 

Common stock issued

 

570

 

 

6

 

 

3,595

 

 

 

 

 

 

3,601

 

Unrealized loss on foundry
investments

 

 

 

 

 

 

 

 

(13,211

)

 

 

 

Unrealized gain on other investments

 

 

 

 

 

 

 

 

292

 

 

 

 

Recognized gain on sale of foundry investment previously unrealized

 

 

 

 

 

 

 

 

(5,556

)

 

 

 

Deferred stock compensation

 

 

 

 

 

(159

)

159

 

 

 

 

 

 

Amortization of deferred stock compensation

 

 

 

 

 

 

3,418

 

 

 

 

 

3,418

 

Translation adjustments

 

 

 

 

 

 

 

 

(86

)

 

 

 

Net loss for 2004

 

 

 

 

 

 

 

 

 

 

(51,979

)

 

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(70,540

)

Balances, Dec. 31, 2004

 

113,610

 

 

$

1,136

 

 

$

590,270

 

$

(1,867

)

 

$

1,642

 

 

$

(48,590

)

$

542,591

 

 

The accompanying notes are an integral part of this statement.

39




LATTICE SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENT OF CASH FLOWS
(in thousands)

 

 

Year Ended December 31,

 

 

 

2004

 

2003

 

2002

 

Cash flow from operating activities:

 

 

 

 

 

 

 

Net loss

 

$

(51,979

)

$

(91,806

)

$

(175,235

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

68,776

 

99,902

 

94,375

 

Gain on value of foundry investments

 

 

 

(4,017

)

Gain on sale of equity securities

 

(6,071

)

(271

)

 

Loss (gain) on extinguishment of convertible notes

 

(2,756

)

1,381

 

(9,341

)

Tax benefit of option exercises

 

 

 

884

 

In process research and development

 

 

 

29,853

 

Changes in assets and liabilities (net of purchase accounting adjustments)

 

 

 

 

 

 

 

Accounts receivable

 

7,209

 

(422

)

(6,922

)

Inventories

 

7,996

 

9,609

 

12,157

 

Prepaid expenses and other current assets

 

(6,152

)

25,062

 

4,730

 

Deferred income taxes

 

 

 

110,792

 

Foundry investments, advances and other assets

 

(46,271

)

1,101

 

3,562

 

Accounts payable and accrued expenses

 

28,658

 

(3,211

)

(3,497

)

Accrued payroll obligations

 

1,650

 

(519

)

(2,099

)

Income taxes payable

 

(14

)

124

 

(2,609

)

Deferred income

 

835

 

(1,419

)

(6,120

)

Other liabilities

 

4,078

 

(4,753

)

(515

)

Net cash provided by operating activities

 

5,959

 

34,778

 

45,998

 

Cash flow from investing activities:

 

 

 

 

 

 

 

Proceeds from sales or maturities of marketable securities

 

248,838

 

420,543

 

306,923

 

Purchase of marketable securities

 

(257,843

)

(555,612

)

(132,965

)

Acquisition of Agere FPGA

 

 

 

(254,232

)

Other acquisition costs

 

 

 

(2,530

)

Proceeds from sale of equity securities (principally UMC common stock)

 

29,612

 

745

 

9,930

 

Purchase of equity securities

 

 

(474

)

 

Capital expenditures

 

(10,725

)

(9,793

)

(17,451

)

Net cash provided by (used in) investing activities

 

9,882

 

(144,591

)

(90,325

)

Cash flow from financing activities:

 

 

 

 

 

 

 

Extinguishment of 43¤4% Convertible Subordinated Notes

 

 

(223,684

)

(42,077

)

(Extinguishment) Issuance of Zero Coupon Convertible Subordinated Notes

 

(11,999

)

194,597

 

 

Advances of Yen line of credit

 

5,588

 

 

 

Paydown on Yen line of credit

 

(3,076

)

 

 

Net proceeds from issuance of common stock

 

3,186

 

4,701

 

5,676

 

Net cash used by financing activities

 

(6,301

)

(24,386

)

(36,401

)

Net increase (decrease) in cash and cash equivalents

 

9,540

 

(134,199

)

(80,728

)

Beginning cash and cash equivalents

 

35,276

 

169,475

 

250,203

 

Ending cash and cash equivalents

 

$

44,816

 

$

35,276

 

$

169,475

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

 

 

 

Unrealized gain (loss) on foundry investments included in Accumulated other comprehensive income

 

$

(13,211

)

$

24,583

 

$

(24,878

)

Stock and options issued in conjunction with acquisition of Cerdelinx

 

$

 

$

 

$

21,703

 

 

The accompanying notes are an integral part of this statement.

40




LATTICE SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1)—Nature of Operations and Significant Accounting Policies:

Nature of Operations

Lattice Semiconductor Corporation designs, develops and markets high performance programmable logic products and related software. Programmable logic products are widely-used semiconductor components that can be configured by end customers as specific logic circuits, and thus enable shorter design cycle times and reduced development costs. Our end customers are primarily original equipment manufacturers in the communications, computing, consumer, industrial, automotive, medical and military end markets.

We do not manufacture our own silicon wafers. We maintain strategic relationships with large semiconductor foundries to source our finished silicon wafers in Asia. In addition, all of our assembly operations and most of our test operations are performed by outside suppliers in Asia. We perform certain test operations and reliability and quality assurance processes internally. We have achieved an ISO 9001 quality certification, which is an indication of our high internal operational standards.

We place substantial emphasis on new product development. Our product development activities emphasize new proprietary products, enhancement of existing products and process technologies and improvement of software development tools. Product development activities occur in Hillsboro, Oregon; San Jose, California; Broomfield, Colorado; Naperville, Illinois; Bethlehem, Pennsylvania; Austin, Texas; Salt Lake City, Utah; Shanghai, China; and Chippenham, England.

Fiscal Reporting Period

We report based on a 52 or 53 week year ending on the Saturday closest to December 31. For ease of presentation, we have adopted the convention of using March 31, June 30, September 30 and December 31 as period end dates for all financial statement captions. Our fiscal 2004 and 2002 were 52-week years. Our 2003 fiscal year was a 53-week year.

Principles of Consolidation

On August 26, 2002, we completed the stock for stock acquisition of Cerdelinx Technologies, Inc. (“Cerdelinx”) for 2.6 million shares valued at $8.30 per share. This transaction was accounted for as a purchase, and accordingly, the results of operations for Cerdelinx and estimated fair value of assets acquired and liabilities assumed are included in our Consolidated Financial Statements beginning August 26, 2002. This acquisition is discussed further in Note 4.

On January 18, 2002, we completed the acquisition of the field-programmable gate array (“FPGA”) business (“Agere FPGA”) of Agere Systems Inc. (“Agere”) for $250 million in cash. This transaction was accounted for as a purchase, and accordingly, the results of operations for Agere FPGA and estimated fair value of assets acquired and liabilities assumed are included in our Consolidated Financial Statements beginning January 18, 2002. This acquisition is discussed further in Note 5.

On June 15, 1999, we completed the acquisition of all of the outstanding capital stock of Vantis Corporation (“Vantis”) from Advanced Micro Devices, Inc. (“AMD”). The transaction was accounted for as a purchase, and accordingly, the results of operations of Vantis and estimated fair value of assets acquired and liabilities assumed are included in our Consolidated Financial Statements beginning June 16, 1999. This acquisition is discussed further in Note 6.

41




The accompanying Consolidated Financial Statements include the accounts of Lattice Semiconductor Corporation and its subsidiaries, all wholly-owned, after the elimination of all significant intercompany balances and transactions.

Cash Equivalents and Marketable Securities

We consider all investments, which are readily convertible into cash and have original maturities of three months or less, to be cash equivalents. Marketable securities, which are relatively less liquid and have maturities of less than one year, were composed of corporate auction rate securities ($74.6 million and $81.6 million), municipal and local government obligations ($134.6 million and $139.2 million), corporate notes and paper ($34.8 million and $21.7 million), and certificates of deposit collateralizing the yen line of credit ($7.5 million and $0.0 million) at December 31, 2004 and December 31, 2003, respectively.

We account for our marketable securities as available for sale. The carrying value of marketable securities approximates fair value and no realized or unrealized gains or losses have been incurred.

Financial Instruments

The carrying value of our financial instruments approximates fair value. We estimate the fair value of cash and cash equivalents, marketable securities, accounts receivable, other current assets and current liabilities based upon existing interest rates related to such assets and liabilities compared to the current market rates of interest for instruments of similar nature and degree of risk. See Note 12 for a discussion of the fair value of our convertible debt.

Derivative Financial Instruments

As of December 31, 2004, 2003 and 2002 and for the years then ended, we had no outstanding derivatives, including foreign exchange contracts for the purchase or sale of foreign currencies. We do not enter into derivative financial instruments for trading purposes.

Foreign Exchange and Translation of Foreign Currencies

A portion of our silicon wafer purchases are denominated in Japanese yen and we bill our Japanese customers in yen. We maintain a yen-denominated bank account and, beginning in August, 2004 we began using a yen denominated line of credit (see Note 9). Gains or losses from foreign exchange rate fluctuations on unhedged balances denominated in foreign currencies are reflected in Interest and other income (expense). Realized and unrealized gains or losses were not significant for the years presented. We translate accounts denominated in foreign currencies in accordance with SFAS No. 52, “Foreign Currency Translation.” Translation adjustments related to the consolidation of foreign subsidiary financial statements are reflected in Accumulated other comprehensive income in Stockholders’ equity.

Concentrations of Credit Risk

Financial instruments which potentially expose us to concentrations of credit risk consist primarily of marketable securities and trade receivables. We place our investments through several financial institutions and mitigate the concentration of credit risk by placing percentage limits on the maximum portion of the investment portfolio which may be invested in any one investment instrument. Investments consist primarily of A1 and P1 or better rated U.S. commercial paper, U.S. government agency obligations and other money market instruments, “AA” or better rated municipal obligations, money market preferred stocks and other time deposits. Concentrations of credit risk with respect to trade receivables are mitigated by a geographically diverse customer base and our credit and collection process. Accounts receivable are recorded at the invoice amount, do not bear interest, and are shown net of allowances for doubtful accounts of $0.9 million and $1.0 million at December 31, 2004 and 2003, respectively. We perform credit

42




evaluations for all customers and secure transactions with letters of credit or advance payments where necessary. We review our allowance for doubtful accounts monthly and the aging of our accounts receivable weekly. Write-offs for uncollected trade receivables have not been significant to date.

Revenue Recognition

Revenue from sales to OEM customers is recognized upon shipment provided that persuasive evidence of an arrangement exists, the price is fixed and determinable, title has transferred, collection of resulting receivables is probable, there are no customer acceptance requirements and no remaining significant obligations. Certain of our sales are made to distributors under agreements providing price protection and right of return on unsold merchandise. Revenue and cost relating to such distributor sales are deferred either until the product is sold by the distributor or return privileges and price protection rights terminate, and related estimated revenue and estimated costs are then reflected in income. Revenue from software sales was not material for the years presented.

Inventories

Inventories are stated at the lower of first-in, first-out cost or market.

Long-Lived Assets

We account for our long-lived assets, primarily property and equipment and amortizable intangible assets, in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 144, “Accounting for the Disposal of Long-Lived Assets,” which requires us to review the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment is determined by comparing the estimated undiscounted cash flows to the carrying amount. A loss is recorded if the carrying amount of the asset exceeds the estimated undiscounted cash flows. Intangible assets are generally being amortized over five years, and fifteen years for income tax purposes, on a straight-line basis.

Property and Equipment

Property and equipment are stated at cost. Depreciation is computed using the straight-line method for financial reporting purposes over the estimated useful lives of the related assets, generally three to five years for equipment and software and thirty years for buildings. Accelerated methods of computing depreciation are generally used for income tax purposes.

Goodwill

We measure the carrying value of goodwill recorded in connection with our acquisitions (see Notes 4, 5 and 6) for potential impairment in accordance with SFAS No. 142, “Goodwill and Other Intangible Assets.” To apply SFAS No. 142, a company is divided into separate “reporting units,” each representing groups of products that are separately managed. For this purpose, we have one reporting unit. To determine whether or not goodwill may be impaired, a test is required comparing the book value of the “reporting unit” to its trading price. Similar tests are required in the future, at least annually, and more often where there is a change in circumstances that could result in an impairment of goodwill. If the trading price of our common stock is below the book value for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value (trading price plus a control premium). The excess of book value over estimated market value will then be subtracted from the goodwill account with a resulting charge to operations. Subsequent unrealized recoveries in market value, if any, will not be recorded. We completed an initial goodwill impairment assessment as of January 1, 2002 to determine if a transition impairment charge should be recognized under SFAS No. 142. Upon assessment,

43




no transition impairment charge was recorded. We also completed our annual goodwill impairment assessment in December 2004, upon which no impairment charge was recorded.

Research and Development

Research and development costs are expensed as incurred.

Stock-Based Compensation

We account for our employee and director stock options and employee stock purchase plan in accordance with provisions of Accounting Principles Board Opinion No. 25 (“APB 25”), “Accounting for Stock Issued to Employees.” Pro forma disclosures as required under SFAS No. 123, “Accounting for Stock-Based Compensation” and as amended by SFAS No. 148, “Accounting for Stock-Based Compensation-Transition and Disclosure,” are presented below (also see Note 13). The “in the money” portion of stock options granted to employees in connection with acquisitions is accounted for as Deferred stock compensation in Stockholders’ equity and amortized to operations as part of Amortization of intangible assets over the vesting periods of the options.

Our pro forma information is as follows (in thousands, except per share data):

 

 

Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

Net loss, as reported

 

$

(51,979

)

$

(91,806

)

$

(175,235

)

Add: Stock based employee compensation expense included in reported net loss, net of related tax effects

 

3,418

 

5,745

 

2,962

 

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

 

(18,029

)

(28,205

)

(34,068

)

Pro forma net loss

 

$

(66,590

)

$

(114,266

)

$

(206,341

)

Earnings per share:

 

 

 

 

 

 

 

Basic—as reported

 

$

(0.46

)

$

(0.82

)

$

(1.59

)

Basic—pro forma

 

$

(0.59

)

$

(1.02

)

$

(1.87

)

Diluted—as reported

 

$

(0.46

)

$

(0.82

)

$

(1.59

)

Diluted—pro forma

 

$

(0.59

)

$

(1.02

)

$

(1.87

)

 

44




Net Loss Per Share

Net loss per share is computed based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of stock options, warrants to purchase common stock and convertible subordinated notes. The most significant difference between basic and diluted net income per share is that basic net income per share does not treat potentially dilutive securities such as convertible subordinated notes, options and warrants as outstanding. Diluted loss per common share for 2004, 2003 and 2002 is based only on the weighted-average number of common shares outstanding during these periods, as the inclusion of options, warrants and convertible subordinated notes, aggregating approximately 18.4 million, 23.6 million, and 20.5 million shares for 2004, 2003 and 2002, respectively, would have been antidilutive. The options, warrants and convertible notes however, could be dilutive in the future. A reconciliation of the numerators and denominators of basic and diluted net income per share is presented below (in thousands, except per share data):

 

 

Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

Basic and diluted net loss

 

$

(51,979

)

$

(91,806

)

$

(175,235

)

Shares used in basic net loss per share calculations

 

112,976

 

111,794

 

110,193

 

Dilutive effect of stock options, warrants and convertible subordinated notes

 

 

 

 

Shares used in diluted net income per share calculations

 

112,976

 

111,794

 

110,193

 

Basic net loss per share

 

$

(0.46

)

$

(0.82

)

$

(1.59

)

Diluted net loss per share

 

$

(0.46

)

$

(0.82

)

$

(1.59

)

 

Comprehensive Loss

For 2002, comprehensive loss consists primarily of net loss of approximately $175.2 million, unrealized loss on depreciation of our foundry investments of approximately $24.9 million and recognized gain on sale of foundry investments previously unrealized of approximately $3.4 million (see Note 7). For 2003, comprehensive loss consists primarily of net loss of approximately $91.8 million offset by unrealized gains related to the market value of our foundry investments of approximately $24.6 million. For 2004, comprehensive loss consists primarily of net loss of approximately $52.0 million and an unrealized loss recorded related to the market value of our foundry investments of approximately $13.2 million.

Statement of Cash Flows

Income taxes paid approximated $1.0 million in 2004. During 2003 and 2002, respectively, we received income tax refunds, net of payments, of approximately $28.4 million and $37.2 million. Interest paid was insignificant in 2004, and aggregated approximately $6.4 million and $12.0 million in 2003 and 2002, respectively.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, such as accounts receivable, inventory and deferred income taxes and liabilities, such as accrued liabilities, income taxes and deferred income, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the fiscal periods presented. Actual results could differ from those estimates.

45




New Accounting Pronouncements

In March 2004, the Emerging Issues Task Force reached a consensus on recognition and measurement guidance previously discussed under EITF 03-01. The consensus clarifies the meaning of other-than-temporary impairment and its application to investments classified as either available-for-sale or held-to-maturity under SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities.” The recognition and measurement guidance for which the consensus was reached in the March 2004 meeting is to be applied to other-than-temporary impairment evaluations in reporting periods beginning after June 15, 2004. In November 2004, the FASB staff indicated that the FASB will delay until 2005 the FASB Staff Position on EITF Issue No. 03-01, “The Meaning of Other-Than-Temporary Impairment and its Application to Certain Investments.” Management will evaluate the affect of adopting the recognition and measurement guidance when the matter is finalized.

In December 2004, the FASB issued a Statement “Share Based Payment—a revision of SFAS No. 123, “Accounting for Stock Based Compensation,” that addresses the accounting for share-based payment transactions in which a company receives employee services in exchange for either equity instruments of the company or liabilities that are based on the fair value of the company’s equity instruments or that may be settled by the issuance of such equity instruments. The statement eliminates the ability to account for share-based compensation transactions using the intrinsic method currently used by the company and generally would require that such transactions be accounted for using a fair-value-based method and recognized as expense in the company’s Consolidated Statement of Operations. The effective date of the standard is for interim or fiscal periods beginning after June 15, 2005. This statement will have a significant impact on our Consolidated Statement of Operations, as we will be required to expense the fair value of our stock option grants and stock purchases under our employee stock purchase plan. At this time we have not made an estimate of the impact of this statement on our future financial result. Please refer to Note 13 to our Consolidated Financial Statements which provides historical information that may be useful in assessing the impact of this standard on our Consolidated Financial Statements.

(2)—Inventories (in thousands):

 

 

December 31,

 

 

 

2004

 

2003

 

Work in progress

 

$

29,148

 

$

34,327

 

Finished goods

 

9,486

 

12,303

 

 

 

$

38,634

 

$

46,630

 

 

(3)—Property and Equipment (in thousands):

 

 

December 31,

 

 

 

2004

 

2003

 

Land

 

$

2,099

 

$

2,099

 

Construction in progress

 

910

 

 

Buildings

 

28,087

 

28,087

 

Computer and test equipment

 

132,931

 

125,481

 

Office furniture and equipment

 

11,041

 

11,414

 

Leasehold and building improvements

 

15,216

 

14,617

 

 

 

190,284

 

181,698

 

Accumulated depreciation and amortization

 

(142,698

)

(127,898

)

 

 

$

47,586

 

$

53,800

 

 

Depreciation expense was approximately $16.9 million, $18.6 million, and $19.2 million for 2004, 2003, and 2002, respectively.

46




(4)—Acquisition of Cerdelinx:

On August 26, 2002, we completed the stock for stock acquisition of Cerdelinx for 2.6 million shares of our common stock valued at $8.30 per share. Cerdelinx was an early stage fabless semiconductor company focused on the design of application specific standard products targeted toward emerging high-speed communications and storage applications. Cerdelinx had a team of engineers who were developing a portfolio of low-power CMOS transceivers and backplane interfaces with embedded high-speed SERDES I/O to support 10 gigabit-per-second applications. The acquisition serves to enhance our silicon development efforts and our ability to deliver leading-edge programmable solutions within the communications and storage market segments. This acquisition principally comprises intellectual property and a work force. The core technology portion of the intellectual property is valued using a royalty savings methodology which discounts estimated royalties that would be paid on an after tax basis. The in-process technology portion of the intellectual property is valued using a discounted cash flow methodology described in detail below. Work force is valued using a replacement cost methodology which discounts costs to an after tax amount. The transaction was completed pursuant to an Agreement and Plan of Reorganization entered into on July 15, 2002, as amended on July 24, 2002, among Lattice, Cerdelinx and affiliated parties. The components of the purchase price were as follows (in millions):

 

 

Amount

 

Stock issued and liabilities assumed

 

 

$

22.8

 

 

Estimated direct acquisition costs

 

 

1.1

 

 

Total

 

 

$

23.9

 

 

 

In conformity with Financial Accounting Standard SFAS No. 142, the total purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed. As Cerdelinx was not considered a business under SFAS No. 141, “Business Combinations,” no goodwill was recognized. In estimating the fair value of the assets acquired, management considered various factors, including an appraisal. The total purchase price was allocated as follows (in millions):

 

 

Amount

 

Core technology

 

 

$

7.2

 

 

Deferred stock compensation

 

 

5.8

 

 

In process research and development costs

 

 

5.7

 

 

Work force

 

 

4.7

 

 

Liabilities assumed

 

 

(1.2

)

 

Equipment

 

 

1.1

 

 

Non compete agreement

 

 

0.3

 

 

Cash

 

 

0.3

 

 

Total

 

 

$

23.9

 

 

 

There were no significant exit costs incurred or accrued in connection with this transaction. Management does not expect intangible assets acquired to be deductible for income tax purposes.

Employees who joined Lattice as a result of this acquisition held Cerdelinx shares and options which were converted into 0.9 million Lattice shares and options which were either unvested or otherwise restricted from sale over terms up to four years at a grant price from $0.41 per share to $2.54 per share. The spread, which is the difference between grant price and market value of our common stock on the Closing Date, aggregating $5.8 million on these shares and options, was recorded as Paid-in capital and Deferred stock compensation and is being amortized to operations equally over the vesting (or restriction lapsing) period as part of Amortization of intangible assets.

47




In-Process Research and Development (“IPR&D”)

IPR&D consisted of those products obtained through acquisition that were not yet proven to be technologically feasible but had been developed to a point where there was value associated with them in relation to potential future revenue. Because technological feasibility was not yet proven and no alternative future uses were believed to exist for the in-process technologies, the assigned value was expensed immediately after the closing of the acquisition.

The fair value underlying the $5.7 million assigned to acquired IPR&D from the Cerdelinx acquisition (recognized in the third quarter of 2002) was determined by identifying research projects in areas for which technological feasibility had not been established and there were no alternative future uses. The acquired IPR&D consists of low-power CMOS transceivers and backplane interfaces with embedded high-speed SERDES I/O. These products were approximately 60% complete and were estimated to be completed in 2003 at an estimated cost of approximately $2.0 million. During 2004, new products based on this technology were completed. In addition, this technology along with subsequently developed technology is being integrated into other new products expected to be completed in 2005.

The fair value was determined by an income approach where fair value is the present value of projected free cash flows that will be generated by the products incorporating the acquired technologies under development, assuming they are successfully completed. The estimated net free cash flows generated by the products over six year periods were discounted at rates ranging from 15% to 17% in relation to the stage of completion and the technical risks associated with achieving technological feasibility. The net cash flows for such projects were based on management’s estimates of revenue, expenses and asset requirements.

The remaining project has completion risks related to silicon functionality, architecture performance, packaging technology, continued availability of key technical personnel and, product reliability. To the extent that estimated completion dates are not met, the risk of competitors’ product introductions is greater and revenue opportunity may be permanently lost.

The core technology included in the acquisition of Cerdelinx has an estimated weighted average useful life of approximately six years, and the work force and non-compete agreements included in the Cerdelinx acquisition had estimated useful lives of approximately four years resulting in a weighted average useful life of approximately five years.

(5)—Acquisition of Agere FPGA:

On January 18, 2002, we completed the acquisition of Agere FPGA for $250 million in cash. This acquisition increased our share of the PLD market, accelerated our entry into the FPGA portion of the market and provided us with additional technical employees and intellectual property. This acquisition principally comprises intellectual property, which was valued using a discounted cash flow methodology of which goodwill was a by-product. The transaction was completed pursuant to an Asset Purchase Agreement dated as of December 7, 2001 between Lattice and Agere. The components of the purchase price were as follows (in millions):

 

 

Amount

 

Cash

 

$

250.0

 

Estimated direct acquisition costs

 

6.3

 

Total

 

$

256.3

 

 

In accordance with SFAS No. 141, the total purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed. In estimating the fair value of the assets acquired, management

48




considered various factors, including an appraisal. The total purchase price was allocated as follows (in millions):

 

 

Amount

 

Excess of purchase price over net assets acquired

 

$

142.4

 

Current technology

 

63.4

 

In-process research and development

 

24.2

 

Fair value of non-compete agreement

 

13.8

 

Licensed technology

 

10.2

 

Inventory

 

3.5

 

Backlog

 

1.4

 

Property, plant and equipment

 

0.2

 

Accrued liabilities

 

(2.8

)

Total

 

$

256.3

 

 

There were no significant exit costs incurred or accrued in connection with this transaction.

Employees joining us from Agere during the first quarter of 2002 were awarded approximately 1.1 million stock options which vest equally over four years at a grant price of $14.76 per share. The difference between grant price and market value of our common stock on the grant date, aggregating approximately $7.0 million, was recorded as Paid-in capital and Deferred stock compensation and is being amortized to operations ratably over the vesting period as part of Amortization of intangible assets.

In-Process Research and Development (“IPR&D”)

IPR&D consists of those products obtained through acquisition that were not yet proven to be technologically feasible but had been developed to a point where there was value associated with them in relation to potential future revenue. Because technological feasibility was not yet proven and no alternative future uses were believed to exist for the in-process technologies, the assigned value was expensed immediately upon the closing date of the acquisition.

The fair value underlying the $24.2 million assigned to acquired IPR&D in the Agere FPGA acquisition was determined by identifying research projects in areas for which technological feasibility had not been established and there was no alternative future use. Projects in the IPR&D category were the ORCA 4 FPGA family, the next generation FPGA family and the FPSC field-programmable system chips. The following is a brief description of these projects. The ORCA 4 FPGA family project, increasing speed and density and enhancing yields, was approximately 85% complete and estimated to be completed by 2003 at an estimated cost of $1.5 million. This project was completed during 2002 with no material change in cost. The next generation FPGA family project, increasing speed and density while reducing die size, was approximately 50% complete and estimated to be completed by 2004 at an estimated cost of $2.0 million. This project was significantly redefined and is now expected to be completed during 2005. The future development of FPSC field-programmable system chips (field-programmable system chips which combine embedded pre-defined logic circuits with an FPGA platform) was approximately 25% to 90% complete, and estimated to be completed by 2004 at an estimated cost of $2.0 million. This project was completed during 2004 with no material change in cost.

The IPR&D value of $24.2 million was determined by an income approach where fair value is the present value of projected free cash flows that will be generated by the products incorporating the acquired technologies under development, assuming they are successfully completed. The estimated net free cash flows generated by the products over 5-7 year periods were discounted at rates ranging from 23% to 25% in relation to the stage of completion and the technical risks associated with achieving technological feasibility. The net cash flows for such projects were based on management’s estimates of revenue,

49




expenses and asset requirements. Any delays or failures in the completion of these projects could impact our expected return on investment and future results. In addition, our financial condition would be adversely affected if the value of other intangible assets acquired became impaired.

The remaining project has completion risks related to silicon functionality, architecture performance, packaging technology, continued availability of key technical personnel and, product reliability. To the extent that estimated completion dates are not met, the risk of competitors’ product introductions is greater and revenue opportunity may be permanently lost.

The non-compete agreement from Agere and the current and licensed technology included in the acquisition of Agere FPGA has an estimated weighted average useful life of approximately 6.3 years.

(6)—Acquisition of Vantis:

On June 15, 1999, we paid approximately $500.1 million in cash to AMD for all of the outstanding capital stock of Vantis Corporation. The total purchase price of Vantis was $583.1 million, including certain direct acquisition costs, the accrual of certain exit costs and the assumption of certain liabilities related to the Vantis business. Of this purchase price, approximately $422.6 million was allocated to goodwill and intangible assets.

The recorded balances of goodwill and intangible assets, net of accumulated amortization, related to the Vantis acquisition approximated $77.0 million and $0.0 million respectively, at December 31, 2004, and $77.1 million and $23.3 million, respectively, at December 31, 2003. Amortization expense related to these assets approximated $23.3 million, $50.9 million, and $50.9 million for 2004, 2003, and 2002, respectively.

(7)—Foundry Investments, Advances and Other Assets (in thousands):

 

 

December 31,

 

 

 

2004

 

2003

 

Foundry investments and other assets

 

$

59,268

 

$

96,437

 

Wafer supply advances

 

62,811

 

25,810

 

 

 

122,079

 

122,247

 

Less: UMC shares available-for-sale

 

(24,202

)

(35,364

)

 

 

$

97,877

 

$

86,883

 

 

On September 10, 2004, we entered into an Advance Payment and Purchase Agreement (the “Fujitsu Agreement”) with Fujitsu Limited (“Fujitsu”), pursuant to which we will advance $125.0 million to Fujitsu in support of the development and construction of a new 300mm wafer fabrication facility in Mie, Japan. The initial two payments of $25.0 million each were made in October 2004 and January 2005 and were recorded at December 31, 2004. The remaining payments will be made in two stages upon the achievement of certain milestones and will be recorded upon completion of the related milestone. We currently anticipate that the advance payment will be paid in full by the second quarter of 2006.

Our $125.0 million advance will be credited against the purchase price of 300 mm wafers from the new wafer fabrication facility. The Fujitsu Agreement will continue until the full amount of the advance payment has been returned to us in the form of wafers or other repayment, subject to the right of either party to terminate the agreement upon the occurrence of certain events. We may request a refund of the unused amount of the advance payment if we have not used all of our wafer credits by December 31, 2007. The repayment obligation of Fujitsu is unsecured.

In 1995, we entered into a series of agreements with United Microelectronics Corporation (“UMC”), a public Taiwanese company, pursuant to which we agreed to join UMC and several other companies to form a separate Taiwanese corporation, (“UICC”), for the purpose of building and operating an advanced semiconductor manufacturing facility in Taiwan, Republic of China. Under the terms of the agreements, we invested approximately $49.7 million for an approximate 10% equity interest in the corporation and the right to receive a percentage of the facility’s wafer production at market prices.

50




In 1996, we entered into an agreement with Utek Corporation (“Utek”), a public Taiwanese company in the wafer foundry business that became affiliated with the UMC group in 1998, pursuant to which we agreed to make a series of equity investments in Utek under specific terms. In exchange for these investments, we received the right to purchase a percentage of Utek’s wafer production. Under this agreement, we invested approximately $17.5 million. In 2000, UICC and Utek merged into UMC.

We owned approximately 60.8 million shares of UMC common stock at December 31, 2004 of which approximately 23.3 million shares are restricted from sale for more than one year by the terms of our agreement with UMC. Under the terms of the UMC agreement, if we sell any of these restricted shares, our rights to guaranteed wafer capacity at UMC may be reduced on a pro-rata basis based on the number of shares that we sell. If we sell over 10.1 million of these restricted shares, we may lose all of our rights to guaranteed wafer capacity at UMC.

For financial reporting purposes, all of our UMC shares are accounted for as available-for-sale and marked to market in our Consolidated Balance Sheet until they are sold, at which time a gain or loss is recognized in our Consolidated Statement of Operations. Unrealized gains and losses are included in Accumulated other comprehensive income within Stockholders’ equity. An other than temporary impairment of UMC share value could result in a reduction of the Consolidated Balance Sheet carrying value and would result in a charge to our Consolidated Statement of Operations.

During 2002, we sold 7.6 million of our UMC shares for approximately $9.9 million in cash. During 2004, we sold $36.6 million of our UMC shares. The following table summarizes carrying value and gains and losses for our UMC shares for 2004, 2003, and 2002 (in thousands):

Fiscal Year

 

 

 

Unrealized
Gain Included
in
Accumulated
Other
Comprehensive
Income

 

Realized Gain
Included in
Other Income,
Net

 

Unrealized
Loss Included
in
Accumulated
Other
Comprehensive
Income

 

Fair Market
Value
(Carrying
Value) Year
End
December 31

 

2004

 

 

$

 

 

 

$

5,556

 

 

 

$

(13,211

)

 

 

$

39,204

 

 

2003

 

 

$

24,583

 

 

 

$

 

 

 

$

 

 

 

$

81,060

 

 

2002

 

 

$

 

 

 

$

3,398

 

 

 

$

(24,878

)

 

 

$

56,263

 

 

 

It is likely that we will recognize additional gains or losses in future periods.

In 1997 we entered into an advance payment production agreement with Seiko Epson and Epson Electronics America, Inc. (“EEA”), which was subsequently amended in 2002 and March 2004. Under this agreement we advanced $51.3 million to Seiko Epson to finance construction of an eight-inch sub-micron semiconductor wafer manufacturing facility. The advance is to be repaid with semiconductor wafers over a multi-year period. No interest income is recorded. Cumulatively, $26.2 million of these payments have been repaid to us in the form of semiconductor wafers. We currently estimate that approximately $12.9 million of the outstanding advances are expected to be repaid with semiconductor wafers during the next twelve months and are thus reflected as part of Other current assets in our Consolidated Balance Sheet. We are not obligated to make additional payments under this agreement.

51




(8)—Intangible Assets:

The following tables present details of our total purchased intangible assets (in millions):

December 31, 2004

 

 

 

Gross

 

Accumulated
Amortization

 

Net

 

Current technology

 

$

273.6

 

 

$

(245.5

)

 

$

28.1

 

Core technology

 

7.3

 

 

(3.4

)

 

3.9

 

Licenses

 

10.2

 

 

(4.3

)

 

5.9

 

Non-compete agreements

 

14.2

 

 

(13.8

)

 

0.4

 

Workforce

 

4.7

 

 

(2.2

)

 

2.5

 

Backlog

 

1.4

 

 

(1.4

)

 

 

Customer list

 

17.4

 

 

(17.4

)

 

 

Patents and trademarks

 

26.8

 

 

(26.8

)

 

 

Total

 

$

355.6

 

 

$

(314.8

)

 

$

40.8

 

 

December 31, 2003

 

 

 

Gross

 

Accumulated
Amortization

 

Net

 

Current technology

 

$

273.6

 

 

$

(214.4

)

 

$

59.2

 

Core technology

 

7.3

 

 

(1.9

)

 

5.4

 

Licenses

 

10.2

 

 

(2.9

)

 

7.3

 

Non-compete agreements

 

14.2

 

 

(9.1

)

 

5.1

 

Workforce

 

4.7

 

 

(1.2

)

 

3.5

 

Backlog

 

1.4

 

 

(1.4

)

 

 

Customer list

 

17.4

 

 

(15.8

)

 

1.6

 

Patents and trademarks

 

26.8

 

 

(24.3

)

 

2.5

 

Total

 

$

355.6

 

 

$

(271.0

)

 

$

84.6

 

 

The estimated future amortization expense of purchased intangible assets as of December 31, 2004 is as follows (in millions):

Fiscal Year:

 

 

 

Amount

 

2005

 

 

$

14.4

 

 

2006

 

 

10.8

 

 

2007

 

 

9.8

 

 

2008

 

 

5.6

 

 

Later years

 

 

0.2

 

 

 

 

 

$

40.8

 

 

 

52




The estimated future amortization expense of deferred stock compensation attributable to research and development activities as of December 31, 2004 is approximately $1.9 million for 2005.

(9)—Yen based line of credit:

On August 11, 2004, we entered into an agreement with a bank under the terms of which we can borrow up to $6.0 million in Japanese Yen in a revolving line of credit arrangement. Outstanding borrowing is collateralized by marketable securities. Interest on outstanding borrowing is based on the Japanese LIBOR Fixed Rate, and averaged 1.04% for the year ended December 31, 2004. Outstanding borrowing at December 31, 2004 was $2.9 million. This arrangement can be terminated at anytime by either party.

(10)—Lease Obligations:

Certain of our facilities and equipment are leased under operating leases, which expire at various times through 2013. Rental expense under the operating leases was approximately $5.9 million, $5.8 million, and $6.0 million for 2004, 2003, and 2002, respectively. Future minimum lease commitments (before consideration of sublease receipts discussed below) at December 31, 2004 are as follows (in thousands):

Fiscal Year:

 

 

 

Amount

 

2005

 

$

9,049

 

2006

 

7,327

 

2007

 

6,075

 

2008

 

5,615

 

2009

 

1,108

 

Later years

 

1,404

 

 

 

$

30,578

 

 

Included in these amounts are certain properties which are currently subleased. A portion of this sublease income is payable to the property owner. Future minimum sublease receipts, based on agreements in place at December 31, 2004, net of such payments are as follows (in thousands):

Fiscal Year:

 

 

 

Amount

 

2005

 

$

3,026

 

2006

 

997

 

 

 

$

4,023

 

 

53




(11)—Income Taxes:

The components of the (benefit) provision for income taxes for 2004, 2003, and 2002 are presented in the following table (in thousands):

 

 

December 31,

 

 

 

2004

 

2003

 

2002

 

Current:

 

 

 

 

 

 

 

Federal

 

$

 

$

(6,004

)

$

(27,435

)

State

 

(165

)

 

 

Foreign

 

483

 

150

 

353

 

 

 

318

 

(5,854

)

(27,082

)

Deferred:

 

 

 

 

 

 

 

Federal

 

 

 

99,334

 

State

 

 

 

9,614

 

Foreign

 

 

 

 

 

 

 

 

108,948

 

 

 

$

318

 

$

(5,854

)

$

81,866

 

 

The (benefit) provision for income taxes differs from the amount of income tax determined by applying the applicable U.S. statutory federal income tax rate to pretax income as a result of the following differences ($ in thousands):

 

 

Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

 

 

$

 

%

 

$

 

%

 

$

 

%

 

Computed income tax (benefit) at the statutory rate

 

(18,080

)

(35

)

(34,182

)

(35

)

(32,679

)

(35

)

Adjustments for tax effects of:

 

 

 

 

 

 

 

 

 

 

 

 

 

State taxes, net

 

(1,588

)

(3

)

(3,247

)

(3

)

(4,016

)

(4

)

Research and development credits

 

(1,265

)

(2

)

(1,358

)

(1

)

(800

)

(1

)

Foreign Taxes

 

483

 

1

 

150

 

 

353

 

 

Valuation allowance

 

19,680

 

38

 

35,641

 

36

 

118,648

 

127

 

Release of certain reserves

 

 

 

(3,429

)

(4

)

 

 

Amortization of intangibles related to acquisitions

 

1,589

 

3

 

1,445

 

2

 

1,460

 

2

 

Other

 

(501

)

(1

)

(874

)

(1

)

(1,100

)

(1

)

 

 

318

 

1

 

(5,854

)

(6

)

81,866

 

88

 

 

In the fourth quarter of 2002, we recorded a $118.6 million charge to income tax expense, representing a valuation allowance on our recorded deferred tax assets, in accordance with SFAS No. 109, “Accounting for Income Taxes.” SFAS No. 109 provides for the recognition of deferred tax assets if realization of these assets is more likely than not. We have provided a valuation allowance equal to our net deferred tax assets due to uncertainties regarding their realization.

54




The components of our net deferred tax assets are as follows (in thousands):

 

 

December 31,

 

 

 

2004

 

2003

 

Current deferred tax assets:

 

 

 

 

 

Deferred income

 

$

4,275

 

$

3,962

 

Expenses and allowances not currently deductible

 

10,955

 

12,186

 

 

 

15,230

 

16,148

 

Less: valuation allowance

 

(15,230

)

(16,148

)

 

 

$

 

$

 

Non-current deferred tax assets:

 

 

 

 

 

Intangible asset charges not currently deductible

 

$

91,938

 

$

93,131

 

Expenses and allowances not currently deductible

 

6,096

 

5,433

 

Net operating loss and credit carryforwards

 

64,463

 

43,335

 

Other

 

3,589

 

3,589

 

 

 

166,086

 

145,488

 

Less: valuation allowance

 

(166,086

)

(145,488

)

Net non-current deferred tax assets

 

$

 

$

 

 

As of December 31, 2004, we have federal net operating carryforwards (pre-tax) of approximately $135.4 million that expire at various dates between 2021 and 2024. We have state net operating loss carryforwards (pre-tax) of approximately $121.9 million that expire at various dates from 2006 through 2024. We also have federal and state credit carryforwards of $15.8 million, most of which do not expire with the remainder expiring at various dates from 2005 through 2024.

We acquired Cerdelinx on August 26, 2002 (see Note 4). Cerdelinx had federal and state net operating loss and tax credit carryforwards at the time of the acquisition for which we recorded deferred tax assets of $2.6 million with an offsetting valuation allowance. In conjunction with the change in ownership, applicable Internal Revenue Code sections limit the use of these tax benefits to approximately $0.4 million per year.

Congress adopted the American Jobs Creation Act of 2004 which among other things provides companies with foreign subsidiaries the opportunity to repatriate earnings of such subsidiaries at a reduced tax rate. Presently we have substantial tax loss carryforwards which could be used to offset tax liabilities arising from repatriation of foreign subsidiary earnings. We are not planning to repatriate earnings of our foreign subsidiaries.

(12)—Long-term debt:

On June 20, 2003, we issued $200.0 million in Zero Coupon Convertible Subordinated Notes due July 1, 2010. No interest will accrue or be payable related to these notes. Holders of these notes may convert the notes into shares of our common stock at any time before the close of business on the date of their maturity, unless the notes have been previously redeemed or repurchased, if (1) the price of our common stock issuable upon conversion of a note reaches a specified threshold, (2) the notes are called for redemption, (3) if we request a redemption, or make a distribution to common stockholders that is dilutive to note holders or if we become a party to a merger or consolidation or sale of substantially all of our assets occur or (4) the trading price of the notes falls below certain thresholds. The conversion price is approximately $12.06 per share, subject to adjustment in certain circumstances. On or after July 1, 2008, we have the option to redeem all or a portion of the notes that have not been previously repurchased or converted at 100% of the principal amount of the notes. On July 1, 2008, holders have the option to require us to purchase all or a portion of their notes in cash at 100% of the principal amount of the notes. Holders also have the right, subject to certain conditions, to require us to repurchase the notes in the event of a “fundamental change” (as defined in the indenture governing the notes) at 100% of the principal amount of the notes. Generally, a fundamental change is an occurrence resulting in substantially all of our

55




common stock being converted into common stock which is not listed on a United States stock exchange or Nasdaq.

The notes are subordinated in right of payment to all of our senior indebtedness, and are structurally subordinated as to the revenues and assets of our subsidiaries to all debt and other liabilities of our subsidiaries. At December 31, 2004, we had no senior indebtedness and our subsidiaries had approximately $2.2 million of debt and other liabilities outstanding. Issuance costs relative to these convertible notes are included in “Foundry investments, advances and other assets” and aggregated approximately $5.4 million and are being amortized to expense over the lives of the notes using the effective interest method. Accumulated amortization of these issuance costs was approximately $3.2 million and $1.4 million as of December 31, 2004 and December 31, 2003, respectively.

In October 2003, our board of directors authorized management to repurchase up to $100.0 million of our Zero Coupon Convertible Subordinated Notes due July 1, 2010. During 2004, we extinguished approximately $15.0 million of these notes for approximately $12.0 million in cash and recognized a net gain of approximately $2.8 million including the write off of approximately $0.2 million of unamortized issuance costs. During 2003, we extinguished approximately $16.0 million of these notes for approximately $14.2 million in cash and recognized a gain of approximately $1.4 million, net, including the write off of approximately $0.4 million of unamortized issuance costs.

The estimated fair value of the Zero Coupon Convertible Subordinated Notes due July 1, 2010, based on quoted market prices, was approximately $145.1 million at December 31, 2004.

On July 21, 2003, we extinguished for cash all of our outstanding 43¤4% Convertible Subordinated Notes due in 2006, originally issued in October 1999, plus accrued interest. Total cash paid at extinguishment approximated $178.8 million, including par value of $172.3 million, accrued interest of approximately $1.8 million and a call premium of 2.71% of the outstanding notes, or approximately $4.7 million. This call premium, plus unamortized issuance costs of approximately $1.0 million as of the extinguishment date, was recorded as “Other expense” in the quarter ended September 30, 2003.

During 2002, we extinguished approximately $51.9 million face value of our 43¤4% Convertible Subordinated Notes due in 2006 for approximately $42.8 million in cash, including accrued interest. We recognized a gain of approximately $9.3 million in connection with these transactions.

(13)—Stockholders’ Equity:

Common Stock

In December 2000, our Board of Directors authorized management to repurchase up to five million shares of our common stock. As of December 31, 2004, we had repurchased 1,136,000 shares (596,000 in 2001) at an aggregate cost of approximately $20.0 million ($10.6 million in 2001). There were no repurchases of common stock in 2002 through 2004.

Stock Warrants

During 2002, a warrant was issued to a vendor to purchase 119,074 shares of common stock, earned ratably from March 2002 to February 2003. During 2002, the vendor exercised warrants for 206,200 shares at $13.75 per share. During 2003, a warrant was issued to the vendor to purchase 256,661 shares of common stock, earned ratably from March 2003 to February 2004. During 2004, a warrant was issued to the vendor to purchase 294,579 shares of common stock, earned ratably from March 2004 to February 2005. Additionally during 2003 warrants for 200,392 shares expired unexercised, and during 2004 warrants for 220,200 shares expired unexercised leaving warrants for 839,877 shares unexercised as of December 31, 2004, including warrants issued prior to 2002. Expense recorded in conjunction with the vesting of warrants by this vendor was not material to our Consolidated Financial Statements.

56




Stock Option Plans

As of December 31, 2004, we had authorized 9,000,000 and 17,200,000 shares of common stock for issuance to officers and employees under our 2001 Stock Plan and 1996 Stock Incentive Plan, respectively. The 2001 Plan options are granted at fair value at the date of grant, generally vest over four years in increments as determined by the Board of Directors and have terms up to ten years. The 1996 Plan options are typically granted at fair value at the date of grant, generally vest over four years in increments as determined by the Board of Directors and have terms up to ten years.

In conjunction with the acquisition of Cerdelinx on August 26, 2002, we exchanged 246,540 Lattice stock options for all of the options outstanding under the former Cerdelinx stock option plans. These options generally vest over four years and have terms of ten years. In conjunction with the acquisition of I2P on March 16, 2001, we exchanged 223,276 Lattice stock options for all of the options outstanding under the former I2P stock option plans. These options generally vest over four years and have terms of ten years.

The 2001 Outside Directors’ Stock Option Plan, which replaced the 1993 Outside Directors Stock Option Plan, provides for the issuance of stock options to members of our Board of Directors who are not employees of Lattice; 1,000,000 shares of our Common Stock are authorized for issuance thereunder. These options are granted at fair value at the date of grant and become exercisable quarterly over a one year period beginning three years after the date of grant and expire ten years from the date of grant. The following table summarizes our stock option activity and related information for the past three years (number of shares in thousands):

 

 

Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

 

 

Number of
Shares under
Option

 

Weighted
Average
Exercise
Price

 

Number of
Shares under
Option

 

Weighted
Average
Exercise
Price

 

Number of
Shares under
Option

 

Weighted
Average
Exercise
Price

 

Options outstanding at beginning of year

 

 

21,069

 

 

 

$

8.71

 

 

 

24,040

 

 

 

$

15.83

 

 

 

20,075

 

 

 

$

17.71

 

 

Options granted

 

 

3,518

 

 

 

4.71

 

 

 

9,726

 

 

 

7.90

 

 

 

4,877

 

 

 

8.08

 

 

Options canceled

 

 

(784

)

 

 

10.54

 

 

 

(12,583

)

 

 

21.74

 

 

 

(721

)

 

 

17.73

 

 

Options exercised

 

 

(101

)

 

 

5.97

 

 

 

(114

)

 

 

4.16

 

 

 

(191

)

 

 

7.81

 

 

Options outstanding at end of year

 

 

23,702

 

 

 

$

8.07

 

 

 

21,069

 

 

 

$

8.71

 

 

 

24,040

 

 

 

$

15.83

 

 

 

The following table summarizes information about stock options outstanding at December 31, 2004 (number of shares in thousands):

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

Weighted-

 

 

 

 

 

Range of Exercise Prices

 

 

 

Number of
Shares

 

Average
Remaining
Contract Life
(in years)

 

Weighted-
Average
Exercise
Price

 

Number of
Shares

 

Weighted-
Average
Exercise
Price

 

$0.41-$  5.17

 

 

3,440

 

 

 

9.51

 

 

 

$

4.40

 

 

 

293

 

 

 

$

3.43

 

 

$5.92-$  7.28

 

 

5,901

 

 

 

8.22

 

 

 

6.61

 

 

 

2,382

 

 

 

6.35

 

 

$7.34-$  7.88

 

 

4,744

 

 

 

4.07

 

 

 

7.77

 

 

 

4,497

 

 

 

7.79

 

 

$8.13-$  8.21

 

 

5,603

 

 

 

8.71

 

 

 

8.21

 

 

 

3,531

 

 

 

8.21

 

 

$8.39-$32.25

 

 

4,014

 

 

 

5.10

 

 

 

13.52

 

 

 

3,652

 

 

 

13.34

 

 

 

 

 

23,702

 

 

 

7.16

 

 

 

$

8.07

 

 

 

14,355

 

 

 

$

8.98

 

 

 

57




Stock Purchase Plan

Our employee stock purchase plan, which was amended and approved most recently by our stockholders in May 2004, permits eligible employees to purchase shares of common stock through payroll deductions, not to exceed 10% of the employee’s compensation. The purchase price of the shares is the lower of 85% of the fair market value of the stock at the beginning of each six-month period or 85% of the fair market value at the end of such period, but in no event less than the book value per share at the mid-point of each offering period. Amounts accumulated through payroll deductions during the offering period are used to purchase shares on the last day of the offering period. Of the 4,700,000 shares authorized to be issued under the plan, 461,425, 576,064, and 347,107 shares were issued during 2004, 2003 and 2002, respectively, and 869,123 shares were available for issuance at December 31, 2004. The increase in shares issued in 2003 as compared to 2004, and 2002 is primarily attributable to three offering periods closing in 2003 (a 53-week fiscal year) as compared to two periods closing in 2004 and 2002.

Stock Option Exchange Program

On March 14, 2003, we completed an exchange offer related to a stock option exchange program. Under the exchange offer, eligible employees had the opportunity to tender for cancellation certain stock options in exchange for new options to be granted at least six months and one day after the cancellation of the tendered options. Each eligible participant received new options to purchase four shares of common stock for every seven shares subject to options submitted for cancellation. We accepted options to purchase approximately 11.2 million shares for exchange at various exercise prices between $6.30 and $32.25 and granted new options to purchase approximately 6.4 million shares on September 18, 2003, the new grant date. The exercise price per share of the new options of $8.21 was equal to the fair market value of our common stock on the new grant date. In connection with the stock option exchange program, we accelerated the write-off of accrued deferred compensation recorded in conjunction with certain of our acquisitions, due to the cancellation of certain assumed in-the-money stock options. Such acceleration resulted in $2.2 million of additional intangible asset amortization expense in the first quarter of 2003. However, we do not expect to record any additional compensation expense as a result of the exchange program.

Stock Based Compensation

We account for our stock options and employee stock purchase plan in conformity with APB 25 and have adopted the additional pro forma disclosure provisions of SFAS No. 123, as amended by SFAS No. 148. The fair value of our stock-based employee compensation cost (see Note 1), as defined by SFAS No. 123, for stock options and employee stock plan purchase rights was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 

 

Grants for Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

Stock options:

 

 

 

 

 

 

 

Expected volatility

 

48.7

%

57.7

%

59.3

%

Risk-free interest rate

 

2.9

%

2.2

%

2.8

%

Expected life from vesting date

 

1.3 years

 

1.3 years

 

1.7 years

 

Dividend yield

 

0

%

0

%

0

%

Stock purchase rights:

 

 

 

 

 

 

 

Expected volatility

 

26.4

%

32.7

%

64.3

%

Risk-free interest rate

 

1.3

%

1.1

%

3.5

%

Expected life

 

6 months

 

6 months

 

6 months

 

Dividend yield

 

0

%

0

%

0

%

 

58




The Black-Scholes option pricing model was developed for use in estimating the fair value of freely tradable, fully transferable options without vesting restrictions. Our stock options have characteristics which differ significantly from those of freely tradable, fully transferable options. The Black-Scholes option pricing model also requires highly subjective assumptions, including expected stock price volatility and expected stock option term which greatly affect the calculated fair value of an option. Our actual stock price volatility and option term may be materially different from the assumptions used herein.

The resultant grant date weighted-average fair values calculated using the Black-Scholes option pricing model and the noted assumptions for stock options granted was $1.81, $2.38, and $3.70, and for stock purchase rights $1.85, $1.61, and $5.32, for 2004, 2003, and 2002, respectively. For purposes of pro forma disclosures (see Note 1), the estimated fair value of the options is amortized to expense over the options’ vesting period.

(14)—Employee Benefit Plans:

Profit Sharing Plan

We initiated a profit sharing plan effective April 1, 1990. Under the provisions of this plan, as approved by the Board of Directors, a percentage of our operating income, as defined and calculated at the end of March and September for the prior six-month period, is paid to qualified employees. In 2004, 2003 and 2002, the provision charged to operations for this plan was not significant.

Qualified Investment Plan

In 1990, we adopted a 401(k) plan, which provides participants with an opportunity to accumulate funds for retirement. Under the terms of the plan, eligible participants may contribute up to the maximum allowed under IRS regulations. The plan does not allow investments in our securities. The plan allows for us to make discretionary matching contributions in cash. There was no expense recorded related to matching contributions in 2004, 2003 and 2002.

Executive Deferred Compensation Plan

We initiated an Executive Deferred Compensation Plan effective August 1997. Under the provisions of this plan, as approved by the Board of Directors, certain senior executives may annually defer up to 75% of their salary and up to 100% of their incentive compensation. The return on deferred funds is based upon the performance of designated mutual funds or our publicly traded common stock. There is no guaranteed return or matching contribution. Balances at December 31, 2004 and 2003 of approximately $12.9 million and $12.7 million, respectively, are reflected in “Other-long-term liabilities” in our accompanying Consolidated Balance Sheet and the related assets are included in “Other assets” in our accompanying Consolidated Balance Sheet.

(15)—Commitments and Contingencies:

In September and October 2004, three putative class action complaints were filed in the United States District Court for the District of Oregon against Lattice Semiconductor Corporation, our Chief Executive Officer Cyrus Y. Tsui, and our President Stephen A. Skaggs. These complaints were filed on behalf of a putative class of investors who purchased our stock between April 22, 2003 and April 19, 2004. They generally allege violations of federal securities laws arising out of our previously announced restatement of financial results for the first, second, and third quarters of 2003. Consistent with the usual procedures for cases of this kind, these cases were amended and consolidated into a single action. In such amended and consolidated complaint filed January 27, 2005 our former President and our former Controller were added as defendants. We believe that the complaints are without merit, and we intend to vigorously defend against the lawsuits.

59




In September and October 2004, two shareholder derivative complaints were filed, purportedly on behalf of Lattice Semiconductor Corporation, in the Circuit Court of the State of Oregon for the County of Washington, against all of our current directors, certain former directors, and certain executive officers. The derivative plaintiffs make allegations substantially similar to those in the putative class action complaints, as well as allegations of breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets, and unjust enrichment. Consistent with the usual procedures for cases of this kind, these cases were consolidated into a single putative shareholder derivative action. An amended and consolidated complaint is expected to be filed by April 1, 2005.

All of the complaints generally seek an unspecified amount of damages, as well as attorney fees and costs. The cases are still in the preliminary stages, and it is not possible for us to quantify the extent of our potential liability, if any. An unfavorable outcome in any of these matters could have a material adverse effect on our business and financial results. In addition, defending any litigation may be costly and divert management’s attention from the day-to-day operations of our business.

We are exposed to certain asserted and unasserted potential claims. There can be no assurance that, with respect to potential claims made against us, we could resolve such claims under terms and conditions that would not have a material adverse effect on our business and financial results

(16)—Related Party:

Larry W. Sonsini was a member of our Board of Directors until April 2004, and is presently the Chairman of Wilson Sonsini Goodrich & Rosati, Professional Corporation, a law firm that provides us with corporate legal services. Legal services billed to Lattice aggregated approximately $0.6 million, $0.5 million, and $0.9 million, respectively, for 2004, 2003 and 2002. Amounts payable to the law firm were not significant at December 31, 2004 or 2003, respectively.

(17)—Segment and Geographic Information:

We operate in one industry segment comprising the design, development, manufacture and marketing of high performance programmable logic products. Our sales by major geographic area were as follows (in thousands):

 

 

Years Ended December 31,

 

 

 

2004

 

2003

 

2002

 

United States

 

$

65,044

 

$

66,740

 

$

92,086

 

Export sales:

 

 

 

 

 

 

 

Europe

 

50,867

 

52,142

 

58,871

 

Asia Pacific (other than Japan and China)

 

42,584

 

37,062

 

36,775

 

Japan

 

31,134

 

23,000

 

17,635

 

China

 

29,802

 

20,298

 

12,914

 

Other

 

6,401

 

10,420

 

10,845

 

Total revenue from export sales

 

160,788

 

142,922

 

137,040

 

Total revenue

 

$

225,832

 

$

209,662

 

$

229,126

 

 

Resale of product through two distributors accounted for approximately 14% and 10%, 18% and 19%, and 22% and 29% of total worldwide revenue for 2004, 2003, and 2002, respectively. No individual customer accounted for more than 10% of revenue for any of the years presented. More than 90% of our property and equipment is located in the United States.

60




(18)—Subsequent Events:

In the first quarter through March 11, 2005 we extinguished $5.3 million of our Zero Coupon Convertible Subordinated Notes due July 1, 2010 for $4.5 million resulting in a gain of $0.7 million which will be included in Interest and other income (expense) for the March 31, 2005 quarter.

61




Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of
Lattice Semiconductor Corporation

We have completed an integrated audit of Lattice Semiconductor Corporation’s (the “Company”) 2004 Consolidated Financial Statements and of its internal control over financial reporting as of December 31, 2004 and audits of its 2003 and 2002 Consolidated Financial Statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Our opinions, based on our audits, are presented below.

Consolidated Financial Statements and financial statement schedule

In our opinion, the Consolidated Financial Statements listed in the index appearing under Item 8 present fairly, in all material respects, the financial position of the Company and its subsidiaries at December 31, 2004 and 2003, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2004 in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule listed in the index appearing under Item 8 presents fairly, in all material respects, the information set forth therein when read in conjunction with the related Consolidated Financial Statements. These financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and financial statement schedule based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit of financial statements includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

Internal control over financial reporting

Also, in our opinion, management’s assessment, included in Management’s Report on Internal Control Over Financial Reporting appearing under Item 9A, that the Company maintained effective internal control over financial reporting as of December 31, 2004 based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), is fairly stated, in all material respects, based on those criteria. Furthermore, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2004, based on Internal Control - Integrated Framework issued by the COSO. The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express opinions on management’s assessment and on the effectiveness of the company’s internal control over financial reporting based on our audit. We conducted our audit of internal control over financial reporting in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. An audit of internal control over financial reporting includes obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other

62




procedures as we consider necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ PRICEWATERHOUSECOOPERS LLP

March 15, 2005

63




Item 9. Changes in and Disagreements with Accountants On Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the Exchange Act). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report.

Management’s Report on Internal Control Over Financial Reporting

The management of the company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) or 15d-15(f) under the Securities Exchange Act of 1934. The company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding reliability of financial reporting and the preparation and fair presentation of published financial statements for external purposes in accordance with generally accepted accounting principles.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of the company’s internal control over financial reporting as of December 31, 2004. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework. Based on our assessment, we concluded that, as of December 31, 2004, the company’s internal control over financial reporting was effective.

Management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2004, has been audited by PricewaterhouseCoopers LLP, the independent registered public accounting firm who also audited the company’s Consolidated Financial Statements, as stated in their report which appears herein.

Changes in Internal Control over Financial Reporting

As disclosed in prior periodic reports, in January 2004, the Audit Committee of our Board of Directors, with the assistance of outside legal counsel and our independent registered public accounting firm, commenced an internal investigation of the facts and circumstances surrounding inappropriate journal entries affecting the deferred income and accrued expense accounts. As a result of the investigation, it was determined that the unaudited Consolidated Financial Statements for each of the three month periods ended September 30, 2003, June 30, 2003 and March 31, 2003 required restatement. After reviewing the restatement adjustments and performing an evaluation of our controls and disclosure procedures, management concurred with the Audit Committee that improvements to internal controls were needed relating to: (1) separation of duties and (2) establishment of standards for review and approval of journal entries as well as related file documentation. We received notice from our independent registered public accounting firm that, in connection with the 2003 year-end audit, the independent registered public accounting firm had identified a material weakness relating to our internal controls and

64




procedures. Management agreed with this finding. As disclosed in prior periodic reports, we took several actions during 2004 which remedied the material weakness identified by our independent registered public accounting firm. During 2005, we plan to take additional steps to improve our internal controls relating to these issues, namely implementing improvements to information systems for distribution accounting, which may constitute material changes to our internal controls.

Item 9B. Other Information

None.

65




PART III

Certain information required by Part III is incorporated by reference from our definitive proxy statement (the “Proxy Statement”) for the Annual Meeting of Stockholders to be held on May 3, 2005, pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended, which we will file not later than 120 days after the end of the fiscal year covered by this report. With the exception of the information expressly incorporated by reference from the Proxy Statement, the Proxy Statement is not to be deemed filed as a part of this report.

Item 10. Directors and Executive Officers of the Registrant.

Information regarding our directors that is required by this item is incorporated by reference from the information contained under the caption “Proposal 1: Election of Directors” and “Board Meetings and Committees” in the Proxy Statement. Information regarding our executive officers that is required by this item is set forth in Part I of this report under the caption “Executive Officers and Directors of the Registrant.” Information regarding Section 16(a) reporting compliance that is required by this item is incorporated by reference from the information contained under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” in the Proxy Statement.

We have adopted a code of ethics that applies to all of our employees, including our principal executive officer, principal financial officer, principal accounting officer, and persons performing similar functions. A copy of the code of ethics is filed as an exhibit to this Annual Report on Form 10-K. Amendments to the code of ethics or any grant of a waiver from a provision of the code of ethics requiring disclosure under applicable SEC rules, if any, will be disclosed on our website at www.latticesemi.com.

Item 11. Executive Compensation.

The information contained under the captions entitled “Directors’ Compensation,” “Employment Agreements,” “Compensation Committee Interlocks and Insider Participation,” “Report of the Compensation Committee,” “Executive Compensation,” “Options Granted and Options Exercised in 2004” and “Comparison of Total Cumulative Stockholder Return” in the Proxy Statement is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information contained under the caption entitled “Security Ownership of Certain Beneficial Owners and Management” in the Proxy Statement is incorporated herein by reference.

66




Equity Compensation Plan Information

The following table summarizes information, as of December 31, 2004, with respect to shares of our common stock that may be issued under our existing equity compensation plans. The table does not include information with respect to shares subject to outstanding options assumed by us in connection with mergers and acquisitions. Footnote (5) to the table sets forth the total number of shares of our common stock issuable upon the exercise of those assumed options as of December 31, 2004, and the weighted average exercise price of those options. No additional options may be granted under those assumed plans.

 

 

(A)

 

(B)

 

(C)

 

 

 

Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options,
Warrants and
Rights

 

Weighted-
Average 
Exercise
Price per
share  of
Outstanding
Options,
Warrants and
Rights

 

Number of
Securities
Remaining
Available for
Future Issuance
Under Equity
Compensation
Plans (Excluding
Securities Reflected
in Column (A))

 

 

 

(in thousands except per share amounts)

 

Equity compensation plans approved by security holders(1)

 

 

21,542

 

 

 

$

7.89

 

 

 

4,111

(2)

 

Equity compensation plans not approved by security holders

 

 

840

(3)

 

 

$

12.54

 

 

 

293

(4)

 

Total

 

 

22,382

 

 

 

$

8.07

 

 

 

4,404

 

 


(1)          Includes shares of our common stock issuable upon exercise of options from the 1996 Stock Incentive Plan, the 2001 Stock Plan, the 1993 Outside Directors Stock Option Plan and the 2001 Outside Directors’ Stock Option Plan.

(2)          Includes approximately 869 shares reserved for issuance under our Employee Stock Purchase Plan.

(3)          Consists of shares of our common stock issuable upon exercise of warrants issued to a vendor as compensation for services. The warrants have an exercise price equal to the closing market price on the date of issue and are earned by the vendor ratably over the life of the service period, usually one year, and usually have a term of 5 years.

(4)          Consists of shares of our common stock held for the benefit of certain executives by our executive deferred compensation plan. The plan is funded entirely by participants through deferral of salary, bonus awards or gains on the exercise of stock options. Distributions to participants are made pursuant to elections made by participants in accordance with plan provisions, generally at the time of the election to defer. There have been no company matching contributions to the plan and the assets of the plan remain subject to claims of the company’s general creditors.

(5)          The table does not include information for the stock options assumed by us in connection with mergers and acquisitions. As of December 31, 2004, a total of approximately 2,160 shares of our common stock were issuable upon exercise of those assumed options. The weighted-average exercise price of those assumed options is $9.85 per share.

Item 13. Certain Relationships and Related Transactions.

The information contained under the caption entitled “Legal Services” in the Proxy Statement is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services.

The information contained under the caption entitled “Audit and Related Fees” in the Proxy Statement is incorporated herein by reference.

67




PART IV

Item 15. Exhibits and Financial Statement Schedules.

(a)(1) and (2) Financial Statements and Financial Statement Schedules.

The information required by this Item is included under Item 8 of this Report.

(a)(3) Exhibits.

Exhibit
Number

 

Description

3.1

 

The Company’s Restated Certificate of Incorporation filed February 24, 2004 (Incorporated by reference to Exhibit 3.1 filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).

3.2

 

The Company’s Bylaws, as amended and restated as of February 3, 2004 (Incorporated by reference to Exhibit 3.2 filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).

4.4

 

Indenture, dated as of June 20, 2003, between the Company and U.S. Bank National Association (Incorporated by reference to Exhibit 4.1 filed with the Company’s Registration Statement on Form S-3 on August 13, 2003).

4.5

 

Form of Note for the Company’s Zero Coupon Convertible Subordinated Notes (Incorporated by reference to Exhibit 4.2 filed with the Company’s Registration Statement on Form S-3 on August 13, 2003).

10.10*

 

Form of Stock Option Agreement (Incorporated by reference to Exhibit 10.9, File No. 33-31231).

10.11*

 

Employment Letter dated September 2, 1988 from Lattice Semiconductor Corporation to Cyrus Y. Tsui (Incorporated by reference to Exhibit 10.10, File No. 33-31231).

10.15*

 

1993 Outside Directors Stock Option Plan (Incorporated by reference to Exhibit 10.15 filed with Company’s Annual Report on Form 10-K for the fiscal year ended April 3, 1993).

10.16*

 

Employee Stock Purchase Plan, as amended and restated effective February 3, 2004 (Incorporated by reference to Appendix D to the Company’s 2004 Proxy Statement filed April 8, 2004).

10.20

 

Foundry Venture Side Letter dated September 13, 1995 among Lattice Semiconductor Corporation, United Microelectronics Corporation and FabVen (Incorporated by reference to Exhibit 10.2 filed with the Company’s Current Report on Form 8-K filed October 3, 1995)(1).

10.21

 

FabVen Foundry Capacity Agreement dated as of August  , 1995 among FabVen, United Microelectronics Corporation and Lattice Semiconductor Corporation (Incorporated by reference to Exhibit 10.3 filed with the Company’s Current Report on Form 8-K filed October 3, 1995)(1).

10.22

 

Foundry Venture Agreement dated as of August  , 1995, between Lattice Semiconductor Corporation and United Microelectronics Corporation (Incorporated by reference to Exhibit 10.4 filed with the Company’s Current Report on Form 8-K filed October 3, 1995)(1).

10.23

 

Advance Production Payment Agreement dated March 17, 1997 among Lattice Semiconductor Corporation and Seiko Epson Corporation and S MOS Systems, Inc. (2).

68




 

10.24*

 

Lattice Semiconductor Corporation 1996 Stock Incentive Plan as amended and Related Form of Option Agreement (Incorporated by reference to Exhibits (d)(1) and (d)(2) to the Company’s Schedule TO filed on February 13, 2003).

10.31

 

Asset Purchase Agreement by and between Agere Systems Inc. and Lattice Semiconductor Corporation, dated December 7, 2001 (Incorporated by reference to Exhibit 10.1 filed with the Company’s Current Report on Form 8-K filed on December 18, 2001).

10.32

 

Amendment dated December 21, 2001 to Advance Production Payment Agreement dated March 17, 1997 among Lattice Semiconductor Corporation and Seiko Epson Corporation and S MOS Systems, Inc. (Incorporated by reference to Exhibit 10.32 filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2001)(1).

10.33*

 

2001 Outside Directors’ Stock Option Plan (Incorporated by reference to Exhibit 4.2 filed with the Company’s Registration Statement on Form S-8 filed on August 10, 2001).

10.34*

 

2001 Stock Plan as amended and Related Form of Option Agreement (Incorporated by reference to Exhibits (d)(3) and (d)(4) to the Company’s Schedule TO filed on February 13, 2003).

10.35

 

Intellectual Property Agreement by and between Agere Systems Inc. and Agere Systems Guardian Corporation and Lattice Semiconductor Corporation as Buyer, dated January 18, 2002 (Incorporated by reference to Exhibit 10.35 filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2001).

10.36*

 

Octillion Communications Inc. 2001 Stock Plan (Incorporated by reference to Exhibit 4.1 filed with the Company’s Registration Statement on Form S-8 filed on September 6, 2002).**

10.37*

 

Lattice Semiconductor Corporation Executive Deferred Compensation Plan, as Amended and Restated effective as of August 11, 1997 (Incorporated by reference to Exhibit 99.3 filed with the Company’s Registration Statement on Form S-3, as amended, dated October 17, 2002).

10.38*

 

Amendment No. 1, to the Lattice Semiconductor Corporation Executive Deferred Compensation Plan, as Amended, dated November 19, 1999 (Incorporated by reference to Exhibit 99.4 filed with the Company’s Registration Statement on Form S-3, as amended, dated October 17, 2002).

10.39

 

Registration Rights Agreement, dated as of June 20, 2003, between the Company and the initial purchaser named therein (Incorporated by reference to Exhibit 4.3 filed with the Company’s Registration Statement on Form S-3 on August 13, 2003).

10.40*

 

Lattice Semiconductor Corporation Restated Executive Incentive Plan, dated as of February 5, 2002 (Incorporated by reference to Exhibit 10.40 filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).

10.41

 

Form of Indemnification Agreement executed by each director and executive officer of the Company and certain other officers and employees of the Company and its subsidiaries (Incorporated by reference to Exhibit 10.41 filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).

10.42

 

Amendment dated March 25, 2004 to Advance Production Payment Agreement dated March 17, 1997, as previously amended, among Lattice Semiconductor Corporation and Seiko Epson Corporation and S MOS Systems, Inc. (Incorporated by reference to Exhibit 10.42 filed with the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004)(1).

69




 

10.43

 

Advance Purchase and Payment Agreement dated September 10, 2004 between Lattice Semiconductor Corporation and Fujitsu Limited (Incorporated by reference to Exhibit 10.1 filed with the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004)(1).

14.1

 

Standards of Ethics and Conduct (Incorporated by reference to Exhibit 14.1 filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2003).

21.1

 

Subsidiaries of the Registrant.

23.1

 

Consent of Independent Registered Public Accounting Firm.

24.1

 

Power of Attorney (included on the signature page of this Annual Report on Form 10-K).

31.1

 

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act, as amended.

31.2

 

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act, as amended.

32.1

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


(1)          Pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, confidential treatment has been granted to portions of this exhibit, which portions have been deleted and filed separately with the Securities and Exchange Commission.

(2)          Pursuant to Rule 24b-2 under the securities Exchange Act of 1934, confidential treatment has been requested for portions of this exhibit, which portions have been deleted and filed separately with the Securities and Exchange Commission.

*                    Management contract or compensatory plan or arrangement required to be filed as an Exhibit to this Annual Report on Form 10-K pursuant to Item 14(c) thereof.

**             Cerdelinx Technologies, Inc. was initially incorporated as Octillion Communications Inc.

(b) See (a)(3) above.

(c) See (a)(1) and (2) above.

70




 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hillsboro, State of Oregon, on the 15th day of March, 2005.

 

LATTICE SEMICONDUCTOR CORPORATION

 

/s/ JAN JOHANNESSEN

 

Jan Johannessen

 

Corporate Vice President and

 

Chief Financial Officer

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Cyrus Y. Tsui and Jan Johannessen, or either of them, his or her attorneys-in-fact, each with the power of substitution, for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on the 15th day of March, 2005 on behalf of the Registrant and in the capacities indicated:

Signature

 

Title

/s/ CYRUS Y. TSUI

 

Chief Executive Officer and Chairman of the Board

Cyrus Y. Tsui

 

(Principal Executive Officer)

/s/ JAN JOHANNESSEN

 

Corporate Vice President and Chief Financial Officer

Jan Johannessen

 

(Principal Financial and Accounting Officer)

/s/ DAVID E. CORESON

 

Director

David E. Coreson

 

 

/s/ MARK O. HATFIELD

 

Director

Mark O. Hatfield

 

 

/s/ DANIEL S. HAUER

 

Director

Daniel S. Hauer

 

 

/s/ PATRICK S. JONES

 

Director

Patrick S. Jones

 

 

/s/ SOO BOON KOH

 

Director

Soo Boon Koh

 

 

/s/ HARRY A. MERLO

 

Director

Harry A. Merlo

 

 

 

71




Schedule II

LATTICE SEMICONDUCTOR CORPORATION
VALUATION AND QUALIFYING ACCOUNTS
(in thousands)

 

Column A

 

 

Column B

 

Column C

 

Column D

 

Column E

 

Column F

 

Classification

 

Balance at
beginning
of period

 

Charged
to costs
and
expenses

 

Charged
to other
accounts
(describe)

 

Write-offs,
net of
recoveries

 

Balance at
end of
period

 

Fiscal year ended December 31, 2002:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for deferred taxes

 

$

 

$

118,648

 

 

$

7,347

(1)

 

 

$

 

 

$

125,995

 

Allowance for doubtful accounts

 

1,475

 

(401

)

 

 

 

 

 

 

1,074

 

 

 

$

1,475

 

$

118,247

 

 

$

7,347

 

 

 

$

 

 

$

127,069

 

Fiscal year ended December 31, 2003:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for deferred taxes

 

$

125,995

 

$

35,641

 

 

$

 

 

 

$

 

 

$

161,636

 

Allowance for doubtful accounts

 

1,074

 

(50

)

 

 

 

 

 

 

1,024

 

 

 

$

127,069

 

$

35,591

 

 

$

 

 

 

$

 

 

$

162,660

 

Fiscal year ended December 31, 2004:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for deferred taxes

 

$

161,636

 

$

19,680

 

 

$

 

 

 

$

 

 

$

181,316

 

Allowance for doubtful accounts

 

1,024

 

(85

)

 

 

 

 

 

 

939

 

 

 

$

162,660

 

$

19,595

 

 

$

 

 

 

$

 

 

$

182,255

 


(1)          Valuation allowances recorded in conjunction with deferred tax assets acquired with our acquisition of Cerdelinx in 2002.

S-1



Exhibit 10.23

 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

ADVANCE PRODUCTION PAYMENT AGREEMENT

THIS ADVANCE PAYMENT AGREEMENT (“this Agreement”), is entered into this March 17, 1997, by and among SEIKO EPSON CORPORATION, a Japanese corporation having its principal place of business at 3-5, Owa 3-chome, Suwa-shi, Nagano-ken 392, Japan (“Epson”), S MOS Systems Inc., a California corporation, having a place of business at 150 River Oaks Parkway, San Jose, California 95134-1951, U.S.A. (“SMOS”) and Lattice Semiconductor Corporation, a Delaware corporation, having a place of business at 5555 N.E. Moore Ct., Hillsboro, Oregon 97124-6421, U.S.A. (“Lattice”).

 

1.      Background.

 

1.1   Epson

 

Epson is in the business of designing, manufacturing, testing and selling semiconductor devices, among other products.  Epson manufactures such semiconductor devices at its plant located at 281 Fujimi, Fujimi-machi, Suwa-gun, Nagano-ken 399-02, Japan (the “Fujimi Facility”) and its plant located at 166-3 Jurizuka, Sakata-shi, Yamagata-ken 998-01, Japan (the “Sakata Facility”).

 

1.2   SMOS

 

SMOS is an affiliate of Epson and is Epson’s authorized distributor in the United States for semiconductor devices.  SMOS is in the business of designing, testing and selling semiconductor devices.  SMOS conducts its business at its office located at 150 River Oaks Parkway, San Jose, CA 95134-1951, U.S.A.

 

1.3   Lattice

 

Lattice is in the business of designing, developing, manufacturing and marketing and selling both high- and low-density E2-CMOS® programmable logic devices and related development system software.

 

1.4   Scope of Agreement

 

Epson and SMOS have an ongoing business relationship with Lattice whereby Epson fabricates semiconductor devices for Lattice.  The parties entered into an advance production payment agreement dated July 5, 1994 for development and manufacture of 0.8-0.5 micron, 2-3 metal layer, 6 inch CMOS semiconductor wafers.  The parties desire to expand their relationship.  Specifically, Lattice desires to develop and sell high performance, advanced architecture semiconductor devices, and Epson desires to construct [*], 8 inch wafer CMOS process line installed in the Site (as hereafter defined) in order to fabricate such

 

 



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

semiconductor wafers and distribute them to Lattice through SMOS.  Accordingly, the parties agree that Lattice will pay to Epson an advance production payment (“APP”) only to be used as a credit to purchase the Products from Epson through SMOS over a specified period of time in accordance with this Agreement.  The Products shall be first sold to SMOS from Epson, and then be sold to Lattice from SMOS under the terms and conditions of the Purchase Agreement (as hereafter defined).  (In the event that SMOS has fallen into a situation where it is unable to play the role required under this Agreement for any reason specifically prescribed in this Agreement or any other reason, Epson and Lattice will mutually consult about the substitute form of the transaction contemplated herein.)

 

1.5   Position of SMOS

 

Notwithstanding any provision herein to the contrary, Lattice, Epson and SMOS acknowledges that although this Agreement is executed by each of such three (3) parties, SMOS is a party hereto solely for the purpose to evidencing its role, as the intermediary through which, under the terms of the Purchase Agreement, the Products to be sold to Lattice by Epson will be sold, and to evidence SMOS’S agreement to such an arrangement.  SMOS shall under no circumstances have any rights under this Agreement (it being understood, however, that this Article 1.5 shall not in any way affect the rights of SMOS under the Purchase Agreement).  In particular, and without limiting the generality of the foregoing, SMOS shall have no rights under Article 14 of this Agreement (i.e., any reference to party or parties to this Agreement shall be deemed to be only to Epson and Lattice unless specifically prescribed therein), and Epson and Lattice may amend this Agreement in any respect.  Epson agrees to cause SMOS to comply with all of the terms of this Agreement and the Purchase Agreement.  Any material breach of the Purchase Agreement shall constitute a material breach to this Agreement for the purpose of Article 14.4 of this Agreement.

 

2.      Definitions

 

2.1         APP” will mean the advance production payment of Ten Billion, Four Hundred and Sixty Nine Million and Seven Hundred Thousand Japanese Yen (JPY10,469,700,000) to be made by Lattice to Epson in the manner described in Article 4.  If the parties agree, in accordance with Article 4.4, on additional APP, the definition of “APP” hereof shall be interpreted to include such additional APP.

 

2.2         Equipment” will mean the semiconductor fabrication equipment that Epson will install in the New Facility for purposes of fabricating New Facility Wafers.

 

2



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

2.3         Existing Agreements” will mean those contracts for the development, fabrication, testing and/or sale of semiconductor devices between Epson and Lattice in effect as of the date of this Agreement.

 

2.4         Free Wafers” will have the meaning ascribed to it in Article 8.

 

2.5         Fujimi Facility” will have the meaning ascribed to it in Article 1.1.

 

2.6         New Facility” will mean the [*], 8 inch wafer CMOS process line constructed at the Site using the Equipment.

 

2.7         New Facility Wafers” will mean the semiconductor wafers to be fabricated by Epson for Lattice at the New Facility.

 

2.8         Price” will have the meaning ascribed to it in Article 10.1.

 

2.9         Products” will mean those specific types of New Facility Wafers fabricated using the same masks and the same process flow and identified by the same series or product name or number.  The Products will be ordered, fabricated, delivered and sold pursuant to the terms and conditions of Purchase Agreement(s).  The Products which the parties desire to fabricate at the New Facility will be agreed by and between Epson and Lattice, referring to the Process Road Map for Lattice attached hereto as Exhibit B, which may be reviewed and amended from time to time by mutual agreement of the parties.  The parties acknowledge however, that the final determination of what Products will be fabricated may depend on the results of joint development and product qualification.

 

2.10   Purchase Agreement(s)” will mean the agreements by and between SMOS and Lattice pursuant to which SMOS agrees to sell and Lattice agrees to purchase the Products.  It is the intention of the parties to execute the Purchase Agreement, the terms of which shall be negotiated and agreed between SMOS and Lattice, after the execution of this Agreement.

 

2.11   Projected Completion Schedule” will have the meaning ascribed to it in Article 3.1.2.

 

2.12   Purchase Commitment” will have the meaning ascribed to it in Article 7.1 and Exhibit D attached hereto.

 

2.13   Sakata Facility” will have the meaning ascribed to it in Article 1.1.

 

2.14   Site” will mean that portion of the Sakata Facility where the New Facility will be constructed.

 

3



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

2.15   Supply Commitment” will have the meaning ascribed to it in Article 6.1 and Exhibit D.

 

2.16   “[*] Process” will mean the [*], 8 inch wafer, CMOS process owned, licensed or developed by Epson which will be used at the New Facility.  The [*] Process will include (a) all process flow, process steps, process conditions, and modifications thereto, used to manufacture semiconductor wafers at the New Facility as well as (b) all methods, formulae, procedures, technology and know-how associated with such process steps and process conditions.  The [*] Process will not include any methods, formulae, procedures, technology or know-how licensed or received from Lattice under this Agreement, the Existing Agreements or other agreements executed between the parties in the future unless otherwise agreed in writing.  If the parties find it necessary or convenient to document process flow for any Product, such documentation will be signed by the parties and attached to the appropriate Purchase Agreement as an exhibit.

 

2.17   Subsidiary” will mean any corporation, partnership, joint venture or other legal entity which agrees in writing to be bound by the terms and conditions of this Agreement and more than fifty percent (50%) of whose ownership rights are controlled directly or indirectly by Epson or Lattice, as the case may be, but only so long as such control exists.

 

3.      Construction and Representation.

 

3.1   Construction of the New Facility

 

3.1.1        Location and Costs

Epson hereby agrees, subject to its receipt of the full amount of  the APP as provided in Article 4.1 to construct the New Facility at  the Site and to install the Equipment therein.

 

3.1.2        Completion Schedule

The projected completion schedule for the construction of the New Facility (the “Projected Completion Schedule”) is set forth in Exhibit A attached hereto.  In the event Epson has reason to believe that any item in the Projected Completion Schedule designated as a “Construction Milestone” will be delayed by more than thirty (30) calendar days, Epson will promptly notify Lattice in writing and (a) explain the reason for the delay, (b) describe the estimated amount of time that construction will be delayed and (c) describe the action that Epson will take to minimize the delay.

 

3.1.3        Business Interruption Insurance

Epson will use its best efforts to obtain business interruption insurance coverage for the New Facility once the construction of the New Facility is

 

4



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

complete.  The insurance will cover at least such risks as are usually insured against by companies engaged in the manufacture of semiconductor devices in Japan.  Epson will maintain such business interruption insurance coverage during the term of this Agreement.  Epson will furnish to Lattice, upon written request, full information concerning the business interruption insurance coverage.

 

3.1.4        First Shipment Delay

In the event that the first mass production of the first Product is expected to be delayed beyond the process road map described in the latest version of Exhibit B, firstly, the shipment of such Product shall be made by utilizing existing facilities in the Sakata Facility subject to successful completion of the relevant process at such existing facility.  Such alternative shipment shall not be applied for off-setting the APP.  Epson shall provide regular action plans for the cure of the delay, and make monthly progress reports to Lattice.  If no cure is achievable by the beginning of October 1998, and if the delay is not caused by Lattice, then Epson shall, in addition to the Free Wafers as prescribed in Article 8 hereof, provide additional free wafers [*].

 

3.1.5        Design Requirements 

Epson acknowledges that Lattice may require certain safety and security requirements for semiconductor fabrication facilities, and Epson agrees to work with Lattice to incorporate such requirements into the design of the New Facility to the extent reasonably requested by Lattice and commercially feasible.

 

3.2   Representations of Epson 

In order to induce Lattice to enter into this Agreement and to make the APP hereunder, Epson hereby represents and warrants that:

 

3.2.1        Corporate Status

Epson (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, (b) has the corporate power to own or lease its assets and to transact the business in which it is currently engaged and (c) is in compliance with all requirements of law except to the extent that the failure to comply therewith will not materially affect the ability of Epson to perform its obligations under this Agreement.

 

3.2.2        Corporate Authority 

(a) Epson has the corporate power, authority and legal right to execute, deliver and perform this Agreement and has taken as of the date hereof all necessary corporate action to execute this Agreement, (b) the person executing this Agreement has actual authority to do so on behalf of Epson and (c) there are

 

5



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

no outstanding assignments, grants, licenses, encumbrances, obligations or agreements, either written, oral or implied, that prohibit execution of this Agreement.

 

3.2.3        Ownership of the Site 

Epson has such right, title and interest in and to the Site and the structures located thereon as is required to permit the operation of the Site as currently conducted and contemplated to be conducted under this Agreement.

 

3.2.4        No Material Litigation

No litigation, investigation or administrative proceeding is presently pending, or to the knowledge of Epson, threatened against Epson which, if adversely determined, would materially affect Epson’s ability to carry out the terms and conditions of this Agreement.  If such material litigation, investigation or administrative proceeding is commenced against Epson, Epson shall notify Lattice thereof within thirty (30) days of the commencement.

 

3.3   Representation of SMOS 

In order to induce Lattice to enter into this Agreement and to make the APP hereunder, SMOS hereby represents and warrants that:

 

3.3.1        Corporate Status

SMOS (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, (b) has the corporate power to own or lease its assets and to transact the business in which it is currently engaged and (c) is in compliance with all requirements of law except to the extent that the failure to comply therewith will not materially affect the ability of SMOS to perform its obligations under this Agreement.

 

3.3.2        Corporate Authority 

(a) SMOS has the corporate power, authority and legal right to execute, deliver and perform this Agreement and has taken as of the date hereof all necessary corporate action to execute this Agreement, (b) the person executing this Agreement has actual authority to do so on behalf of SMOS and (c) there are no outstanding assignments, grants, licenses, encumbrances, obligations or agreements, either written, oral or implied, that prohibit execution of this Agreement.

 

3.3.3        No Material Litigation 

No litigation, investigation or administrative proceeding is presently pending, or to the knowledge of SMOS, threatened against SMOS which, if adversely determined, would materially affect SMOS’s ability to carry out the terms and conditions of this Agreement.  If such material litigation, investigation or

 

6



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

administrative proceeding is commenced against SMOS, SMOS shall notify Lattice thereof within thirty (30) days of the commencement.

 

3.4   Representations of Lattice 

In order to induce Epson to enter into this Agreement and to make the Supply Commitment, Lattice hereby represents and warrants that:

 

3.4.1        Corporate Status 

Lattice is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, (b) has the corporate power to own or lease its assets and to transact the business in which it is currently engaged and (c) is in compliance with all requirements of law except to the extent that the failure to comply therewith will not materially affect the ability of Lattice to perform its obligations under this Agreement.

 

3.4.2        Corporate Authority

(a) Lattice has the corporate power, authority and legal right to execute, deliver and perform this Agreement and has taken as of the date hereof all necessary corporate action to execute this Agreement, (b) the person executing this Agreement has actual authority to do so on behalf of Lattice and (c) there are no outstanding assignments, grants, licenses, encumbrances, obligations or agreements, either written, oral or implied, that prohibit execution of this Agreement.

 

3.4.3        No Material Litigation

No litigation, investigation or administrative proceeding is presently pending, or to the knowledge of Lattice, threatened against Lattice which, if adversely determined, would materially affect Lattice’s ability to carry out the terms and conditions of this Agreement.  If such material litigation, investigation or administrative proceeding is commenced against Lattice, Lattice shall notify Epson thereof within thirty (30) days of the commencement.

 

4.      APP

 

4.1   APP

Lattice shall pay to Epson an amount equal to Ten Billion, Four Hundred sixty nine Million and Seven Hundred Thousand Japanese Yen (JPY10,469,700,000) (“APP”), which APP will be credited against certain future purchases by Lattice of New Facility Wafers as provided in Article 5.  Lattice will pay the whole amount of APP in accordance with the payment schedule described in Exhibit C hereof.

 

4.2   Payment Method

 

7



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

All payments made by Lattice to Epson will be in immediately available funds and will be made by wire transfer in Japanese Yen to the following bank account of Epson at:

 

[*]

For the Account of Seiko Epson Corporation.

 

4.3   Non-Refund of APP

The APP will not be refundable except as provided in Articles 6.4.1 or 14.8.

 

4.4   Additional APP

Epson acknowledges that Lattice may wish to pay to Epson additional APP of Sixty Million U.S. Dollars (US$60,000,000), to be converted to, and paid in Japanese Yen using U.S. dollar/Japanese Yen exchange rate prevailing in Tokyo, as published in Nihon Keizai Shinbun (Nikkei Newspaper), as at the end of a month immediately preceding the month during which the parties execute an amendment to this Agreement to effectuate such additional APP.  Lattice will notify Epson by the end of 1999, or when the unused APP balance becomes less than Five Billion, Two Hundred Thirty Four Million, Eight Hundred and Fifty Thousand Japanese Yen (JPY5,234,850,000), whichever occurs first, whether or not it wishes to pay such additional APP.  If Lattice so wishes to pay to Epson additional APP, Lattice’s additional APP shall be deemed to be a part of the APP for all purposes hereunder, including but not limited to the same Price, procedure to offset from the additional APP, and Free Wafers.  The specific terms for such additional APP, including payment terms, term of this Agreement and the additional Supply/Purchase Commitment shall be determined and added as an addendum to this Agreement within ninety (90) days of Lattice’s first notification stated above.

 

5.      Credit of APP

 

5.1   Credit of APP

The Purchase price of all New Facility Wafers purchased by Lattice under the Purchase Agreement will be credited against the amount of the APP until the aggregate Japanese Yen value of all New Facility Wafers (excluding the Free Wafers) purchased and received by Lattice, calculated pursuant to Article 5.2, equals or exceeds the amount of the APP.  The criteria and time required for wafer acceptance by Lattice will be described in the Purchase Agreement.

 

5.2   Calculation of Aggregate Credit Value

The amount of APP will be offset and reduced on Japanese Yen to Japanese Yen basis, at the end of each calendar month of this Agreement, by an amount equal to

 

8



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

the Price for the New Facility Wafers multiplied by the total number of New Facility Wafers (excluding the Free Wafers) shipped to Lattice pursuant to thePurchase Agreement during the calendar month, with adjustment of the increase pursuant to the methods provided in the Purchase Agreement, however under no circumstances shall the APP balance be increased, except as provided for in Article 14.8 of this Agreement.  Further, any wafer provided to Lattice under Article 6.4.1 from alternative facility, besides the New Facility, shall not be used to offset the APP.

 

5.3   Invoices

Epson will cause SMOS to provide Lattice with invoices under the Purchase Agreement which, for the purpose of APP application, specify the purchase price of the New Facility Wafers.  Also, SMOS shall provide Lattice and Epson with the monthly report describing, among others, the outstanding balance of the APP (after the application of all prior offsets, reductions and credits) as of the commencement of the month subject to the invoices, the number of New Facility Wafers shipped to Lattice during that calendar month and the applied Price, and the outstanding balance of the APP as of the end of such calendar month.  Such report shall be signed by the respective responsible person at Epson, SMOS and Lattice, provided that Lattice shall not be required to sign any such report unless it is satisfied with the accuracy and completeness thereof.  Lattice may, for its signature, review all invoices and reports for inaccuracies and if any such inaccuracies are found and confirmed by Epson and SMOS, Lattice may request to make corrections to these invoices and reports.

 

5.4   Obligation after Completion of Off-Setting the APP

Lattice will be required to pay for all New Facility Wafers in accordance with the Purchase Agreements once the Advance Payment has been fully offset and reduced.  Lattice will make the payments to Epson in Japanese Yen based on the Price.  Further, Epson will be required to fulfill the Supply Commitment and Lattice will be required to fulfill the Purchase Commitment until Lattice has purchased [*] New Facility Wafers.  After Lattice has purchased this fixed volume of the New Facility Wafers, during the effective period of this Agreement, Epson and Lattice will continue to make efforts to supply and purchase at the rate to be mutually agreed under fair and competitive prices to be determined between the parties.

 

6.      Supply Commitment

 

6.1   Contents of Supply Commitment

It is the intent of Lattice to purchase and Epson to supply New Facility Wafers until a total of [*] New Facility Wafers have been supplied to Lattice by Epson through SMOS and received and accepted by Lattice (“Supply Commitment”).

 

9



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

The Supply Commitment and the supply schedule thereof are set forth in Exhibit D.  The Supply Commitment herein shall remain in effect until Lattice has received and accepted a total of [*] New Facility Wafers (exclusive of the Free Wafers) through SMOS from Epson under this Agreement.  Dealing of New Facility Wafers rejected by Lattice for any reason shall be as described in the Purchase Agreement.  The Supply Commitment for a particular month may be modified as specifically set forth in this Agreement, but under no circumstances shall the aggregate Supply Commitment of [*] New Facility Wafers be reduced.

 

6.2   Purchase Agreements

The Supply Commitment will apply to Products covered by the Purchase Agreements.  The parties anticipate that such Purchase Agreements will apply to Products distributed by Lattice which require fabrication using the [*] Process.

 

6.3   Excess Capacity

Epson will use its best efforts to provide Lattice, through SMOS, with excess capacity of the New Facility if Lattice requires so in the manner specified below.  In this case, APP shall be applied to Lattice’s orders of New Facility Wafers in excess of the Supply Commitment of the month.  Also, the Free Wafers prescribed in Article 8 shall be provided for such excess volume of the New Facility Wafers.

 

First, in the event that Lattice desires to purchase New Facility Wafers in excess of the Purchase Commitment, Lattice will specify in writing the amount of capacity required, the Product(s) it desires to purchase and the date from which such capacity is required, and notify Epson of it through SMOS.

 

Second, Epson will then determine how much capacity is available and notify Lattice of its determination through SMOS.  Epson will give Lattice priority over third parties for excess capacity of the New Facility except to the extent that Epson is already obligated to provide such third parties with capacity.

 

Third, the parties will then mutually agree upon a preliminary excess capacity allocation.  Any excess capacity allocated under this Article 6.3 will be applied to the Supply Commitment and to the Purchase Commitment.

 

In order to provide Lattice with first priority for unused capacity using the specific process for Lattice, Epson agrees to give Lattice monthly written notice of any unused capacity using the specific process for Lattice for the next [*], and to provide Lattice with the first right to reserve such unused capacity for any New Facility Wafers which Lattice desires to purchase in excess of the Purchase Commitment.  Lattice will have a reasonable time to elect to reserve such excess capacity.  The parties acknowledge that “specific process for Lattice” above refers to Lattice’s [*] process, and that Epson’s capacity plan at the time of executing this Agreement shows that approximately [*] of total production capacity of the New

 

10



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

Facility will be for [*] process, subject to change by then-current production plan of Epson.  Epson will notify Lattice if the capacity set aside for [*] process will change by [*] of the total capacity.

 

6.4   Failure to Meet Supply Commitment

 

6.4.1        Failure Due to Epson 

In the event that (a) Epson fails to fulfill the Supply Commitment by the end of any month during the term of this Agreement or (b) Epson has reason to believe that it will be unable to fabricate the Supply Commitment by the end of such month, then Epson will take the following measures:

 

First, Epson will promptly notify Lattice in writing and describe the nature of the difficulty.

 

Second, Epson will use its best efforts to remedy the difficulty in an expeditious manner by the end of the second full month following the month in which Epson is unable to meet the Supply Commitment (in other words, the third month including the month in which the difficulty occurs).

 

Third, Epson will use its best efforts to make available during the above referenced three (3) month period sufficient capacity at the Sakata Facility, the Fujimi Facility or Epson’s other qualified facility to cover the deficiency between the Supply Commitment and the actual capacity subject to completion of product qualification.  The parties acknowledge, however, that Epson cannot guarantee the use of such alternative capacity.

 

Fourth, if Epson’s inability to fulfill the Supply Commitment is due to force majeure prescribed in Article 15.14, Epson will use its best efforts to make available alternative capacity at the Sakata Facility and/or Fujimi Facility.  The parties acknowledge, however, that Epson cannot guarantee the use of existing capacity at the Sakata Facility or Fujimi Facility.

 

Notwithstanding any provision of this Agreement to the contrary, in the event that Epson fails to fulfill the Supply Commitment (including any failure by virtue of the action or inaction of SMOS or any of the deficiency within the three (3) month period referenced above), such failure shall constitute a material breach of this Agreement and Epson, SMOS and Lattice shall discuss the relief of such breach prior to Lattice’s termination of this Agreement based on the right permitted in Article 14.4 (which termination may be made without the notice and cure period contemplated by Article 14.4).

 

11



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

6.4.2        Failure Due to Lattice 

Notwithstanding anything contained in Article 6.4.1 to the contrary, in the event that Epson fails to fulfill the Supply Commitment in any  month due to (a) design defects in Products caused by Lattice, (b) design changes requested by Lattice, (c) process flow changes requested by Lattice or (d) any other reason caused by Lattice, Epson will only be required to make reasonable efforts to fulfill the Supply Commitment in such month.  Provisions concerning Lattice’s failure to fulfill its Purchase Commitment are set forth in Article 7.2.

 

6.4.3        Failure Due to Both Parties 

Notwithstanding anything contained in Article 6.4.1, 6.4.2 or 7.1 to the contrary, in the event that Epson fails to fulfill the Supply Commitment and Lattice fails to fulfill the Purchase Commitment due to difficulties caused jointly by Lattice and Epson, the parties will mutually agree in writing upon a fair and equitable solution.

 

6.4.4        Failure Due to Catastrophe

In the event that any fire, flood, earthquake, explosion or any other catastrophe prevents Epson from fabricating New Facility Wafers for Lattice, (a) Epson will immediately implement the measures required by Article 6.4.1, (b) Epson will permit Lattice to inspect the New Facility, and (c) the parties will begin good faith negotiations to agree on a corrective action plan.

 

7.      Purchase Commitment.

 

7.1   Content of Purchase Commitment 

Lattice intends to purchase each month the number of New Facility Wafers (the “Purchase Commitment”) equal to the Supply Commitment until [*] wafers have been purchased.  Lattice will not be required to fulfill the Purchase Commitment in the event that Epson fails to fulfill the Supply Commitment in the manner specified in Article 6.4.1.  Instead, subject to the terms of the Purchase Agreement, Lattice will be required to purchase those New Facility Wafers that Epson is able to fabricate up to the Purchase Commitment for each month.  Lattice will not be required to fulfill the Purchase Commitment in the event of difficulties caused by both Epson and Lattice.  Instead, the parties will mutually agree in writing upon a fair and equitable solution.

 

7.2   Sale of Unused Capacity

In the event that Lattice is unable to fulfill the Purchase Commitment in any month for reasons not due to Epson, Epson will use its best efforts to sell unused capacity to other customers, or to allocate unused capacity for the fabrication of Epson products during such month.  Further, the Supply Commitment for such month will be reduced to the same extent that Lattice is unable to fulfill the

 

12



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

Purchase Commitment.  When Lattice desires to increase its monthly purchases after Epson has sold or otherwise allocated unused capacity, then Epson will use its best efforts to increase capacity for Lattice to the Supply Commitment in an expeditious manner.  The parties will mutually agree upon the specific rate at which Epson will be required to ramp up capacity to the Supply Commitment.

 

8.      Free Wafers

As a consideration for Lattice’s payment of APP, Epson shall provide Lattice with [*] free wafers of a Product (“Free Wafers”) through SMOS pursuant to the Purchase Agreement for every [*] New Facility Wafers ordered by Lattice after the execution of this Agreement [*] until Epson has supplied [*] New Facility Wafers (excluding the Free Wafers).

 

9.      Fabrication, Purchase and Sale

 

9.1   General Terms and Conditions 

The terms and conditions for the prototype wafer fabrication, wafer fabrication, order and acceptance, shipping, insurance and warranty for the Products will be set forth in the Purchase Agreements.  The parties have agreed to certain order and forecast systems as described in Exhibit F, which will be incorporated in the Purchase Agreement.  The parties acknowledge that a best estimation and target of defect densities as at the date of this Agreement is set forth in Exhibit H attached hereto, which will be reviewed and amended from time to time by the parties hereto, and will be incorporated into all Purchase Agreements.

 

9.2   Start of Production

Qualification testing for the Products will be conducted in the manner specified in the Purchase Agreement.  Once any Product has been qualified, Epson will begin mass production of such Product in the manner specified by the Purchase Agreement.

 

9.3   Turn Around Time

The parties acknowledge that the lead time for shipment of New Facility Wafers, defined as the time from Lattice’s purchase order release until delivery of New Facility Wafers, known as “turn around time”, is of the essence, and agree that the parties shall set annual target turn around time and make their joint efforts to achieve such target in accordance with Exhibit I.

 

10.    Wafer Pricing and Payment.

 

10.1 Determination of Price

 

13



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

The general method for determining the price of Products (“Price”) shall be as set forth in Exhibit E.  Epson agrees that at any time the Prices to Lattice [*].  The Price herein shall be applicable until Lattice has completed the purchase of [*] New Facility Wafers under the terms of this Agreement.

 

10.2 Shipping, Insurance, Taxes, Duties and Other Fees

Epson will deliver the Products on a C.I.F., San Jose basis, and SMOS will deliver such Products to Lattice on an F.O.B., San Jose basis.  Bearing of sales, use, excise, ad valorem, withholding or other taxes or duties that may be applicable to purchase of the Products by Lattice shall be prescribed in the Purchase Agreement.

 

10.3 Payment

Other than through offset of the APP, Lattice will not be required to pay for any New Facility Wafers delivered under this Agreement or any Purchase Agreement until the APP has been fully offset and reduced.  Once the APP is fully offset and reduced, Lattice will be required to pay Epson in the manner specified in the Purchase Agreement based on the Price until Lattice has completed the purchase of [*] New Facility Wafers under the terms of this Agreement.

 

11.    Technical Cooperation and Support

 

The parties desire to engage in various types of joint development and technical cooperation activities required to fabricate Products and to effectuate the terms and conditions of this Agreement.  The parties, including SMOS, will discuss such joint development possibilities, and will conclude appropriate agreement(s).

 

12.    Intellectual Property Rights

 

All intellectual property rights clauses relating to the [*] Process and the Products will be set forth in the Purchase Agreement.  Lattice agrees that any indemnity or warranty that Lattice expressly provides to Epson or SMOS under the Purchase Agreement will be fully enforceable by Epson even though Epson has not executed the Purchase Agreement.  Furthermore, Epson agrees that any indemnity or warranty that Epson or SMOS purports to provide to Lattice under the Purchase Agreement will be fully enforceable by Lattice even though Epson has not executed the Purchase Agreement.  In the event that any claims for intellectual property rights infringements described in the Purchase Agreement prevent the parties from fulfilling the Supply Commitment and the Purchase Commitment, the parties will mutually agree on a fair and equitable solution without affecting in any way the right of either party to terminate this Agreement for cause pursuant to Article 14.4 as a consequence of failure of the other party to fulfill this Agreement and the Purchase Agreement as the case may be.  The parties acknowledge that the covenants contained in this Article 12 are an essential part of this Agreement.

 

14



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

13.    Confidential Information.

 

13.1 Definitions.

“Confidential Information” means technical information, specifications, data, drawings, designs or know-how, prices, order volumes, forecasts, financial information, strategic plans, and other important business information disclosed between Epson and Lattice, or SMOS and Lattice in connection with this Agreement.  Confidential Information includes information or material that is expressly covered by confidentiality provisions of Existing Agreements or the Purchase Agreement, it being understood that such provisions will apply.

 

13.2 Marking.

If Confidential Information is provided in a tangible form, it will be marked as confidential or proprietary.  If Confidential Information is provided orally, it will be treated as confidential and proprietary if it is treated as confidential or proprietary at the time of disclosure by the disclosing party and described as such in a writing provided to the other party within thirty (30) days of the oral disclosure, which writing will be marked as confidential or proprietary.  Material that is not marked as required by this Article 13.2 will not be deemed Confidential Information.

 

13.3 Restrictions on Use.

During the term of this Agreement and for a period of [*] years following disclosure of any Confidential Information, the receiving party will: (a) hold the Confidential Information in confidence using the same degree of care that it normally exercises to protect its own proprietary information but no less than a reasonable degree of care, (b) restrict disclosure and use of Confidential Information solely to those employees (including any contract employees or consultants) of such party on a need-to-know basis, and not disclose it to other employees or parties, and (c) restrict the number of copies of Confidential Information to the number required to carry out its obligations under this Agreement.

 

13.4 Exceptions to Confidentiality Obligations.

Neither party will use or disclose the other party’s Confidential Information except as permitted by this Agreement.  The receiving party, however, will have no obligations concerning the disclosing party’s Confidential Information if the disclosing party’s Confidential Information:

 

a)                                      is made public before the disclosing party discloses it to the receiving party;

 

15



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

b)                                     is made public after the disclosing party discloses it to the receiving party (unless its publication is a breach of this Agreement or any other agreement between Epson and Lattice);

 

c)                                      is rightfully in the possession of the receiving party before the disclosing party discloses it to the receiving party;

 

d)                                     is independently developed by the receiving party without the use of the Confidential Information, if such independent development is supported by documentary evidence; or

 

e)                                      is rightfully obtained by the receiving party from a third party who is lawfully in possession of the information and not in violation of any contractual, legal or fiduciary obligation to the disclosing party with respect to the information.

 

Each party may disclose any Confidential Information to the extent that such party has been advised by counsel that such disclosure is necessary to comply with laws or regulations provided that such party shall give the other party reasonable advance notice of such proposed disclosure, shall use its best efforts to secure confidential treatment of such Confidential Information, and shall advise the other party in writing of the manner of the disclosure.

 

13.5 Return of Confidential Information. 

Upon termination of this Agreement, a party who has received Confidential Information from the other party pursuant to this Agreement will return, within fourteen (14) days of the disclosing party’s request for return, all Confidential Information that was obtained or learned by the receiving party from the disclosing party, or delivered to the receiving party, together with all copies, excerpts and translations thereof.

 

14.    Term and Termination of Agreement.

 

14.1 Term.

The term of this Agreement will extend from the date first written above until the latest of (a) Epson’s completion of the supply of, and receipt and acceptance by Lattice of, [*] New Facility Wafers in total [*], (b) the completion of off-setting APP, or (c) March 31, 2003, unless terminated earlier pursuant to Article 14.2, 14.3 or 14.4.  After the expiration of this Agreement, Epson and Lattice shall continue to make efforts to supply and purchase a certain volume of wafers per month under fair and competitive prices to be determined between the parties.

 

14.2 Termination.

 

16



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

Either party may terminate or suspend this Agreement immediately and without liability (except for the terms provided in Articles 14.5 and 14.6) upon written notice to the other party if any one of the following events occurs;:

 

a)                                      the other party files a voluntary petition in bankruptcy or otherwise seeks protection under any law for the protection of debtors;

 

b)                                     a proceeding is instituted against the other party under any provision of any bankruptcy laws which is not dismissed within ninety (90) days;

 

c)                                      the other party is adjudged bankrupt;

 

d)                                     a court assumes jurisdiction of all or a substantial portion of the assets of the other party under a reorganization law;

 

e)                                      a trustee or receiver is appointed by a court for all or a substantial portion of the assets of the other party;

 

f)                                        the other party becomes insolvent, ceases or suspends all or substantially all of its business;

 

g)                                     the other party makes an assignment of the majority of its assets for the benefit of creditors; or

 

h)                                     the other party fails to pay all or a substantial portion of its debts as they become due or admits in writing its inability to pay all or a substantial portion of its debts as they become due; or

 

i)                                         force majeure, as prescribed in Article 15.14, becomes in effect and performance of the obligations under this Agreement will not be restored within six (6) months after such force majeure’s occurrence.

 

14.3 Termination due to Acquisition or Sale of Assets.

In the event that a direct competitor or one party acquires, through merger, consolidation, acquisition or otherwise, an interest in excess of fifty percent (50%) of the voting securities or assets of the other party, or such other party transfers all or substantially all of its business to which this Agreement relates to a direct competitor of such party, the non-acquiring or non-transferring party will be permitted, upon written notice to the other party, to require that the transactions contemplated by this Agreement and the Purchase Agreements be phased out and terminated at a rate not to exceed, [*] of the business existing at the time of the acquisition or transfer according to the following schedule:

 

17



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

A

B

 

 

[*]

[*]

 

 

 

 

 

A — Time elapsed since acquisition or transfer of assets

 

 

B — Level to which business may be phased out measured as a percentage of business existing at the time of the acquisition or transfer of assets

 

Alternatively, the business may be phased out and terminated under this Article 14.3 in a manner otherwise agreed upon in writing by the parties.

 

14.4 Termination for Cause.

If either party fails to perform or violates any material obligation of this Agreement, then, sixty (60) days after providing written notice to the breaching party specifying the default (the “Default Notice”), the non-breaching party may terminate this Agreement, without liability, unless:

 

a)                                      the breach specified in the Default Notice has been cured within the sixty (60) day period; or

 

b)                                     the default reasonably required more than sixty (60) days to correct, and the defaulting party has begun substantial corrective action to remedy the default within such sixty (60) day period and diligently pursues such action, in which event, the non-breaching party may not terminate or suspend this Agreement unless one hundred twenty (120) days has expired from the date of the Default Notice without such corrective action being completed and the default remedied.

 

14.5 Termination by Epson.

In the event that Epson terminates this Agreement pursuant to this Article 14, then, unless otherwise agreed upon in writing, Epson may offset and reduce the APP to cover all direct material and labor costs for work in process rendered

 

18



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

unusable by termination and will ship such work in process to Lattice, at Lattice’s expense, if requested to do so.  Upon such termination, Epson shall refund the remaining portion of APP (reduced by the amount of any such offset and reduction to cover direct material and labor costs for work in process rendered unusable by the termination) no later than thirty (30) business days after the date of termination.

 

14.6 Termination by Lattice.

In the event that Lattice terminates this Agreement pursuant to this Article 14, then, unless otherwise agreed in writing, Lattice may either (a) request that Epson refund the remaining portion of APP (from which Epson may offset and reduce to cover all direct material and labor costs for work in process rendered unusable by the termination) and then Epson will refund the remaining portion of APP (as so offset and reduced) or (b) request Epson to complete all work in process and ship them under normal terms and conditions, and then Epson will refund the remaining portion of APP (excluding, without limitation, the costs and expenses which have arisen in connection with completing all work in process and shipping thereof), with in either such case such refund to be paid upon the earlier of:

 

(a)  receipt of sufficient funding from a financial institution or other source for purposes of paying the refund, or

 

(b)  thirty (30) days from the date of termination.

 

14.7 Retention of Rights after Termination.

Notwithstanding anything contained in this Article 14 to the contrary, in the event that either party is entitled to terminate this Agreement pursuant to Articles 14.2 (f), (g) or (h) or either party is subject to a bankruptcy, reorganization or liquidation proceeding, the other party may elect to (a) retain its rights in this Agreement existing immediately prior to termination pursuant to Article 14.2 (f), (g) or (h) or the initiation of such proceeding or (b) treat any such proceeding or attempted rejection of this Agreement by a bankruptcy trustee as an event of termination.  Unless otherwise provided, in the event of such termination, Epson shall refund the remaining portion of the APP in accordance with Article 14.5 or 14.6 as applicable.

 

14.8 Reconciliation.

In the event of termination that results in a refund of the APP balance pursuant to Article 14 (or would result in such a refund if the APP balance were increased by the net return material account balances, if any, under the Purchase Agreement), Epson shall cause SMOS to bring current the APP, Free Wafers and return material account balances as provided for in the Purchase Agreement in order to reconcile the account with Lattice, and to refund the mutually agreed net amount.

 

14.9 Survival of Obligations.

The following Articles will survive any expiration, termination or cancellation of this Agreement and the parties will continue to be bound by the terms and conditions thereof: 12, 13, 14, and 15.

 

19



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

15.    Miscellaneous.

 

15.1 Order of Precedence.

In the event of any conflicts between this Agreement and any Purchase Agreement, any purchase orders, acceptances, correspondence, memoranda, listing sheets or other documents forming part of an order for the Products placed by Lattice and accepted by SMOS (or Epson), priority will be given first to this Agreement, second to the Purchase Agreements, third to SMOS’s or Epson’s acceptance, fourth to Lattice’s order and then to any other documents.  In no event, however, will either party’s standard terms and conditions be applicable to the transactions between Lattice and SMOS (or Epson) unless expressly accepted in writing by the other party.

 

15.2 Governing Law.

This Agreement shall be governed by and construed in accordance with the laws of California, U.S.A. without reference to conflict of law principles.

 

15.3 Dispute Resolution.

 

15.3.1      Meeting of Executives. 

In the event that any dispute or disagreement between the parties as to any provision of this Agreement arises, prior to taking any other action, the matter will be referred to responsible executives of the parties for consideration and resolution.  Any party may commence such proceedings by delivering a written request to the other party for a meeting of such responsible executives.  The other party will be required to set a date for the meeting to be held within thirty (30) days after receipt of such request and the parties agree to exercise their best efforts to settle the matter amicably.

 

15.3.2      Location of Meeting. 

In the event that Epson initiates the proceedings described in Article 15.3.1, the first meeting will be held Hillsboro, Oregon and all subsequent meetings will alternate between Tokyo, Japan, and Hillsboro, Oregon.  In the event that Lattice initiates the proceedings described in Article 15.3.1, the first meeting will be held in Tokyo, Japan and all subsequent meetings will alternate between Hillsboro, Oregon and Tokyo, Japan.

 

15.3.3      Demand for Arbitration. 

Any dispute relating to and/or arising out of this Agreement will be decided exclusively by binding arbitration under procedures which ensure efficient and speedy resolution.  Such an arbitration may be commenced by either party involved in the dispute (i) after the expiration of a sixty (60) day period following the written request to resolve the dispute, and/or (ii) at such earlier time as any party involved repudiates and/or refuses to continue with its

 

20



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

obligations to negotiate in good faith.  The arbitration hearing will be conducted in the State of Hawaii, and will be in the English language (with translators and interpretations as reasonable for the presentation of evidence and/or conduct of the arbitration).  Notwithstanding anything to the contrary, any party may apply to any court of competent  jurisdiction for interim injunctive relief as may be allowed under applicable law with respect to irreparable harm which cannot be avoided and/or compensated by such arbitration proceedings, without breach of this Article 15.3.3 and without any abridgement of the powers of the arbitrators.  The arbitration will be conducted under the Rules of the Asia Pacific Arbitration Center.  Notwithstanding anything to the contrary, (i) the arbitrators will have the power to order discovery to the extent they find such discovery necessary to achieve a fair and equitable result and (ii) the arbitrators shall require pre-hearing exchange of documentary evidence to be relied upon by each of the respective parties in their respective cases in chief, and pre-hearing exchange of briefs, witness lists, and summaries of expected testimony.

 

The arbitrators will make their decision in writing.

 

15.3.4      Arbitrators. 

The arbitration will be conducted by three (3) arbitrators.  No person with a beneficial interest in the dispute under arbitration may be an arbitrator.  The parties will make reasonable efforts to select arbitrators with experience in the field of computers and law.

 

15.3.5      Binding Effect. 

The decision or award rendered or made in connection with such arbitration will be binding upon the parties and judgment thereon may be entered in any court having jurisdiction and/or application may be made to such court for enforcement of such decision or award.  However, the arbitrators will not have the authority to create any licenses.  They will only be permitted to enforce licenses which the parties have otherwise agreed to in the Agreement or the Existing Agreements.

 

15.3.6      Expenses. 

The expenses of the arbitrators will be shared equally by the parties; each party will otherwise be responsible for the costs and attorney’s fees incurred by it; provided, however, if the arbitrators appointed in Article 15.3.4 find that the position of the non-prevailing party or parties in such arbitration was without substantial justification or was frivolous, the arbitrators may assess all of the costs and expenses together with reasonable attorney’s fees against the non-prevailing party or parties.

 

15.4 Consequential Damages. 

 

21



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, SPECIAL, CONSEQUENTIAL OR INCIDENTAL DAMAGES (INCLUDING LOST PROFITS) WHETHER BASED ON WARRANTY, CONTRACT, TORT OR ANY OTHER LEGAL THEORY REGARDLESS OF WHETHER SUCH PARTY HAD ACTUAL OR CONSTRUCTIVE NOTICE OF SUCH DAMAGES; PROVIDED, HOWEVER, THIS LIMITATION WILL NOT APPLY IF THE DAMAGES OCCUR AS A RESULT OF GROSS NEGLIGENCE OR WILLFUL MISCONDUCT OF EITHER PARTY IN THE PERFORMANCE OF THEIR RESPONSIBILITIES UNDER THIS AGREEMENT.

 

15.5 Assignment.

Neither party will assign, transfer or otherwise dispose of this Agreement in whole or in part without the prior consent of the other party in writing, and such consent will not be unreasonably withheld.  Except in the case set forth in Article 14.3, above, this Agreement may be assigned to any Subsidiary or to a successor who has acquired a majority of the business or assets of the assigning party.

 

15.6 Public Announcements.

Neither party will publicly announce the execution or existence of this Agreement or disclose the terms and conditions of this Agreement without first submitting the text of such announcement to the other party and receiving the approval of the other party of such text, which approval, unless public disclosure is required by a court or a government agency, may be withheld for any reason.  However, Lattice may disclose the existence and the terms of this Agreement in any document legitimately required to be filed with the Securities and Exchange Commission (and may file a copy of this Agreement required legitimately with such filing) or in accordance with generally accepted accounting procedures under the rules of the Securities and Exchange Commission or the National Association of Securities Dealers Automated Quotations stock market.

 

15.7 Notice and Communications.

Any notices required or permitted to be given hereunder will be in English and be sent by (i) registered airmail or (ii) cable, facsimile or telex to be confirmed by registered airmail, addressed to:

 

22



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

To Epson:

 

281 Fujimi, Fujimi-machi, Suwa-gun

Nagano-ken 399-02, Japan

Attn: Nobuo Hashizume,

Director and Corporate General Manager

Semiconductor Operations Division

Tel:  81-266-61-1211

Fax:  81-266-61-1270

 

To SMOS:

 

150 River Oaks Parkway, San Jose, CA 95134-1951

U.S.A.

Attn: Tadakatsu Hayashi, President and CEO

Tel:  1-408-922-0200

Fax:  1-408-922-0238

 

To Lattice:

 

5555 N.E. Moore Ct., Hillsboro, Oregon,

97124-6421, U.S.A.

Attn: Cyrus Tsui

Chairman, President and Chief Executive Officer

Tel:  1-503-681-0118

Fax:  1-503-681-3077

 

Any such notice will be deemed given at the time of its receipt by the addressee.

 

15.8 Relationship of the Parties. 

Epson and Lattice are independent contractors and neither of them will be nor represent themselves to be the legal agent, partner or employee of the other party for any purpose.  Neither party will have the authority to make any warranty or representation on behalf of the other party nor to execute any contract or otherwise assume any obligation or responsibility in the name of or on behalf of the other party.  In addition, neither party will be bound by, nor liable to, any third person for any act or any obligations or debt incurred by the other party, except to the extent specifically agreed to in writing by the parties.

 

15.9 Waiver and Amendment.

Failure by either party, at any time, to require performance by the other party or to claim a breach of any provision of this Agreement will not be construed as a waiver of any right accruing under this Agreement, nor will it affect any subsequent breach or the effectiveness of this Agreement or any part hereof, or

 

23



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

prejudice either party with respect to any subsequent action.  A waiver of any right accruing to either party pursuant to this Agreement will not be effective unless given in writing.

 

15.10          Severability.

In the event that any provision of this Agreement will be unlawful or otherwise unenforceable, such provision will be severed, and the entire agreement will not fail on account thereof, the balance continuing in full force and effect, and the parties will endeavor to replace the severed provision with a similar provision that is not unlawful or otherwise unenforceable.

 

15.11          Rights and Remedies Cumulative.

The rights and remedies provided herein will be cumulative and not exclusive of any other rights or remedies provided by law or otherwise.

 

15.12          Headings.

The Article headings in this Agreement are for convenience only and will not be considered a part of, or affect the interpretation of, any provision of this Agreement.

 

15.13          Governing Language.

This Agreement and all communications pursuant to it will be in the English language.  If there is any conflict between the English version and any translated version of this Agreement, the English version will govern.

 

15.14          Force Majeure.

Except as otherwise expressly provided for herein, no party will be liable in any manner for failure or delay in fulfillment of all or part of this Agreement directly or indirectly owing to any causes or circumstances beyond its control, including, but not limited to, acts of God, governmental order or restrictions, war, war-like conditions, hostilities, sanctions, revolutions, riot, looting, strike, lockout, plague or other epidemics, fire and flood.

 

15.15          Counterparts.

This Agreement may be executed in any number of counterparts, and all such counterparts will together constitute but one Agreement.

 

15.16          Integration.

This Agreement sets forth the entire agreement and understanding between the parties as to its subject matter and supersedes all prior agreements, understandings and memoranda between the parties, except for the Existing Agreements.  No amendments or supplements to this Agreement will be effective for any purpose except by a written agreement signed by the parties.

 

24



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

15.17          Government Approvals; Export Control Laws.

Epson will file all reports and notifications that may be required to be filed with any agency of the Government of Japan in order to allow the performance of this agreement according to its terms.  Lattice will file all reports and notifications that may be required to be filed with any agency of the Government of  U.S.A. in order to allow the performance of this Agreement according to its terms.  Neither party will transmit indirectly or directly any Products or technical information contained in the Confidential Information except in accordance with applicable Japanese and United States export control laws, regulations and procedures.

 

25



* Omitted and filed separately with the SEC pursuant to a confidential treatment request

IN WITNESS WHEREOF, the parties have signed this Agreement as of the date first above written.

 

LATTICE SEMICONDUCTOR CORPORATION

 

By:

/s/ CYRUS TSUI

Name: Cyrus Tsui

Title: Chairman, President and Chief Executive Officer

 

SEIKO EPSON CORPORATION

 

By:

/s/ NOBUO HASHIZUME

Name: Nobuo Hashizume

Title: Director and Corporate General Manager

Semiconductor Operations Division

 

S MOS Systems, Inc.

 

By:

/s/ TADAKATSU HAYASHI

Name: Tadakatsu Hayashi

Title: President and CEO

 

 

26



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

EXHIBIT A

“Projected Completion Schedule”

EXHIBIT B

“Process Road Map for Lattice”

EXHIBIT C

“Payment Schedule”

EXHIBIT D

“New Facility Production Capacity and

Supply/Purchase Commitment”

EXHIBIT E

Price Determination Procedure”

“APP Offset Procedure”

“[*]”

EXHIBIT F

“Forecast System”

EXHIBIT G

“Epson’s [*] Technology Road Map and [*] Process”

EXHIBIT H

“Defect Density Goal”

EXHIBIT I

“Turn Around Time”

 

27



* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

EXHIBIT A
NEW FACILITY START-UP SCHEDULE

 


*Above schedule is for Epson new facility general start-up plan.

 

28



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

EXHIBIT B

 

PROCESS ROAD MAP FOR LATTICE

 

[*]

 

29



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

EXHIBIT C

Payment Schedule

[*]

 

30



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

EXHIBIT D

New Facility Production Capacity Plan and Supply/Purchase Commitment

[*]

 

31



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

EXHIBIT E

Price Determination Procedure

[*]

 

32



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

APP Offset Procedure

[*]

 

[*]

 

33



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

EXHIBIT F

Forecast System

[*]

 

 

34



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

EXHIBIT G

EPSON’s [*] Technology Road Map

[*]

 

35



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

EPSON’s [*] Process (1/2)

 

[*]

 

 

36



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

 

EPSON’S [*] Process (2/2)

 

[*]

 

 

37



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

EXHIBIT H

Defect Density Goal

[*]

 

38



 

* Omitted and filed separately with the SEC pursuant to a confidential treatment request

EXHIBIT I

Turn Around Time

[*]

 

39


Exhibit 21.1

LATTICE SEMICONDUCTOR CORPORATION

SUBSIDIARIES OF THE REGISTRANT

 

 

Name

 

 

 

 

Jurisdiction of Incorporation

 

1.

 

Lattice Semiconductor GmbH

 

Germany

2.

 

Lattice Semiconducteurs SARL

 

France

3.

 

Lattice Semiconductor AB

 

Sweden

4.

 

Lattice Semiconductor Asia Limited

 

Hong Kong

5.

 

Lattice Semiconductor KK

 

Japan

6.

 

Lattice Semiconductor (Shanghai) Co. Ltd.

 

China

7.

 

Lattice UK Limited

 

United Kingdom

8.

 

Lattice Semiconductor SRL

 

Italy

9.

 

Lattice Semiconductor International Corporation

 

Delaware, USA

10.

 

Lattice Semiconductor Canada Corporation

 

Canada

11.

 

Lattice Semiconductor Corp. Worldwide

 

Cayman Islands

 

 



Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-93289, No. 333-50192, No. 333-88128, No. 333-99249, No. 333-107946, No. 110595 and No. 333-120958) and Form S-8 (No. 33-33933, No. 33-35259, No. 33-38521, No. 33-76358, No. 33-51232, No. 33-69496, No. 333-15737, No. 333-40031, No. 333-59990, No. 333-69467, No. 333-81035, No. 333-67274, No. 333-99247 and No. 333-120959) of Lattice Semiconductor Corporation of our report dated March 15, 2005 relating to the financial statements, financial statement schedules, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PRICEWATERHOUSECOOPERS LLP

Portland, Oregon

March 15, 2005



Exhibit 31.1

CERTIFICATION

I, Cyrus Y. Tsui, certify that:

1.                 I have reviewed this annual report on Form 10-K of Lattice Semiconductor Corporation;

2.                 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.                 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.                 The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.                 The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 15, 2005

/s/ CYRUS Y. TSUI

 

Cyrus Y. Tsui

Chief Executive Officer

 



Exhibit 31.2

CERTIFICATION

I, Jan Johannessen, certify that:

1.                 I have reviewed this annual report on Form 10-K of Lattice Semiconductor Corporation;

2.                 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.                 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.                 The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.                 The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 15, 2005

/s/ JAN JOHANNESSEN

 

Jan Johannessen

Chief Financial Officer

 



Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Cyrus Y. Tsui, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Lattice Semiconductor Corporation on Form 10-K for the year ended December 31, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report fairly presents, in all material respects, the financial condition and results of operations of Lattice Semiconductor Corporation.

By:

/s/ CYRUS Y. TSUI

March 15, 2005

Name:

Cyrus Y. Tsui

 

Title:

Chief Executive Officer

 

I, Jan Johannessen, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Lattice Semiconductor Corporation on Form 10-K for the year ended December 31, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report fairly presents, in all material respects, the financial condition and results of operations of Lattice Semiconductor Corporation.

By:

/s/ JAN JOHANNESSEN

March 15, 2005

Name:

Jan Johannessen

 

Title:

Chief Financial Officer